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Microbial infection involves complex and dynamic interplay of host defense and
pathogen virulence pathways that requires new methods for mechanistic investigation.
Towards this goal, I have developed chemical reporters of nucleic acid and protein
synthesis and posttranslational modifications to explore their functions in bacterial
pathogenesis as well as basic biological pathways.
Initially, I developed amino acid chemical reporters that allow the cell-selective
labeling of bacterial proteomes to facilitate the analysis of bacterial protein expression
during infection of host cells. These reporters are based on unnatural amino acids that are
incorporated into the bacterial proteome instead of methionine or phenylalanine when
used in combination with mutant aminoacyl-tRNA-synthetases. This technology allows
the visualization of bacterial protein synthesis during infection as well as the enrichment,
identification and proteomic analysis of bacterial proteins from infected host cells.
Additionally, I developed a chemical reporter for the study of protein
AMPylation, a key posttranslational modification used by various bacterial pathogens to
rewire host-signaling pathways. This reporter is used by all of the known AMPylation
enzyme classes and allows the proteomic identification of enzyme-specific substrates in
cell lysates. This project also stimulated the development of a chemical reporter for RNA
synthesis, which in contrast to previous RNA reporters allows labeling of mRNA
polyadenylation tails.

In conclusion, I have developed chemical reporters for the cell selective labeling
of bacteria in the presence of mammalian cells, a chemical reporter for protein
AMPylation, and a chemical reporter for RNA synthesis and mRNA polyadenylation.
These reagents should help to identify bacterial proteins that are differentially expressed
during infection, new AMPylation substrates and the analysis of mRNA polyadenylation
dynamics in basic cell biology and microbial pathogenesis studies in the future.

Für meine Familie
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1

Introduction

The genomic revolution has offered unique opportunities to understand basic biology and
human disease. With increasingly high-throughput and cost-effective sequencing
methods, the genomes of many organisms and mutations associated with human diseases
have been annotated (Cooper & Shendure 2011). In parallel, large-scale gene deletion
and overexpression studies as well as protein-protein interaction screens have uncovered
complex signaling networks (S. J. Dixon et al. 2009; Choudhary & Mann 2010). These
studies have not only revealed the genetic basis for many fundamental biological
processes but have also presented new possibilities for personalized medicine.
Nonetheless, significant challenges lay ahead for translating genetically encoded
information into biological function and therapeutic development. Starting at the nucleic
acid level, many biological phenotypes are controlled by multiple genes that many not be
readily apparent by perturbation of individual genes or alleles. Furthermore, the
phenotype of interest may only be transient or controlled by epigenetic mechanisms not
evident by reading the genetic code (Goldberg et al. 2007; M. Guttman & Rinn 2012). To
complex matters further, the genome of most organisms encode protein and enzyme
families that exhibit overlapping biochemical activities and crosstalk (López-Otín &
Hunter 2010), which are regulated by specific interactions with other factors in time and
space inside of cells (Seet et al. 2006). Beyond nucleic acids and proteins, glycans, lipids
and other small molecule cofactors provide important regulators of cellular function by
direct modification of substrates (Walsh et al. 2005), which are directly coupled to
primary metabolism that has become increasing important in human disease (Vander
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Heiden et al. 2009). The resulting signaling pathways are therefore often not linear and
typically comprise more complex

Figure 1 Two-step labeling of biomolecules. a) Bioorthogonal chemical reporters and
chemoselective reactions allow covalent labeling of biomolecules with detection or
affinity tags for imaging or proteomics applications, respectively. b) Staudinger ligation
allows labeling of alkyl-azides with triarylphoshine reagents. c) Cu(I)-catalyzed
cycloaddition between alkyl-azides and terminal alkynes affords triazole adducts, which
can operate in both orientations. d) Activated cyclooctynes can react with alkyl-azides
for Cu-free labeling.

positive and negative feedback networks to amplify or shutdown cellular functions
(Nurse & Hayles 2011). These complex and regulated properties allow cells to response
to changes their environment and interact with other cells in higher organisms that can
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give rise to remarkably biological phenotypes but when misregulated can yield disease.
These biological challenges demand a better understanding of the chemistry inside cells
and animals that is ever changing in response to mutation and environmental cues. The
integration of intrinsic factors encoded within genomes with extrinsic factors in the
environment is therefore crucial and require new approaches to evaluate changes in
nucleic acid biosynthesis, protein turnover and modifications. As new technology has
accelerated the advances in genomics, here we highlight advances in bioorthogonal
chemical reporters that have enabled the imaging and functional analysis of nucleic acids,
proteins, glycans, lipids as well as other metabolites in biology.
The last decade has seen the remarkable development of highly selective chemical
reactions, which have allowed specific labeling of molecules in diverse biological
contexts (Fig. 1) (Prescher & Carolyn R Bertozzi 2005; Sletten & Carolyn R Bertozzi
2011). This two-step labeling and detection strategy involves metabolic or enzymatic
installation of a chemical reporter that can be selectively reacted with specifically
functionalized probes for the visualization or identification of target molecules (Fig. 1a).
Central to this chemical labeling strategy is the introduction of azide and alkyne groups
as abiotic, minimally perturbing functionalities onto small molecules and their selective
covalent reaction with activated phosphine-, alkyne- or azide-modified probes (Fig. 1).
Since these functional groups are foreign to living organisms and uniquely reactive with
each other, this class of chemical reactions has been described as bioorthogonal (Prescher
& Carolyn R Bertozzi 2005). The first example of these bioorthogonal reactions was the
Staudinger ligation introduced by the Bertozzi laboratory (Fig. 1b) (Saxon & C R
Bertozzi 2000). These studies demonstrated that alkyl-azides can react with ester-
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functionalized triphenylphosphine reagents to form covalent adducts in aqueous solution
and on the surface of mammalian cells (Saxon & C R Bertozzi 2000) as well as in living
animals (Prescher et al. 2004). Alternatively, the Sharpless and Meldal laboratories
showed that catalytic amounts of Cu(I) can accelerate the [3 + 2] cycloaddition of alkylazides with terminal alkynes to form stable triazole products (Fig. 1c)(Tornøe et al. 2002;
Rostovtsev et al. 2002a), which elaborates on thermal reactions originally described by
Huisgen and coworkers (Huisgen 1963). The Cu(I)-catalyzed azide-alkyne cycloaddition
(CuAAC, Figure 58) is highly chemoselective and represents the prototypic click
chemistry reaction, which is widely used in chemical synthesis and bioorthogonal
reactions since the azide and alkyne groups can be used in either orientation, are
relatively stable and readily accessible. Notably, the terminal alkyne is comparable in size
with the azide and when used as a primary chemical reporter in combination with azidefunctionalized probes provides the optimal signal-to-noise for bioorthogonal labeling
(Fig. 1c) (Speers & Cravatt 2004; Charron et al. 2009a). While the cytotoxicity of Cu(I)
can preclude in vivo applications, the development of activated cyclooctyne reagents has
circumvented this limitation and has enabled imaging of bioorthogonal chemical
reporters in living organisms (Fig. 1d) (Laughlin et al. 2008a; Laughlin & Carolyn R
Bertozzi 2009b).
The significant advances made in bioorthogonal chemistry have inspired a series
of azide- and alkyne-functionalized chemical reporters as molecular global positioning
systems for nucleic acid and protein synthesis as well as other biomolecules. Key to this
bioorthogonal labeling strategy is the ability of native or engineered enzymes to accept
azide or alkyne-functionalized chemical reporters. Provided the activity and selectivity of
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the enzymes are not significantly altered by chemical reporters, this approach allows the
visualization and biochemical analysis of endogenous biomolecules. This approach
provides several important advantages for biological applications. First, the separation of
metabolic or enzymatic incorporation and detection decouples sterically-demanding
fluorophores or affinity tags, which often interfere with biological activity, from
enzymatically processed metabolites. Secondly, in comparison to protein-based reagents
(e.g. antibodies), bioorthogonal chemical reporters provide direct detection of the
modified substrates and are relative independent of adjacent functional groups, which
may confound the specificity of protein reagents. Lastly, the ability to pulse-label specific
populations of molecules in cells with bioorthogonal chemical reporters provides an
important means to monitor dynamics akin to classic radioactive tracers, but provides
much more sensitive detection and allows the identification of labeled targets. Since
newly synthesized molecules can be easily separated from the steady state population in
this manner, chemical reporters are excellent tools for monitoring the dynamics of
biomolecules in response to extrinsic stimuli. Bioorthogonal chemistry has also
facilitated the analysis of small molecule inhibitor interactions with proteins for
biochemical target identification and activity-based protein profiling, which is beyond the
scope of this review and summarized elsewhere (Nomura et al. 2010). Herein we will
review the currently available chemical reporters and highlight how they can be applied
to monitor temporal changes in cellular activity (Fig. 2a), profile different cell types,
states or mutations (Fig. 2b) and identify targets of specific enzymes in vitro (Fig. 2c).
We close with an outlook on future developments that should expand the utility of
bioorthogonal chemical reporters in even more complex biological settings in vivo.
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Figure 2 Chemical reporters can be used for comparative analysis in vivo and in vitro. a)
Pulse-labeling of isolated cells or organisms with a chemical reporter leads to the
metabolic incorporation of the reporter into a defined biomolecule population. Chasing
this population with the native metabolites or differentially labeled reporter enables the
monitoring of specific turnover rates. b) Pulse-labeling of two distinct cellular
populations or organisms allows the comparative analysis of their metabolically labeled
biomolecule pools. c) The application of chemical reporters in cell lysates, with purified
substrates, or in combination with substrate arrays allows for enzyme-specific substrate
detection.
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1.1

Bioorthogonal chemical reporters for nucleic acid turnover and modifications

Gene expression arrays and deep-sequencing methods provide important profiles of
steady state DNA and RNA expression, but understanding the rate of nucleic acid
synthesis, degradation and modification is crucial for elucidating their function in
different biological contexts. The modification of nucleosides with alkynes has afforded
bioorthogonal chemical reporters of DNA and RNA synthesis. For example, Salic and
coworkers have demonstrated that 5-ethynyl-2’-deoxyuridine (EdU) (Salic & Mitchison
2008) and 5-ethynyluridine (EU) (Jao & Salic 2008) can be metabolized by mammalian
cells and incorporated into DNA and RNA for bioorthogonal detection and pulse-chase
experiments, respectively (Fig. 3a,b). These nucleic acid reporters function in animals
and provide sensitive reagents to compare DNA and RNA turnover in different tissues
using fluorescence. More recently, fluorinated arabinosyl-EdU has also been developed
to improve the sensitivity of DNA labeling with reduced cytotoxicity compared to EdU
(Fig. 3c) (Neef & Luedtke 2011). In addition to uridine derivatives, 5-ethynyl-2’deoxycytosine (EdC) (Guan et al. 2011) and N-6-propargyladenosine (N6pA) (Grammel
et al. 2012) can be utilized by mammalian cells to label DNA and RNA, respectively
(Fig. 3d,e). In addition, N6pA labeling allows the pulse-chase analysis of RNA
polyadenylation. Alternatively, He and coworkers have employed a specific
glycosyltransferase to install 6-azido-glucose onto 5-hydroxymethylcytosine (5-hmc)
marks in DNA for subsequent bioorthogonal detection (Fig. 3f) (C.-X. Song et al. 2011).
This chemoenzymatic bioorthogonal detection of 5-hmc has provided an important
method for characterizing the mechanism of DNA oxidation and demethylation catalyzed
by Tet1-3 proteins in eukaryotic cells (He et al. 2011; Ito et al. 2011). As the turnover and
modification of nucleic acids is becoming increasingly relevant in dissecting epigenetic
7

mechanisms, these nucleic acid chemical reporters will likely become more widely used
in biology.
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Figure 3 Chemical reporters for nucleic acid synthesis and modifications. a) 5-ethynyl2’-deoxyuridine (EdU) is incorporated into DNA. b) 5-ethynyluridine (EU) is
incorporated into RNA. c) 5-ethynyl-2’-deoxyfluorouridine (F-ara-EdU) is incorporated
in to DNA. d) 5-ethynyl-2’-deoxycytosine (EdC) in incorporated into DNA. e) N-6propargyladenosine (N6pA) is incorporated into RNA and into mRNA polyadenylation
tails. f) The DNA modification 5-hydroxymethylcytosine (5-hmc) can be enzymatically
labeled with 6-azido-glucose for subsequent bioorthogonal detection.

1.2

Bioorthogonal chemical reporters for protein turnover

Azide- and alkyne-bearing amino acids allow the co-translational labeling of newly
synthesized proteins and provide a direct measure of the translational activity in cells
(Fig. 4). Two strategies for unnatural amino acid incorporation have been developed that
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enable site-specific or residue-specific labeling of proteins. The site-specific approach
pioneered by the Schultz laboratory allows the incorporation of an unnatural amino acid
at a predetermined position in a protein of interest using amber suppression (C.-X. Song
et al. 2011). This technique is based on engineering an orthogonal triad of tRNA,
aminoacyl-tRNA-synthetase (aaRS) and unnatural amino acid, which allows the sitespecific installation of azide- and alkyne amino acids on individual proteins in bacteria,
yeast and mammalian cells (C. C. Liu & P. G. Schultz 2010). For example, the
pyrrolysine (Pyl) system has been particularly useful for site-specific incorporation of
amino acid reporters such as PCL (Hancock et al. 2010) or ACPK (S. Lin et al. 2011)
(Fig. 4a). For the global analysis of translation, the Tirrell laboratory has developed
residue-selective

incorporation

of

azide

and

alkyne

amino

acids

such

as

azidohomoalanine (AHA) and homopropargylglycine (HPG) that substitute for
methionine (Met) in newly synthesized proteins (Fig. 4b) (Johnson et al. 2010). AHA and
HPG are readily taken up and utilized by the wild type methionyl-tRNA-synthetase
(metRS) in prokaryotic and eukaryotic cells, which enables the analysis of newly
synthesized proteins by bioorthogonal labeling with fluorescence and affinity probes. The
availability of two uniquely reactive orientations (azide versus alkyne) also makes it
possible to label and visualize two distinct protein populations with AHA and HPG,
respectively (L. Wang & P. G. Schultz 2004; C. C. Liu & P. G. Schultz 2010). In contrast
to metabolic labeling with isotopically labeled amino acids, AHA and HPG labeled
proteins can be bioorthogonally reacted with affinity tags and selectively recovered from
total cell lysates for mass spectrometry-based protein identification using gel-based
methods or multi-dimensional protein identification technology (MudPIT) (Beatty &
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Tirrell 2008). Quantitative elution of selectively captured proteins can be challenging
using biotinylated affinity tags and streptavidin beads due to the strength of this
interaction (KD ~ 10-15), thus several cleavable linker systems (disulfide (Nessen et al.
2009), acid-sensitive (Szychowski et al. 2010), azobenzenes (Y.-Y. Yang, Grammel, et
al. 2010), and proteolytic cleavage sites (Speers & Cravatt 2005)) have been developed to
facilitate protein elution and bioorthogonal chemical proteomics applications.
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Figure 4 Amino acid reporters can co-translationally incorporated into proteins. a)
Analogs of the amino acid pyrrolysine (Pyl) with alkyne (N -[(2-propynyloxy)carbonyl]ε

lysine, PCL) or azide (azido-cyclopentyl-carboxy-lysine, APCK) groups can be siteselectively incorporated into individual proteins through the expression of orthogonal
aminoacyl-tRNA-synthetase and tRNA. b) Various analogs of the amino acid methionine
(Met) can be selectively incorporated instead of Met throughout the bacterial or
mammalian proteome to install an alkyne (homopropargylglycine, HPG) or azide
(azidohomoalanine, AHA) group. c) O-propargyl-puromycin (OP-puro) covalently labels
the C-terminus of nascent peptides.
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The ability to differentiate newly synthesized from pre-existing proteins with
AHA and HPG has revealed important biological insights. For example, Henikoff and
colleagues have used AHA pulse labeling for enrichment of newly synthesized
nucleosomes (Deal et al. 2010). It is generally appreciated that nucleosome turnover
erases histone marks and serves as an important epigenetic mechanism (S. Henikoff
2008). Previous studies measured histone H3.3 incorporation as a surrogate for
nucleosome turnover or used overexpressed histone transgenes to follow nucleosome
dynamics (Mito et al. 2005; Dion et al. 2007). In contrast, AHA allows pulse labeling of
endogenous histones and provides an affinity handle for enrichment and subsequent
analysis of nucleosome-associated DNA with tiling arrays. This approach, termed
CATCH-IT by the authors, provides better temporal resolution compared to previous
histone replacement methods and revealed more rapid turnover of nucleosomes at active
genes, specific epigenetic marks and replication origins (Deal et al. 2010). Dynamic
protein synthesis is also particularly important in neurons, as localized translation is
believed to shape axon growth, guidance and regeneration in the brain for synaptic
plasticity and memory (Gkogkas et al. 2010; Jung et al. 2011). To explore these issues,
Schuman and colleagues have used AHA and HPG labeling to visualize specific sites and
measure rates of protein synthesis in primary neurons after bioorthogonal labeling with
fluorescent dyes and quantum dots (Dieterich et al. 2010). Another application of AHA
labeling in primary neuronal cultures revealed localized protein synthesis adjacent to the
transmembrane receptor DCC (Tcherkezian et al. 2010). These studies show how
bioorthogonal amino acid reporters provide valuable tools for monitoring discrete protein
populations and imaging protein synthesis at high resolution.
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1.2.1 Cell-selective labeling of proteomes.
Studying cells in their native environment and in interaction with other cell types is
crucial in many areas of biology. Methods for cell-selective proteome labeling would
therefore be valuable for dissecting the activity of heterogeneous cell populations. While
AHA and HPG do not provide a means to separate proteomes of individual cell types,
Tirrell and colleagues have identified a number of metRS mutants (metRS*) that
facilitate the incorporation of the otherwise translationally inactive amino acid reporters
such as azidonorleucine (ANL) (Fig. 5a) (Link et al. 2006; Tanrikulu et al. 2009). Since
ANL incorporation is dependent on metRS* activity, ANL can be selectively directed to
certain cell types by expression of metRS* (Ngo et al. 2009). For example, bacterial cells
expressing metRS* can be selectively labeled with ANL in the presence of mammalian
cells (Ngo et al. 2009). To differentiate bacterial proteins from host proteins during
infection, our laboratory developed 2-aminooctynoic acid (AOA) (Fig. 5a), which is also
activated by metRS* to label the Gram-negative bacterial pathogen Salmonella
typhimurium inside murine macrophages (Grammel et al. 2010). AOA appears to provide
better signal-to-noise than ANL and enables the proteomic identification of endogenously
expressed S. typhimurium proteins during infection (Fig. 5b) (Grammel et al. 2010). In
addition to these Met reporters, an alkyne phenylalanine (Phe) analog, paraethynylphenylalanine (PEP) (Fig. 5c) can also function as a cell-selective amino acid
reporter in combination with a phenylalanine-tRNA-synthetase mutant (A294G of pheS)
(Grammel et al. 2012). Amino acids such as Phe are present in higher frequencies than
Met and the possible combination of these reporters may allow greater coverage of
proteomes or even selective labeling of two different proteomes. An extension of these
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strategies and especially translation to eukaryotic systems might allow selective labeling
of individual cell types in multicellular organisms in the future.
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Figure 5 Cell selective proteome labeling with engineered tRNA synthetases. a)
Engineered methionyl-tRNA-synthetase reporters: azidonorleucine (ANL) and 2aminooctynoic acid (AOA). b) para-ethynylphenylalanine (PEP) can be incorporated
residue-selectively instead of the amino acid phenylalanine (Phe) through the expression
of an engineered phenylalanyl-tRNA-synthetase. c) The expression of engineered tRNA
synthetases allows the selective incorporation of the bioorthogonal amino acid reporters
ANL, AOA or PEP into bacterial proteomes during infection – alkynyl reporter is shown.

1.2.2 Bioorthogonal labeling and capture of nascent polypeptides.
Notwithstanding the advances made possible with amino acid reporters, some limitations
should be noted. First and foremost, the global replacement of natural amino acids with
unnatural counterparts might destabilize proteins and interfere with activity. Short pulselabeling periods can minimize this issue and prevent toxicity effects. Secondly, the Met
and Phe amino acid reporter incorporation is proportional to the number of residues per
protein, which could misrepresent the abundance of proteins. To address these issues,
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Salic and colleagues have shown that O-propargyl-puromycin (OP-puro) (Fig. 4c), an
alkyne analog of the covalent translational inhibitor puromycin, can be used to label
nascent polypeptide chains in mammalian cell culture as well as in mice (J. Liu et al.
2012). OP-puro labeled proteins can be imaged by fluorescence microscopy and captured
to retrieve nascent polypeptide chains. In contrast to amino acid reporters, which are
incorporated into the proteome with a certain bias, exactly one OP-puro is attached to
each nascent polypeptide, an important feature for comparative proteomic studies. It
should be noted that OP-puro-protein conjugates are rapidly degraded by the proteosome
(J. Liu et al. 2012), a fact to be considered for future proteomic studies. Collectively,
these bioorthogonal protein synthesis reporters have provided more sensitive methods for
monitoring protein dynamics and have already revealed important biological
mechanisms, which should complement recent large-scale ribosome profiling methods
(Ingolia et al. 2011; Heiman et al. 2008).
1.3

Bioorthogonal chemical reporters for posttranslational modifications

In addition to nucleic acid and protein synthesis, bioorthogonal chemical reporters have
been developed for diverse posttranslational modifications (PTMs) in bacteria,
eukaryotes and plants (Fig. 6-8).
1.3.1 Glycosylation.
The covalent modification of proteins with mono or oligosaccharides is one of the most
ubiquitous and most complex forms of PTMs in biology (Varki 1999). Glycoproteins
decorate the exterior of eukaryotic cells and mediate a wide range of interactions with
soluble extracellular factors, neighboring cells and microbes. Additionally, glycosylation
plays an important role inside cells by regulating protein trafficking, turnover and signal
14
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transduction. Indeed, the complex roles of glycans and the challenges associated with
their detection and synthesis was a major driving force for the development of
bioorthogonal ligation reactions (Prescher & Carolyn R Bertozzi 2006; C R Bertozzi &
Kiessling 2001). The Staudinger ligation reaction and the first azide monosaccharide
reporter, N-azidoacetyl-D-mannosamine (ManNAz, Fig. 6a) was developed in the context
of monitoring cell surface sialic acid-containing glycans (Saxon & C R Bertozzi 2000).
This landmark study has spurred the development of many bioorthogonal chemical
reporters highlighted in this review and in particular other azide- and alkynefunctionalized monosaccharides for sialic acid glycoconjugates (Chang et al. 2009;
Luchansky et al. 2004), mucin-type O-linked glycoproteins (Fig. 6b) (Hang et al. 2003;
Zaro, Bateman, et al. 2011), fucosylated glycans (Fig. 6c) (Rabuka et al. 2006; Sawa et
al. 2006), and intracellular O-GlcNAc modified proteins (Fig. 6d) (Khidekel et al. 2003;
Vocadlo et al. 2003; Zaro, Y.-Y. Yang, et al. 2011), which have improved the detection
and proteomic analysis of these glycoprotein families (Zaro, Y.-Y. Yang, et al. 2011;
Hanson et al. 2007). In addition to profiling glycoproteins, the metabolic incorporation of
chemical reporters into cell surface glycans can be used to select cell populations with
aberrant glycosylation levels (Yarema et al. 2001). An early example of this strategy
using a ketone-functionalized sialic acid precursor and hydrazide labeling revealed
mutations in glycan biosynthetic enzymes associated with congenital human diseases
such as sialuria (Yarema et al. 2001). Remarkably, these glycan reporters in combination
with activated cyclooctyne probes have now enabled the dynamic imaging of cell surface
glycans in live developing zebrafish embryos and in worms (Laughlin & Carolyn R
Bertozzi 2009a; Laughlin et al. 2008b), which opens the door for differential analysis of
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glycan biosynthesis in specific tissues and cell types in vivo. Beyond eukaryotes, glycan
chemical reporters have also been incorporated into bacteria such as Campylobacter
jejuni (F. Liu et al. 2009), Helicobacter pylori (Koenigs et al. 2009) and Escherichia coli
(Dumont et al. 2012) as well as plants (Anderson et al. 2012).
Metabolic and chemoenzymatic chemical reporters are providing new insight into
O-GlcNAc modification of cytoplasmic and nuclear proteins. The discovery of GlcNAc
on serine (Ser) and threonine (Thr) residues was unexpected, but this dynamic and
regulated PTM is emerging as an important sensor of metabolic state of cells and is
associated with diseases such as diabetes, neurodegeneration and cancer (Hart et al.
2011). Initial studies demonstrated that chemical reporter GlcNAz could be utilized by the
hexosamine salvage pathway and incorporated into O-GlcNAc modified proteins in
mammalian cells (Vocadlo et al. 2003) and even be used for proteomic studies (Sprung et
al. 2005). More recently, an alkyne-modified GlcNAc analog (GlcNAlk, Fig. 6d) has
enabled more sensitive bioorthogonal detection as well as greater proteomic coverage and
uncovered glycosylation of the E3 ubiquitin ligase NEDD4 (Zaro, Y.-Y. Yang, et al.
2011). Alternatively, Hsieh-Wilson and colleagues have developed a chemoenzymatic
method that allows labeling of O-GlcNAc modified proteins in tissue/cell lysates with a
ketone (Khidekel et al. 2003) or azide (Clark et al. 2008) group using an engineered beta1,4-galactosyltransferase (Fig. 6e). The tagged O-GlcNAc-modified proteins can then be
evaluated by fluorescence (Clark et al. 2008), mass-shift western blotting (Rexach et al.
2010) and quantitative proteomic s(Khidekel et al. 2007), which has revealed differential
dynamics of O-GlcNAc modified proteins in neurons and O-GlcNAc regulation of
CREB-mediated gene expression in vivo (Rexach et al. 2012). Beyond these studies,
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azide- and alkyne sugar nucleotide reporters have also been useful for in vitro profiling
glycosyltransferase substrate specificities (Pratt et al. 2004) as well as in vivo imaging of
glycans (T. Zheng et al. 2011; Baskin et al. 2010). These studies highlight the utility of
bioorthogonal chemical reporters for monitoring glycan biosynthesis, glycoproteomics
and in vivo imaging of glycans in model organisms.
1.3.2 Lipidation.
Lipid modifications of proteins modulate their membrane affinity, localization and
trafficking for cell signaling (Resh 2006). Even though some forms of protein lipidation
can now be predicted based on conserved amino acid motifs (Resh 2006), direct
biochemical detection of lipidated proteins is still required for functional studies,
discovery of unannotated substrates and novel types of lipidation. For example, Sfarnesylation or geranylgeranylation of cysteine (Cys) residues on the C-terminus of
proteins can be predicted by bioinformatics based on conserved CaaX or CC motifs
(Resh 2006), respectively. However, biochemical detection of S-prenylation is still
crucial since many of these lipidated proteins are small GTPases (e.g. K/H/N-Ras) that
control cell signaling and when mutated are major drivers of oncogenesis (Karnoub &
Weinberg 2008). The corresponding prenyltransferases are thus active targets of drug
development for cancer and other human diseases (Berndt et al. 2011; Meta et al. 2006).
To this end, azide(Kho et al. 2004) and alkyne (Charron et al. 2011; DeGraw et al. 2010)
isoprenoid reporters have been developed that allow bioorthogonal detection and
proteomic analysis S-prenylated proteins in mammalian cells. Interestingly, our
proteomic analysis of alkyne-farnesol (alk-FOH) (Fig. 7a) modified proteins in
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Figure 7 Different forms of protein lipidation can be analyzed with chemical
reporters. a) Alk-FOH allows metabolic labeling of S-farnesylated and Sgeranylgeranylated proteins in mammalian cells. b) und c) Alkynyl-fatty acid
reporters of different chain length enable selective metabolic labeling of Nmyristoylated or S-palmitoylated proteins. d) An azide analog of cholesterol can
be metabolically incorporated onto the C-terminus of sonic hedgehog. e) Alkynylfatty acid reporters can also be metabolically incorporated into bacterial
lipoproteins. f) The azido-decanoic acid can function as a substrate for lipoic acid
ligase (LplA) for sequence-specific tagging of proteins.
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Protein

macrophages has enabled large-scale profiling of S-prenylated proteins and revealed
isoform-specific S-farnesylation of zinc-finger antiviral protein (ZAP) is crucial for the
membrane targeting and antiviral activity of this interferon-induced effector (Charron G
et al submitted).
Azide and alkyne fatty acids are also utilized by native enzymes in bacteria and
eukaryotes(Hang et al. 2011). Myristoylation of N-terminal glycine (Gly) residues by Nmyristoyltransferases that occurs primarily cotranslationally (Farazi et al. 2001), is
readily labeled and visualized by myristic acid reporters in mammalian cells (Fig. 7b)
(Hang et al. 2007; Charron et al. 2009a; D. D. O. Martin et al. 2008). In contrast to Nmyristoylation, which is stable and constitutive, the S-palmitoylation of Cys residues can
be reversible, regulated by a family of DHHC-palmitoyltransferases (DHHC-PATs), not
readily predicted by primary amino acid sequence and particularly challenging to
biochemical analyze (Linder & Deschenes 2007). Metabolic labeling with alkyne
palmitic acid reporters (Fig. 7c) in combination with bioorthogonal detection by our
laboratory (Charron et al. 2009a) and others (B. R. Martin & Cravatt 2009; Hannoush &
Arenas-Ramirez 2009; Yap et al. 2010) has largely solved this problem, enabling
fluorescence visualization and proteomic analysis of S-palmitoylated proteins (B. R.
Martin & Cravatt 2009; B. R. Martin et al. 2011; J. P. Wilson et al. 2011; Yount et al.
2010). Notably, bioorthogonal palmitoylome profiling and hydroxylamine-mediated acyl
biotin exchange (ABE) proteomics (Wan et al. 2007; Roth et al. 2006) has significantly
increased the diversity of S-palmitoylated proteins in eukaryotes (Hang & Linder 2011)
and even revealed new fatty-acylated proteins in innate immunity (Yount et al. 2010) and
neuronal activity (Kang et al. 2008). In addition to lipidation of cytoplasmic proteins,
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secreted proteins are also lipid-modified and readily labeled by chemical reporters as
highlighted by fatty acid and cholesterol reporter labeling of Wnt (Gao et al. 2011) and
sonic hedgehog proteins (Fig. 7d) (Heal et al. 2011), respectively. It should be noted that
bioorthogonal chemical reporters have also been developed for monitoring the
metabolism and trafficking of free, unconjugated lipids in mammalian cells (Neef &
Carsten Schultz 2009; Milne et al. 2010).
Bioorthogonal lipid reporters have been especially useful for monitoring protein
S-palmitoylation dynamics. For instance, tandem pulse-chase labeling of T cells with
protein synthesis and palmitoylation reporters provides a robust method for quantifying
S-acylation dynamics relative to protein turnover, which revealed accelerated
depalmitoylation of signaling kinases such as Lck upon T cell activation (M. M. Zhang et
al. 2010). In addition, the large-scale analysis of S-palmitoylation dynamics using
bioorthogonal labeling and SILAC showed that many proteins are stably fatty-acylated
while other proteins involved in cell signaling undergo rapid S-acylation cycles (B. R.
Martin et al. 2011). To understand how specific S-palmitoylated proteins are regulated,
our laboratory has employed palmitate chemical reporters in the model system
Schizosaccharomyces pombe (fission yeast) to evaluate the distinct functions of different
DHHC-PATs. Through pulse labeling of synchronized cell populations and proteomic
analysis of wild type and mutant S. pombe strains, we have discovered that the regulated
expression of a single DHHC-PAT can control S-palmitoylation of specific protein
substrates, cell signaling and ultimately the ability of fission yeast to undergo meiosis or
cellular differentiation (Mingzi M Zhang n.d.). These early applications of bioorthogonal
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lipid reporters are beginning to reveal the differential modification of S-palmitoylated
proteins and their mechanisms of regulation as well as their impact on cellular function.
Lipid reporters also allow labeling of bacterial proteins and sequence-specific
tagging of engineered proteins. Protein lipidation in bacteria involves the installation of a
diacylglyceryl group onto N-terminal Cys residue within a well-defined lipobox-motif
(Sankaran & Wu 1994). Although algorithms are available for the prediction of canonical
bacterial lipoproteins(Babu et al. 2006), the majority of lipidated proteins in bacteria are
poorly characterized and may exist in other forms. For example, the E. coli protein toxin
hemolysin is activated through fatty-acylation of a lysine (Lys) residue (Issartel et al.
1991). In this regard, the application of fatty acid reporters to bacteria allows both the
rapid profiling of canonical bacterial lipoproteins as well as the discovery of
unconventionally lipidated proteins in bacteria (Fig. 7e) (Rangan et al. 2010). In addition
to fatty acids, phosphopantetheinyl reporters can be directly transferred onto bacterial
proteins involved in polyketide biosynthesis (Mercer et al. 2009). For protein tagging
applications, these lipid reporters also allows site-specific labeling of recombinant
proteins containing N-myristoylation and S-prenylation motifs by co-expression of the
associated lipid transferases in bacteria (Heal et al. 2008; Gauchet et al. 2006; Wollack et
al. 2009; Yi et al. 2010). Alternatively, lipoic acid ligase tagging has been developed for
sequence-specific tagging of proteins in mammalian cells for fluorescence imaging
applications (Fig. 7f) (Yao et al. 2012; Uttamapinant et al. 2010). As specific antibodies
for lipid modifications have been difficult to generate, bioorthogonal chemical reporters
have been valuable for the detection and discovery of lipidated proteins, analysis of
lipidation dynamics and regulation as well as protein engineering (Hang et al. 2011).
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1.3.3 Acetylation.
Protein acetylation of Lys residues plays important roles in epigenetic regulation of
transcription, signaling and metabolism (X.-J. Yang & Seto 2008; Kouzarides 2007).
With the explosion of Lys acetylated proteins from recent proteomic studies in
mammalian cells and bacteria (Choudhary et al. 2009; Q. Wang, Y. Zhang, et al. 2010),
unraveling what substrates are regulated by specific Lys acetyltransferases (KATs) and
deacetylases (KDACs) in various signaling pathways is a major challenge. In this regard,
alkyne analogs of acetate and acetyl-CoA such as 4-pentynoate and 4-pentynoyl-CoA can
function as chemical reporters of Lys acetylation in cells and in vitro, respectively (Fig.
8a) (Hang & Linder 2011). Metabolic labeling of mammalian cells with 4-pentynoate
readily labels known Lys acetylated proteins such as histones, which allows simple
fluorescence profiling of acetylated proteins in different cell types (Y.-Y. Yang, Ascano
& Hang 2010). In addition, 4-pentynoyl-CoA is utilized by the KAT p300 for in vitro
bioorthogonal profiling of candidate protein substrates in cell lysates (Y.-Y. Yang,
Ascano & Hang 2010). As acetylation also occurs on the N-terminus of
proteins(Polevoda & Sherman 2003) and Ser/Thr residues (Mukherjee et al. 2007),
acetylation reporters should also facilitate the analysis of these modifications and their
associated enzymes. Other forms of Lys acylation such as propionylation, butrylation,
malonylation, succinylation and crotylation have also been reported (M. Tan et al. 2011;
Z. Zhang et al. 2011; Chen et al. 2007; Du et al. 2011), which may also benefit from
specific bioorthogonal reporters or labeling strategies in the future.
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Figure 8 Many posttranslational modifications can be analyzed with cofactor
analogs or selective chemical modification reagents. a) Sodium-4-pentynoate
allows metabolic labeling of acetylated proteins, while 4-pentynoyl-CoA can be
used for in vitro analysis of acetyltransferase substrates. b) Numerous S-adenosylL-methionine

reporters have been developed (AdoEnYn, Hey-SAM, Pob-SAM),

whose extended side chains are transferred by protein methyltransferases onto
their native substrates. c) 6-alkynyl-NAD is a chemical reporter for ADP-mono
and poly-ribosylation. d) N6pATP serves as a chemical reporter for protein
AMPylation. e) N6benzyl-ATPγS serves as a substrate for engineered kinases and
allows chemical substrate modification with a nitrobenzyl-hapten for antibody
detection. f) The oxidative modification of cysteines to sulfenic acid can be
monitored by reaction with an alkynyl-dimedone reagent for subsequent
bioorthogonal detection of protein sulfenation.

25

Figure 8
a

NH2
N

Acetylation

O
O

H
N

S

O

ONa

OH

H
N

sodium 4-pentynoate

O

O
O
O P O P O
O
O

b
Methylation

N
N

H2N

N

N

S

O

NH2

N

N

H2N

O
COOH

S

NH2
N

N
N

COOH

N

N

H2N

O

N

S
O
COOH

OH OH

OH OH

AdoEnYn

N

O

O
OH
O P O
O

4-pentynoyl-CoA

NH2

N

N

OH OH

Hey-SAM

c

Pob-SAM

O

NH

HN

N

N
N

AMPylation

ADP-Ribosylation

d
NH2
O
O
O P O P O
O
O

N
O

N
O

N
O
O
O
O P O P O P O
O
O
O

OH OH

OH OH

N

N
N

O
OH OH

N6pATP

6-alkynyl-NAD

Phosphorylation

e
NH
N

N
O
O
O
S P O P O P O
O
O
O

N

O2N

O2N

OH

O
S

Protein

N

O

O

engineered
kinase

OH OH

S
O

thiol
alkylation

Protein
semisythetic hapten

N6benzyl-ATP!S

f
Oxidation

O
SH

H2O2

S

O

OH
O

Protein

Protein

O
P
O

oxidation

S
O

Protein

alkynyl-dimedone
sulfenation

alkynyl-dimedone Cys adduct

26

1.3.4 Methylation.
The modification of Lys or arginine (Arg) residues with one or more methyl groups is a
common PTM in epigenetics and various signaling pathways (Y.-Y. Yang et al. 2011).
The general cofactor for nearly all cellular methylation reactions is S-adenosyl-Lmethionine (AdoMet or SAM), from which the methyl group is transferred onto proteins,
nucleic acids or other substrates. The development of bioorthogonal methylation
reporters has therefore attracted considerable interest by many groups.

Initially,

Weinhold and colleagues demonstrated that various DNA methyltransferases are able to
transfer allylic or propargylic groups from SAM reporters onto DNA substrates (Bedford
& Clarke 2009; Rathert et al. 2008). The authors hypothesized that the improved
reactivity of these reagents could be explained by the conjugative stabilization of the
forming p orbital on the reactive carbon during the SN2-reaction. This observation was
instrumental in the development of the first alkyne SAM reporter for site-selective
labeling of protein methyltransferase substrates such as histone H3 (AdoEnYn) (Fig. 8b)
(Dalhoff et al. 2006). AdoEnYn possesses an extended unsaturated pentameric side chain,
with a double bond in the β-position relative to the sulfonium center and a terminal
alkyne group. A suite of additional AdoMet reporters capable of labeling Lys and Arg
methyltransferase substrates with terminal alkyne groups was subsequently reported (W.
Peters et al. 2010). A propargyl AdoMet reporter with the smallest alkyne substituent was
utilized by the Lys methyltransferase SETDB1 but unfortunately not active with other
tested methyltransferases such as SET7, PRMT1, PRDM8 (Binda et al. 2011; R. Wang,
W. Zheng, et al. 2011; Islam et al. 2011). Alternatively, Luo and colleagues have
identified protein methyltransferase mutants that can utilize other SAM chemical
reporters. After screening a small panel of cofactor analogs against a series of active site
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methyltransferase mutants, a G9a mutant that is able to accept (E)-hex-2-en-5-ynyl-SAM
(Hey-SAM) and modify recombinant histone H3 was identified (Fig. 8b) (Binda et al.
2011). In addition to Lys methyltransferases, a double mutant of protein Arg
methyltransferase PRMT1 that can utilize 4-propargyloxy-but-2-enyl-SAM (Pob-SAM)
was developed (Fig. 8b) (Islam et al. 2011). Interestingly, when added to cell lysates, the
double mutant of PRMT1 in combination with Pob-SAM specifically labeled a number of
proteins. In both cases the most active SAM reporters carried an β-unsaturation
consistent with the studies by Weinhold and coworkers. This approach in combination
with mass spectrometry-based protein identification should facilitate the identification of
specific methyltransferase substrates in the future.
1.3.5 ADP-Ribosylation.
Proteins can be reversibly modified with mono-ADP-ribose on a range of different
residues (R. Wang, W. Zheng, et al. 2011). This modification was initially described as
the virulence mechanism for a number of different bacterial toxins, but is now
appreciated as a common PTM with many important biological functions in eukaryotes as
well (Hottiger et al. 2010; Hassa et al. 2006). Protein mono-ADP-ribosylation is carried
out by a diverse set of mono-ADP-ribosyltransferases (MARTs) that require the cofactor
nicotinamide adenine dinucleotide (NAD), from which the ADP-ribose moiety is
transferred onto the protein substrate. Additionally, in eukaryotes the ADP-ribose
modification can be extended by addition of ADP-ribosyl groups to the 2’-OH of the
ribose moieties to form poly-ADP-ribosylated proteins. This modification is carried out
by poly-ADP-ribosylpolymerases (PARPs) that also use NAD as donor for the ADPribosyl group. The growing list of ADP-ribosylation substrates and potential new
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ribosylation enzyme classes has motivated the development of ADP-ribosylation
reporters for substrate detection and identification (Hassa et al. 2006). Lin and colleagues
initially generated 8-alkyne-NAD and 6-alkyne-NAD (Fig. 8c) and showed that both of
these chemical reporters are accepted by diphteria toxin (DT), a well-characterized
MART that modifies elongation factor eEF-233. The analysis of these chemical reporters
with PARPs, PARP-1 and Tankyrase-1, revealed 6-alkyne-NAD was most effective for
monitoring the modification of p53 and TRF-1, respectively (Du et al. 2009; Jiang et al.
2010). Incubation of cell lysates with recombinant PARP-1 and 6-alkyne-NAD enabled
bioorthogonal detection and identified of poly-ADP-ribosylated proteins, demonstrating
the utility of these reagents for ADP-ribosylation analysis.
1.3.6 AMPylation.
Though originally discovered in the context of glutamine synthetase regulation in E. coli
(Jiang et al. 2010), AMPylation (adenylylation) has become more widely appreciated
since the discovery of secreted bacterial effector enzymes that modify host small
GTPases during infection (Kingdon et al. 1967, Woolery et al. 2010). AMPylation
describes the enzymatic transfer of an adenosine monophosphate (AMP) from ATP onto
hydroxyl protein side chains under the formation of a phosphodiester bond. The
conserved protein domains (fic domain, adenylyl transferase domain) responsible for the
AMPylation activity are widely present among prokaryotes and eukaryotes, suggesting a
ubiquitous role for this PTM (Yarbrough et al. 2009; Worby et al. 2009; Müller et al.
2010). Recent studies have also revealed specific phosphoesterases that can remove the
AMP moiety suggesting that this modification can be dynamic and regulated (Kinch et al.
2009). The re-emergence and prevalence of potential AMPylation enzymes has motivated
29

the development of specific antibodies (Hao et al. 2011), mass spectrometry detection
methods (Li et al. 2011) as well as an bioorthogonal AMPylation reporter from our
laboratory. Modification of ATP at the N6-position with a propargyl group provides an
alkyne-decorated AMPylation reporter (N6pATP) (Fig. 8d) that can be enzymatically
transferred onto specific sites of cognate protein substrates by all known classes of
AMPylation enzymes (Yan Li et al. 2011). Furthermore, N6pATP can be used to
proteomically identify AMPylation substrates at endogenous levels in cell lysates
(Grammel et al. 2011), which should facilitate the characterization of AMPylated
proteins in diverse organisms.
1.3.7 Phosphorylation.
The reversible addition of phosphate onto Ser, Thr or tyrosine (Tyr) residues on proteins
are perhaps the best studied PTMs (Pawson & Scott 2005; Tarrant & Cole 2009), for
which

specific

antibodies

and

quantitative

proteomic

methods

have

been

developed(Macek et al. 2009). Nonetheless, the large number of phosphoproteins and
regulatory enzymes (kinases and phosphatases) with potential overlapping biochemical
activity makes dissecting phosphorylation-dependent signaling pathways still very
challenging. Robust biochemical methods for directly monitoring enzyme-specific
phosphorylation events are desirable. The identification of adenosine triphosphate (ATP)
analogs that can be utilized by engineered kinase mutants by Shokat and coworkers has
been instrumental in breaking the degeneracy of kinase activities and allowed the
identifying specific protein substrates (Fig. 8e) (Shogren-Knaak et al. 2001; C. Zhang et
al. 2005). To distinguish kinase-specific phosphorylation events from existing
phosphoproteins in cell lysates, γ-thioATP was employed as substrate such that the
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unique reactivity of the sulfhydryl group could be selectively alkylated with detection and
enrichment reagents (Carlson et al. 2010; Allen et al. 2005; Allen et al. 2007; Blethrow et
al. 2008). The alkylation of thiophosphate groups with a nitrobenzyl-hapten allowed
specific antibody recognition of this semisynthetic epitope over alkylated Cys residues
for identification of kinase-specific substrates (Allen et al. 2005; Allen et al. 2007).
Although this system does not utilize alkyne- or azide-functionalized reagents, this twostep labeling protocol is itself bioorthogonal and showcases the utility of bump-hole
approaches for identifying enzyme-specific substrates in systems with overlapping
biochemical activity.
1.3.8 Oxidation.
The oxidation of amino acid side chains can result in significant rearrangements of
protein structure as in the case of the green fluorescent protein (GFP) or more subtle
changes such as hydroxylation of amino acid residues. These PTMs are perhaps the least
amendable to bioorthogonal labeling methods, nonetheless, specific chemical reagents
have been identified that enable bioorthogonal detection of some protein oxidation
reactions.

For example, the functionalization of dimedone with an azide or alkyne

enabled the selective labeling sulfenic acid modified proteins in cells and subsequent
bioorthogonal detection and proteomic analysis (Fig. 8f) (Leonard et al. 2009; Paulsen et
al. 2012). Interestingly, Carroll and coworkers demonstrated that stimulation of the
epidermal growth factor receptor (EGFR) results in elevated hydrogen peroxide levels
which in turn oxidizes Cys797 of EGFR to enhance its tyrosine kinase activity. These
observations suggest an interestingly positive feedback loop to amplify EGFR-dependent
signaling (Paulsen et al. 2012). By taking advantage of the unique chemical reactivity,
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bioorthogonal reporters can be developed for specific forms of protein oxidation and
reveal previously unappreciated mechanisms of cell signaling.
1.3.9 Summary and Future Outlook.
Bioorthogonal reactions in conjunction with chemical reporters are providing powerful
ways of tracking biomolecules in living systems and illuminating new aspects of biology.
While the past decade has seen incredible advances in bioorthogonal reactions and
specific chemical reporters (Carolyn R Bertozzi 2011), equally momentous leaps will be
necessary to apply these chemical tools to complex biological problems. Some of the
limitations of bioorthogonal detection are already being addressed with faster and more
selective chemical reactions (Jewett & Carolyn R Bertozzi 2010) as well as label-free
chemical imaging methods (Pezacki et al. 2011). On the chemical reporter end, many of
the cofactor-based reporters only work with enzymes in vitro and would benefit from the
development of caged precursors or engineered enzymes for in vivo labeling applications.
Moreover, the generation of enzyme-specific chemical reporters akin to the systems
developed for kinases is needed for several PTMs to characterize specific protein targets.
These two-component systems for bioorthogonal chemical reporters could then be
introduced into model organisms for cell-specific imaging and proteomics applications.
By virtue of their specific and dynamic incorporation into biomolecules, bioorthogonal
chemical reporters can provide snapshots of the chemistry inside of cells that integrate
the activity of metabolic pathways and specific enzymes in response to environmental
cues. The development of new bioorthogonal chemical reporters and their application
should help translate genomic information into biological function and uncover key
mechanisms of human diseases.
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2

Cell-selective labeling of Salmonella typhimurium with 2-amino-7-octynoic acid
(AOA) during infection1

2.1

Abstract

2.2

Background

Bacterial pathogens have evolved sophisticated mechanisms to evade host defenses and
cause disease (Bhavsar et al. 2007). The emergence of new and antibiotic-resistant
bacterial pathogens demands a better understanding of virulence mechanisms for
antibacterial drug discovery. While the discovery of bacterial toxins, quorum sensing and
protein secretion pathways has revealed some key virulence mechanisms, the precise
mechanisms by which intracellular bacterial pathogens subvert host immune responses
are still unclear (Bhavsar et al. 2007). The analysis of individual virulence factors has
demonstrated that bacterial pathogens alter their protein expression to infect and replicate
in host tissues (Haraga et al. 2008). However, the system-wide identification and analysis
of bacterial proteins that are uniquely expressed or secreted during infection is paramount
for understanding mechanisms of bacterial pathogenesis (Haraga et al. 2008; Rodland et
al. 2008). Comparative genomics and mutagenesis studies have revealed bacterial genes
that are important for infection, but their precise biochemical mechanisms and temporal
expression pattern can be elusive due to post-transcriptional regulation. Direct
biochemical analysis of bacterial proteomes during infection is needed. The large excess

1

This work was carried out in collaboration with Mingzi M Zhang (The Rockefeller

University), who cloned metG from E. coli into pCOLAduet-1. Mass spectrometry runs
for proteomic analysis were carried out by the Proteomics Resource Center of The
Rockefeller University.
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of host proteins in mixed pathogen-host lysates presents a significant challenge for
proteomic analysis of bacterial proteins during infections and even after physical
isolation of intact bacteria significant amounts of host proteins still remain (Rodland et al.
2008; Shi et al. 2006). This is particularly important since many bacterial virulence
factors are often expressed at low levels (Haraga et al. 2008). New strategies are therefore
required to selectively enrich bacterial proteins from host proteomes for their analysis
during infection.
The incorporation of unnatural amino acids in bacteria has provided new methods
to differentiate bacterial proteins from host proteomes. For example, the incorporation of
phenylalanine analogs in mycobacteria by amber stop codon suppression technology has
enabled the selective labeling of green fluorescent protein expressed in M. tuberculosis
during intracellular infection of macrophages (F. Wang et al. 2010). Alternatively,
alkyne- or azide-functionalized methionine (Met) surrogates can be incorporated by the
endogenous methionyl-tRNA synthetase (MetRS) into bacterial proteomes (Beatty et al.
2005; Kiick et al. 2002). These amino acid chemical reporters allow the metabolic
labeling of newly synthesized proteins, which in combination with bioorthogonal ligation
methods, such as Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) can be used to
detect and identify Met-containing proteins (Dieterich et al. 2006). Additionally, MetRS
mutants have been identified in E. coli (MetG) that can incorporate azidonorleucine
(ANL, Figure 9a), a Met surrogate that is not efficiently activated by the wild-type
MetRS or other endogenous aminoacyl-tRNA synthetases (Link et al. 2006; Tanrikulu et
al. 2009). ANL can therefore be used as an orthogonal amino acid reporter to selectively
label proteins in non-pathogenic E. coli by bacterial expression of MetRS mutants in the
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presence of mammalian cells (Ngo et al. 2009). While these studies have demonstrated
selective targeting of bacterial proteomes in the presence of host cells, the analysis of
endogenously expressed bacterial proteins during infection has not been achieved using
unnatural amino acid reporters (F. Wang et al. 2010; Ngo et al. 2009). The following
chapter of this thesis describes a new orthogonal alkynyl-amino acid reporter (2-amino-7octynoic acid, AOA, Figure 9a) for specific imaging and enrichment of bacterial
proteomes during infection of mammalian cells, which we applied to the intracellular
bacterial pathogen Salmonella typhimurium (Figure 9b).

Figure 9 Orthogonal (cell-selective) amino acid reporters for bacterial translation.

2.3

Results

2.3.1 Expression of MetG in Escherichia coli and in vitro labeling with 2-amino-7octynoic acid (AOA)
Based on the reported superior selectivity of azide- compared to alkyne-functionalized
secondary CuAAC reagents (Speers & Cravatt 2004) and our own experience with fatty
acid chemical reporters (Charron et al. 2009) we evaluated whether an alkynyl-isostere of
ANL, 2-amino-7-octynoic acid (AOA, Figure 1a), could be accepted by previously
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reported MetRS mutants (Link et al. 2006; Tanrikulu et al. 2009). MetRS mutants were
generated from the E. coli metG gene (L13G, L13N Y260L H301L: NLL, L13P Y260L
H301L: PLL) by site-directed mutagenesis and ligated into pCOLAduet-1 for overexpression in E. coli (only L13G and NLL were cloned in pCOLAduet-1, PLL was
directly cloned in pWSK29, see below). AOA was synthesized by alkylation of diethyl
acetamidomalonate

with

hex-5-ynyl-4-methylbenzenesulfonate

followed

by

saponification, decarboxylation, and deacetylation to yield the racemic product (Figure
10).2

O

KOtBu (1.1 eq)
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Figure 10 Synthesis of 2-amino-7-octynoic acid (AOA).

E. coli pCOLAduet_MetGNLL and E. coli pCOLAduet_MetGL13G overnight
cultures were diluted 1:30 into M9 minimal and grown for 3 h. The cultures were
pelleted, resuspended in an equal volume of M9 minimal medium with or without IPTG
and with or without AOA or ANL, and grown for 3 h at 37 °C with aeration. Cells were
lysed with SDS lysis buffer and reacted with azido-rhodamine (az-rho) or alkynerhodamine (alk-rho) by CuAAC and analyzed by SDS-PAGE and in-gel fluorescence
scanning (Charron et al. 2009). Over-expression of MetGNLL or MetGL13G facilitates

2

Due to the racemic nature of AOA, any indicated concentration refers to the effective

concentration of the L-isomere, unless otherwise noted.
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incorporation of AOA into the E. coli proteome (Figure 11) (further analysis of AOA
incorporation was carried out in S. typhimurium, see below). As reported previously,
MetGNLL provides better ANL incorporation than MetGL13G, however this difference is not
as pronounced with AOA, which is incorporated less efficiently in E. coli than ANL.
These results were encouraging to test AOA incorporation in the bacterial pathogen S.
typhimurium.

Figure 11 Expression of MetGNLL or MetGL13 facilitates AOA incorporation in E. coli. E.
coli pCOLAduet_MetGNLL and E. coli pCOLAduet_MetGL13 (induced with 1 mM
IPTG) was labeled with 1 mM azidonorleucine (ANL) or 1 mM 2-amino-7-octynoic acid
(AOA) for 3 h in M9 minimal medium. Cells were lysed, reacted with az-rho or alk-rho
by CuAAC and analyzed by in-gel florescence screening. AA: amino acid, IPTG:
Isopropyl β -D-1-thiogalactopyranoside, NLL: MetGNLL, L13: MetGL13G, Fluor.:
fluorescence, CM: coomassie blue.
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2.3.2 Expression of MetG in Salmonella typhimurium and in vitro labeling with 2amino-7-octynoic acid (AOA)
Since the metG gene in E. coli and S. typhimurium are 95 % identical, overexpression of
E. coli metG in S. typhimurium should facilitate amino acid activation. To allow mutant
MetG overexpression in S. typhimurium MetGL13G, MetGNLL, and MetGPLL were cloned in
the low copy number plasmid pWSK29 under the expression control of the lac promoter,
which provides constitutive expression in S. typhimurium. All plasmids were transformed
into the S. typhimurium strain IR715. For the in vitro analysis of the S. typhimurium
strains expressing MetRS mutants, bacteria were grown in full Luria-Bertani (LB)
medium to stationary phase and diluted into M9 minimal medium containing Met, AOA,
or ANL. Protein lysates were reacted with the az-rho detection tag by CuAAC and
analyzed by SDS-PAGE and in-gel fluorescence scanning.
To determine the most efficient MetG mutant and orthogonal amino acid reporter
combination for selective labeling of the S. typhimurium proteome, we compared the
three MetG mutants MetGL13G, MetGNLL, and MetGPLL for ANL and AOA incorporation in
S. typhimurium in vitro. All three MetRS mutants permit incorporation of ANL and AOA
into the S. typhimurium proteome (Figure 12a). Expression level of all MetG mutants
were comparable as judged by S-tag Western blot analysis of the epitope tag fused to all
MetRS constructs (Figure 12a). Both triple mutants (NLL, PLL) conveyed more efficient
incorporation of ANL and AOA over the single mutant (L13G). In addition, AOA
showed superior signal-to-noise ratios compared to labeling with ANL for all three
MetRS mutants (Figure 12b). These data demonstrate that both orthogonal amino acid
reporters function in S. typhimurium expressing MetG mutants, but MetGNLL or MetGPLL

38

in combination with AOA affords the optimal orthogonal enzyme-substrate pair for
metabolic labeling of S. typhimurium proteins.

Figure 12 Triple mutants (MetGNLL and MetGPLL) in combination with 2-amino-7octynoic acid (AOA) provide optimal signal-to-noise in S. typhimurium. a) S.
typhimurium

pWSK29_MetG,

pWSK29_MetGL13G,

pWSK29_MetGNLL,

or

pWSK29_MetGPLL was labeled with ANL or AOA in minimal medium. b) Quantification
of fluorescence signal. AA: amino acid, STM: S. typhimurium IR715, az-rho: azidorhodamine, alk-rho: alkyne-rhodamine, CB: coomassie blue, α-S-Tag: anti-S-Tag
Western blot, NI: normalized fluorescence intensity, normalized for negative control and
coomassie blue staining.

To confirm selectivity of AOA for newly synthesized Met-containing proteins, we
conducted protein synthesis inhibitor and Met competition experiments. Pre- and coincubation of S. typhimurium pWSK29_MetGNLL with the protein synthesis inhibitor
tetracycline (Tet) effectively abrogated AOA-labeling (Figure 13a). Met efficiently
competed away AOA-incorporation in a dose-dependent manner (Figure 13b). The
synthetic route of AOA results in a racemic mixture. Some
translationally incorporated into proteins and

D-amino

D-amino

acids can be

acids can be toxic to various

organisms (Champney & Jensen 1970; Friedman 1999). Therefore we wanted to know
39

whether D-AOA interferes with AOA labeling of S. typhimurium. Pig acylase I was used
to kinetically resolve the racemic mixture of AOA (Chenault et al. 1989), which afforded
enantiomerically enriched (ee) L-AOA (Figure 14). The purity of ee L-AOA was not
further quantified, but the NMR analysis revealed that L-AOA was the predominant
species present. Racemic AOA was used at 2 mM and compared to 1 mM ee L-AOA.
Both preparations showed identical labeling efficiencies at comparable effective
concentrations (Figure 13c) and we could not detect any growth differences of S.
typhimurium between the racemic and the enantiomerically pure AOA preparation. These
data demonstrate that AOA can selectively label newly synthesized Met-containing
proteins in gram-negative bacterial pathogens such as S. typhimurium upon expression of
MetGNLL.

40

Figure 13 2-amino-7-octynoic acid (AOA) serves as a co-translational chemical reporter
for methionine (Met) in S. typhimurium. a) S. typhimurium pWSK29_MetGNLL was
treated with Met (1 mM) or AOA (1 mM), in the presence or absence of tetracycline
(Tet) for 30 min. b) S. typhimurium pWSK29_MetGNLL was incubated with increasing
concentrations of Met and AOA (1 mM). c) Comparison of the labeling efficiency of D/LAOA and L-AOA. CB: Coomassie blue, az-rho: azido-rhodamine.
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Figure 14 Determination of the absolute stereochemistry of kinetically resolved 2-amino7-octynoic acid (AOA). The methyl ester of AOA (racemic mixture) and kinetically
resolved AOA were formed using thionyl chloride in anhydrous methanol. Both methyl
esters were reacted with R-α-methoxy-α-(trifluoromethyl)phenylacetyl chloride (MTPA
chloride) to form S-MTPA-S/R-1-COOMe and S-MTPA-S-1-COOMe (as determined
subsequently by 1H NMR), respectively. 1H NMR spectra were taken of both MTPA
derivatives as well as a 1:3 mix of the two. The singlet signal of the methyl ester
(COOMe) protons experiences a characteristic chemical shift depending on the absolute
stereochemistry of the chiral center of the amino acid moiety. The signal of the S-Sdiastereomer experiences a greater chemical shift than the S-R-diastereomer.
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2.3.3 Labeling Salmonella typhimurium with 2-amino-7-octynoic acid (AOA)
during infection of mammalian cells
We then evaluated the efficiency of ANL and AOA-labeling of S. typhimurium
proteomes during intracellular infection of mammalian cells. To analyze selective
incorporation of orthogonal amino acid reporters in intracellular S. typhimurium,
RAW264.7 murine macrophages were infected with S. typhimurium pWSK29_MetGNLL
at a multiplicity of infection (MOI) of 100 for 30 minutes. Following infection, extracellular bacteria were killed by addition of gentamicin, a cell-impermeable antibiotic.
After two hours, infected and non-infected macrophages were labeled with different
concentrations of Met, ANL or AOA in the growth medium for 3 hours. Cell pellets
containing bacteria and mammalian cells were lysed with 4% SDS lysis buffer, reacted
with alk-rho or az-rho and analyzed by in-gel fluorescence. Samples infected with S.
typhimurium pWSK29_MetGNLL, validated by S-tag Western blot analysis, and labeled
with ANL or AOA displayed a strong fluorescence signal above background in contrast
to the non-infected samples labeled with ANL or AOA (Figure 15a). Comparison of the
Met control samples revealed the considerably higher background signal of alk-rho, as
observed in vitro. Close inspection of AOA-treated non-infected macrophages showed
marginal concentration dependent labeling with AOA, while ANL incorporation could
not be observed. Quantification of the relative fluorescence intensities of ANL and AOA
suggested that AOA, at an effective concentration of 1 mM, affords the most sensitive
labeling of S. typhimurium proteins during infection (Figure 15b). These results strongly
suggested that ANL and AOA can be selectively incorporated into S. typhimurium during
infection of mammalian cells by the cell selective expression of MetGNLL. We found that

43

AOA in combination with azide-detection reagents displayed superior labeling sensitivity
at all tested concentrations (Figure 15b).
To confirm selective labeling of Salmonella with AOA inside mammalian cells, we
performed fluorescence imaging studies of infected cells. HeLa cells were infected with
S. typhimurium pWSK29_MetGNLL (MOI = 100), 16 h post-infection cells were pulselabeled with AOA or Met for 1 hour, fixed, permeabilized, reacted with az-rho and
stained with anti-Salmonella serum. Imaging of rhodamine fluorescence demonstrated
robust and selective labeling of intracellular bacteria with AOA (Figure 16a). No
rhodamine fluorescence was observed in host cells or S. typhimurium pWSK29_MetGNLL
-infected cells treated with Met under these conditions. AOA-labeled S. typhimurium colocalized with anti-Salmonella serum, validating selective incorporation of AOA into the
bacterial proteome and exclusion from host proteins. In addition, we analyzed S.
typhimurium-infected RAW264.7 macrophages by LAMP-1 antibody staining, a marker
for the Salmonella containing vacuole (SCV) of infected host cells (Haraga et al. 2008).
AOA-labeled S. typhimurium pWSK29_MetGNLL inside RAW264.7 macrophages were
enclosed in LAMP-1 positive compartments (Figure 16b), suggesting that AOA labeling
does not significantly disturb intracellular trafficking of Salmonella in host cells. These
data further validate the utility of AOA for selective metabolic labeling of Salmonella
proteins inside mammalian cells.

44

Figure 15 AOA and ANL allow labeling of S. typhimurium pWSK29_MetGNLL infected
macrophages. a) RAW264.7 cells were infected with S. typhimurium pWSK29_MetGNLL
and pulse-labeled with different concentrations of AOA or ANL 16 hours post-infection.
b) Quantification of fluorescence signal. AA: amino acid, STM: S. typhimurium IR715,
az-rho: azido-rhodamine, alk-rho: alkyne-rhodamine, CB: coomassie blue, α-S-Tag: antiS-Tag Western blot, NI: normalized fluorescence intensity, normalized for negative
control and coomassie blue staining.
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Figure 16 2-amino-7-octynoic acid (AOA) allows selective labeling of S. typhimurium in
mammalian cells during infection.
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2.3.4 Proteomic analysis of 2-amino-7-octynoic acid (AOA) labeled proteins of
Salmonella typhimurium
After selectivity and efficiency of AOA labeling was established, we compared S.
tyhimurium proteins that are metabolically labeled by AOA during growth in liquid
culture to S. tyhimurium proteins that are labeled during infection of macrophages. For
this comparative analysis, S. typhimurium pWSK29_MetGNLL grown in liquid culture (in
vitro) (Figure 18b) and RAW264.7 macrophages infected with S. typhimurium
pWSK29_MetGNLL (16 h post infection) (Figure 18c) were pulse-labeled with AOA or
Met for 1 hour. Generated cell lysates were reacted with azido-azo-biotin (Y.-Y. Yang,
Ascano & Hang 2010), affinity purified with streptavidin and eluted from beads for
protein identification by gel-based proteomics (Figure 18a). The generated raw data was
searched against a concatenated mouse-S. typhimurium database for protein
identification. Only proteins that contained two unique peptides and were not detected in
the Met control were considered for this study. The analysis of infected RAW264.7
macrophages identified a total of 218 proteins that sufficed our filter criteria (Appendix
Table 3). Amongst these proteins, 185 were assigned to the S. typhimurium proteome
(85%), the remainder were mouse proteins (Figure 18d). Additionally, we identified 472
proteins from S. typhimurium pWSK29_MetGNLL pulse-labeled with AOA in minimal
medium (Appendix Table 4). Between the in vitro Salmonella and the intracellular
Salmonella datasets we could identify 96 common proteins, while 89 proteins (48%)
were exclusively observed in the sample derived from infected macrophages (Figure
18e). Interestingly, at least 5 Salmonella proteins (SodM, SsrB, SseA, PipB2 and PhoP)
from infected RAW264.7 cells were previously described as virulence factors (J. Yang et
al. 2008).
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Compared to other proteomic datasets generated from macrophages infected with S.
typhimurium (Shi et al. 2006), our results demonstrate that AOA-pulse-labeling in
conjunction with bioorthogonal ligation methods allows greater enrichment of bacterial
proteins (85% Salmonella proteins with AOA-labeling compared to ∼45% under
comparable conditions without AOA) and reveals additional bacterial proteins that may
be preferentially expressed during infection (Figure 18f). Although the use of AOA and
MetGNLL only targets Met-containing proteins, 96% of the S. typhimurium LT2 proteome
contains one or more Met residues in addition to the N-terminal initiator Met residue.
Hence, the majority of the Salmonella proteome is amenable to labeling with AOA
(Figure 17). Our preliminary proteomic studies demonstrate that AOA-pulse-labeling in
combination with CuAAC allows efficient enrichment and identification of endogenously
expressed bacterial proteins that are differentially synthesized by Salmonella during
infection of host cells.

Figure 17 Methionine distribution in S. typhimurium. Chart shows S. typhimurium
proteome fractions binned by number of methionines per protein (exclusive the Nterminal methionine). Data based on genome of S. typhimurium LT2 SGSC1412
(Washington University).
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Figure 18 2-amino-7-octynoic acid (AOA) allows enrichment and identification of S.
typhimurium proteins from infected mammalian cells. a) Cell lysates were reacted by
CuAAC with azido-azo-biotin (cleavable affinity tag), affinity purified on streptavidin
beads, and selectively eluted with Na2S2O4 by reduction of the azo-bond. The eluate was
separated by SDS-PAGE and subsequently analyzed by mass spectrometry based
proteomics. b) S. typhimurium pWSK29_MetGNLL was labeled with 1 mM AOA or 1 mM
Met in MgM minimal medium. Cell lysates were analyzed by CuAAC mediated in-gel
fluorescence scanning. c) RAW264.7 cells were infected with S. typhimurium
pWSK29_MetGNLL and labeled with 1 mM AOA or 1 mM Met 16 hours post-infection.
Cell lysates were analyzed by CuAAC mediated in-gel fluorescence scanning. Cell
lysates were also reacted by CuAAC with azido-azo-biotin, affinity purified and
selectively eluted by Na2S2O4. Eluate was separated by SDS-PAGE and subsequently
analyzed by mass spectrometry based proteomics. d) A total of 218 S. typhimurium
proteins were identified from infected RAW264.7 cells. Of these proteins, 185 (85%)
were Salmonella proteins and 33 were mouse proteins. e) Comparison of Salmonella
proteins identified from infected macrophages and Salmonella grown in minimal liquid
culture: 376 proteins were identified in liquid culture only, 89 proteins were identified in
infected macrophages only, and 96 were identified in both samples. f) Comparison of
proteins identified from AOA-pulse-labeled infected RAW264.7 cells (amino acid
reporter) and a previously published dataset (Shi et al. 2006) of Salmonella proteins
identified from infected RAW246.7 cells under comparable conditions without AOA
labeling (no amino acid reporter): 100 proteins were exclusively identified in our dataset,
85 proteins were identified in both datasets, and 49 proteins were only identified in the
previously published dataset. az-rho: azido-rhodamine, CB: coomassie blue.
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Figure 18
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2.4

Materials and Methods

2.4.1 General Methods and Materials
Unless otherwise noted all chemical reagents were purchased from Sigma-Aldrich or
Fisher Scientific. 1H and 13C NMR spectra were acquired on a Bruker DPX-400 or Bruker
UltraShield-600 Plus instrument. Chemical shifts are reporter in ppm, and J values are
reported in Hz. MALDI-TOF mass spectra were acquired on a Applied Biosystems
Voyager-DE mass spectrometer or a LC-MS. In-gel fluorescence scanning was
performed with a Amersham Biosciences Typhoon 9400 variable mode imager
(excitation 532 nm, 580 nm filter, 30 nm band-pass). All contrast or brightness
adjustments were applied to the entire gel or blot, including the different controls.
Images adjustments were done in Adobe Photoshop CS.
2.4.2 Synthesis of 2-amino-7-octynoic acid (AOA)
2.4.2.1 Diethyl 2-acetamido-2-(hex-5-yn-1-yl)malonate
Diethyl acetamidomalonate (1.05 g, 4.75 mmol) was dissolved in 30 ml anhydrous 1,4dioxane in a previously flame-dried round bottom flask equipped with a condenser and
set under Argon atmosphere. Potassium tert-butoxide (0.59 g, 5.23 mmol) was added to
the vigorously stirred solution and it was incubated for 2 hours at 60 °C. Hex-5-ynyl-4methylbenzenesulfonate was added drop wise to the stirring solution and the reaction was
refluxed for 24 h. The suspension was cooled to room temperature and solid material was
filtered and washed with diethyl ether. Filtrate was evaporated under reduced pressure,
resulting in a brown oil. This material was purified by column chromatography on silica
gel (30% ethyl acetate/70% hexanes to 40% ethyl acetate/60% hexanes) to afford 520 mg
pure product 1 (37%). Rf = 0.4; 1H NMR (600 MHz, CDCl3): δ = 1.15-1.20 (m, 8H),
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1.44-1.49 (quint., J=7.2 Hz), 1.85 (s, 1H), 1.97 (s, 3H), 2.10-2.13 (m, 2H), 2.25-2.28 (m,
2H), 4.16-4.20 (q, J=7.2 Hz, 4H), 6.75 (s, 1H); 13C NMR (600 MHz, CDCl3): δ = 13.88,
17.95, 22.41, 22.86, 27.80, 31.43, 62.34, 66.36, 68,50, 83.77, 167.97, 168.92; MS (ESI):
calc. for C15H23NO5 [M-H]+ requires 298.16, found 298.05.
2.4.2.2 2-acetamidooct-7-ynoic acid
Diethyl 2-acetamido-2-(hex-5-yn-1-yl)malonate (520 mg, 1.75 mmol) was dissolved in
10 ml 10% NaOH and refluxed for 5 hours. The solution was cooled to room temperature
and acidified to pH 2 with 6 N HCl. Solvent was evaporated under reduced pressure and
the resulting residue was taken up in 10 ml of H2O and refluxed for 5 hours. The reaction
mix was cooled to ambient temperature, acidified to pH 2 with 1 N HCl and extracted
with three portions of ethyl acetate. The organic layers were combined, dried over
MgSO4, filtered, and evaporated under reduced pressure, yielding 240 mg of pure product
2 (70%). 1H NMR (600 MHz, CD3OD): δ = 1.46-1.53 (m, 4H), 1.64-1.70 (m, 1H), 1.801.86 (m, 1H), 1.96 (s, 3H), 2.15-2.17 (m, 3H), 4.33-4.35 (dd, J=5.4, 3.6 Hz, 1H); 13C
NMR (600 MHz, CD3OD): δ = 17.50, 21.02, 24.61, 27.80, 30.76, 52.20, 68.38, 83.36,
172.00, 174.13; MS (ESI): calc. for C10H15NO3 [M-H]+ requires 198.11, found 198.03.
2.4.2.3 2-amino-7-octynoic acid (AOA)
2-acetamidooct-7-ynoic acid (240 mg, 1.22 mmol) was dissolved in 10 ml 2 N HCl and
refluxed for 2 hours. The solution was cooled to ambient temperature and loaded on an
equilibrated DOWEX 50WX4-100 cation-exchange resin. The resin was extensively
washed with water and eluted with 1 M NH4OH. The eluate was evaporated under
reduced pressure to afford 138 mg of 1 (73%). 1H NMR (600 MHz, D2O): δ = 1.40-1.49
(m, 4H), 1.82-1.93 (m, 2H), 2.11-2.16 (m, 2H), 2.27-2.28 (t, J=2.4 Hz, 1H), 3.98-4.00 (t,
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J=6 Hz, 1H); 13C NMR (600 MHz, D2O): 17.21, 23.49, 27.22, 29.97, 54.73, 69.34, 85.75,
175.00; MS (ESI): calc. for C8H13NO2 [M-H]+ requires 156.10, found 155.98.
2.4.2.4 Enantioselective hydrolysis of 2-acetamidooct-7-ynoic acid with acylase I
2-acetamidooct-7-ynoic acid (750 mg) was dissolved in 70 ml H2O and pH was adjusted
to pH 7.5 with 1 M LiOH. 6 mg acylase I (acylase I from porcine kidney) was added and
solution was slowly stirred at 37 °C for 24 hours. The material was lyophilized and 50%
mass was resuspended in 10 ml H2O. Activated charcoal (45 mg) was added and
incubated for 5 min. Charcoal was filtered over Buchner funnel. Aqueous filtrate was
washed twice with diethyl ether. Aqueous phase was evaporated under reduced pressure
at 45 °C. Resulting residue was dissolved in 1 M HCl and purified over DOWEX
50WX4-100 cation-exchange resin. Eluate was evaporated under reduced pressure at 45
°C. 1H NMR (600 MHz, D2O) data was identical to AOA.
2.4.2.5 Determination of the absolute stereochemistry of kinetically resolved AOA
The absolute stereochemistry of enantioselectively hydrolyzed 2-acetamidooct-7-ynoic
acid

was

determined

by

formation

(trifluoromethyl)phenylacetyl-amide,

of

the

MTPA-amide

Mosher-amide)

of

the

(S-α-methoxy-αmethylester

of

enantioselectively hydrolyzed 2-acetamidooct-7-ynoic acid (Dale & Mosher 1973). The
methylester of enantioselectively hydrolyzed 2-acetamidooct-7-ynoic acid was formed as
follows. Enantioselectively hydrolyzed 2-acetamidooct-7-ynoic acid was dissolved in
anhydrous methanol under Argon atmosphere. Solution was cooled to 0 °C and 50
equivalents of thionyl chloride were added. Reaction mix was allowed to warm up to
room temperature over night.

Reaction was quenched with H2O and solvent was

evaporated under reduced pressure. Crude material was purified by column
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chromatography on silica gel (10% methanol/89% dichloromethane/1% acetic acid). The
methylester of AOA was formed accordingly, however, the reaction was refluxed over
night with 30 equivalents of thionyl chloride.
The S-MTPA-amides of both species were formed as follows. The methyl ester was
dissolved in anhydrous pyridine under argon atmosphere. Three equivalents of R-MTPA
chloride was added and the reaction was stirred at room temperature for 90 min.
Reaction completion was assessed by absence of ninhydrin signal. The reaction was
quenched with H2O and the aqueous phase was extracted with diethyl ether. The organic
phase was washed twice with 10% HCl and twice with sat. NaHCO3. The organic phase
was dried over MgSO4, filtered, and evaporated under reduced pressure. The material was
directly analyzed by 1H NMR.
2.4.3 Synthesis of S-2-amino-6-azidohexanoic acid (azidonorleucine, ANL)
2.4.3.1 S-6-azido-2-((tert-butoxycarbonyl)amino)hexanoic acid
S-6-azido-2-((tert-butoxycarbonyl)amino)hexanoic acid was basically synthesized as
previously reported with modifications (Link et al. 2004). Instead of trifluoromethanesulfonyl azide we used imidazol-1-sulfonyl azide hydrochloride as the
diazotransfer reagent (Goddard-Borger & Stick 2007). Imidazol-1-sulfonyl azide
hydrochloride (3.06 g, 14.61 mmol) was added to a stirred solution of BOC-lysine (3 g,
12.18 mmol), K2CO3 (4.55 g, 32.89 mmol), and CuSO4⋅5H2O (30.4 mg, 0.12 mmol) in 60
ml of methanol. The reaction mix was stirred at ambient temperature over night and
diluted with phosphate buffer (0.25 M KH2PO4, 0.25 M K2HPO4). The solution was
carefully acidified to pH 3 and extracted with 3 portions ethyl acetate. The organic layers
were combined, dried over MgSO4, filtered, and evaporated under reduced pressure. The
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resulting crude material was purified by column chromatography on silica gel (25% ethyl
acetate/74% hexanes/1% acetic acid) and afforded 1.95 g product. 1H NMR (600 MHz,
CDCl3): δ = 1.43-1.48 (m, 11H), 1.59-1.65 (m, 2H), 1.67-1.71 (m, 1H), 1.86-1.89 (m,
1H), 3.26-3.28 (t, J=6.6 Hz, 2H), 4.10-4.11 (m, 0.4H), 4.32-4.33 (m, 0.6H), 5.20-5.21 (d,
0.6H), 6.69-6.70 (d, 0.40).
2.4.3.2 S-2-amino-6-azidohexanoic acid (ANL)
ANL was prepared from S-6-azido-2-((tert-butoxycarbonyl)amino)hexanoic acid as
previously reported (Link et al. 2004). 1H NMR (600 MHz, D2O): δ = 1.36-1.50 (m, 2H),
1.55-1.60 (m, 2H), 1.83-1.96 (m, 2H), 3.27-3.29 (t, J=6.6Hz, 2H), 3.98-4.00 (t, J=6Hz,
1H).
2.4.4 Plasmids and bacterial strains
S. enterica typhimurium IR715 was transformed with different pWSK29 derived
plasmids, expressing different mutants of the E. coli methionyl-tRNA synthetase gene
(MetRS, metG). MetG was amplified from E. coli K12 (GAAGATCTTCATG
ACTCAAGTCGCGAAGAA, CTCGAGTTTCACCTGATGACCCGG) and cloned into
pCOLAduet-1 (Novagen) with BglII and XhoI to create a C-terminal S-tagged fusion of
MetRS and the plasmid pMetG1. Three mutant versions of MetRS were created using the
QuikChange XL Site-Directed Mutagenesis Kit or the QuikChange Multi Site-Directed
Mutagenesis Kit (Stratagen): L13G (MetRS-L13G), L13N-Y260L-H301L (MetRS-NLL),
and L13P-Y260L-H301L (MetRS-PLL). MetRS was amplified from pMetG1
(CCTGAGCTCCATGACTCAAGTCGCGAAG,

CCGGAATTCATTACGAGT

CCATGTGCTGGCGTTC) and cloned into pWSK29 using SacI and EcoRI, creating
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pMetG2. pMetG2 encodes a C-terminal S-tag fusion of MetRS under the expression
control of the lac promoter.
2.4.5 Infection of mammalian cells
HeLa cells (5 x 104 cells/well) or RAW264.7 macrophages (5 x 105 cells/well) were split
into a 24 well plate 10 hours before infection. S. typhimurium was grown over night in
full LB with 100 µg/ml Carbenicillin (Cb). Overnight cultures were diluted 1:100 into
fresh LB (Cb) and grown to stationary phase (OD600 = 2). Bacteria were washed once in
PBS and incubated for 30 min in DMEM (10% FBS) on ice. Bacteria were added to
mammalian cells in DMEM (10 % FBS) at MOI = 100 and centrifuged (400 g, 5 min, 4
°C) for spin infection. Subsequently, cells were incubated for 25 min at 37 °C, 5% CO2.
Cells were washed 4x with PBS and DMEM (10% FBS) with 100 µg/ml gentamicin was
added for 90 min to kill all extracellular bacteria. After 90 min medium was exchanged to
DMEM (10% FBS) with 10 µg/ml gentamicin for the remainder of the experiment.
2.4.6 Metabolic labeling (in vitro, during infection)
Over night cultures of bacteria were grown in full LB with 100 µg/ml Carbenicillin (Cb).
Over night cultures were diluted 1:100 into fresh LB (Cb) and grown to stationary phase.
Bacteria were collected by centrifugation (10,000 rpm, 3 min) and resuspended in MgM
(100 mM MES pH 5, 1 mM KH2PO4, 10 µM MgCl2, 5 mM KCl, 7.5 mM NH4OH, 0.5
mM K2SO4, 38 mM glycerol) minimal medium or M9 (1x M9 salts, 20 mM glucose, 2
mM MgSO4, 100 µM CaCl2) minimal medium (Cb). Bacteria were grown in minimal
medium for 15 min and collected by centrifugation. Bacterial pellets corresponding to
500 µl culture volume were resuspended in MgM or M9 minimal medium (Cb)
containing chemical reporter. Bacteria were labeled for 1 hour and collected by
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centrifugation, washed once in PBS, and stored at -80 °C. For tetracycline (Tet) protein
synthesis inhibition, bacteria were grown for 30 min in LB (40 µg/ml Tet) before being
labeled for 30 min in M9 minimal medium (40 µg/ml Tet).
For metabolic labeling of infected mammalian cells, cells were labeled with amino acid
reporter in DMEM (methionine free) for 3 hours, 90 min after infection or labeled for 1
hour (fluorescence microscopy), 16 hours after infection. Subsequently, medium was
aspirated and cells were washed multiple times with PBS.
For proteomic analysis infected macrophages were pulse-labeled with 1 mM AOA or 1
mM Met 16 h after infection for 1 h pulse time. For proteomic analysis of S. typhimurium
labeled in liquid culture, bacteria were grown as described above in MgM minimal
medium and pulse labeled for 1 h with 2 mM AOA or 1 mM Met.
2.4.7 Cell lysis
Bacterial cell pellets and cell pellets of infected mammalian cells were lysed with
CuAAC compatible SDS lysis buffer as previously reported with slight modifications
(Rangan et al. 2010). For this study cells were lysed without lysozyme present in the lysis
buffer and lysed cells were centrifuged at 20,000 g for 15 min at 18 °C to remove cell
debris
2.4.8 CuAAC for fluorescence in-gel profiling
50 µg of cell lysate was brought up to 15 µl with CuAAC buffer (4% SDS, 150 mM
NaCl, 50 mM TEA). CuAAC components were added as a master mix to adjust the total
volume to 50 µl with final concentrations as reported previously. CuAAC was carried out
at room temperature for 1 hour. Protein was precipitated by adding >10 volumes of
methanol and incubation at -20 °C for at least 1 hour. Precipitated protein was pelleted by
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centrifugation at 20,000 g for 15 min at 4 °C. Protein pellets were washed once with cold
acetone and dried on air. Protein pellets were resuspended in 1x Laemmli buffer,
denatured at 95 °C for 5 min and separated by SDS-PAGE (4-20% Tris-HCl, Bio-Rad
Criterion).
2.4.9 Fluorescence microscopy
For fluorescence imaging experiments infections were carried out as described above,
however cells were grown on cover slips. 16 h after infection cells were labeled with 2
mM AOA, or Met for 1 hour in DMEM (methionine free). After metabolic labeling cells
were fixed for 10 min with 3.7% PFA in PBS. Cells were washed 3x with PBS and
permeabilized with 0.1% Triton-X-100, 0.2% saponin in PBS for 10 min. Cells were
washed 3x with PBS and blocked with 10% FBS in PBS for 1 hour at room temperature.
Cells were washed 3x with PBS and subsequently tagged by CuAAC. 300 µl of a
CuAAC master mix (20 µM azRho, 1 mM TCEP (tris(2-carboxyethyl)phosphine
hydrochloride), 100 µM TBTA (tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine), 1
mM CuSO4) was added to each well and CuAAC was carried out for 1 h at room
temperature. Subsequently, cells were washed with 1% Tween20, 0.5mM EDTA in PBS
and PBS. Cells were incubated with primary antibody (LAMP-1, 1:1000. Abcam 24170;
anti-Salmonella serum 1:250) in 0.2% saponin in PBS for 30 min. Cells were washed 3x
with 0.2% saponin in PBS. Then cells were incubated with secondary antibody (Alexa
Fluor® 488 goat anti-rabbit IgG (H+L), 1:1000 , Invitrogen) in 0.2% saponin in PBS for
30 min. Cells were washed 3x with 0.2% saponin in PBS and finally incubated with TOPRO-3 (1:1000) in 0.2% saponin in PBS, before being washed 3x with 0.2% saponin in
PBS. Cover slips were mounted on ProLong Gold (Invitrogen).
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2.4.10 Quantification of in-gel fluorescence scanning
In-gel fluorescence profiles were quantified in ImageJ 1.40g by measuring the mean
intensity of an equally sized square of each gel lane. The observed intensity was
normalized by protein load as measured by coomassie stain intensity and the F.I.
(normalized fluorescence intensity) was formulated as the quotient of this normalized
intensity and the normalized intensity of the empty vector control or the uninfected
sample with equal amino acid reporter concentration.
2.4.11 CuAAC for capture and retrieval
Cell lysates were brought up to a final concentration of 1 mg/ml with 50 mM TEA, 4%
SDS and 150 mM NaCl. CuAAC components were added to 100 µM azido-azo-biotin, 1
mM TCEP, 100 µM TBTA, 1 mM CuSO4 final concentrations and incubated for 1.5
hours at room temperature. Subsequently, protein was precipitated by methanolchloroform precipitation. Before streptavidin bead capture, protein pellets were initially
resuspended in 4% SDS in PBS and finally diluted to 0.2% SDS, 10 mM EDTA in PBS.
2.4.12 Streptavidin bead capture
Streptavidin beads (100 µl/5 mg protein; high capacity streptavidin agarose resin Thermo Scientific) were washed 3x with PBS and equilibrated with 0.2% SDS, 10 mM
EDTA in PBS. Dissolved protein pellets were added to beads in 0.2% SDS, 10 mM
EDTA in PBS and incubated on turning wheel for 1 h at room temperature. Beads were
washed with 2x 10 ml 2% SDS, 10 mM EDTA in PBS, 2x 10 ml of 6 M urea in 250 mM
ABC (ammonium bicarbonate), 2x 10 ml 1 M NaCl in PBS, and 2x 50 mM ABC. Bound
proteins were reduced with 10 mM TCEP in 50 mM ABC for 30 min at room
temperature and subsequently alkylated with 20 mM iodacetamide in 50 mM ABC for 30
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min at room temperature. Proteins were specifically eluted with 400 µl 50 mM Na2S2O4,
0.5% SDS in 50 mM ABC for 1 h in shaker at room temperature. Flow through was
collected and remaining proteins were eluted a second time for 30 min under equal
conditions. Combined eluates were concentrated in Microcon YM-10 centrifugal filters
(Millipore) as per manufactures protocol. Microcon filters were rinsed twice with 50 µl
1% SDS/75 mM β-mercaptoethanol (BME) to collect proteins. Samples were dried under
reduced pressure. Samples were resuspendend in 25 µl 1x LDS sample buffer (5% BME),
heated for 5 min at 95 °C and separated by SDS-PAGE. Gels were stained with GelCode
Blue Stain Reagent (Thermo).
2.4.13 In-gel digestion
Each gel lane was cut into 15 pieces. Each piece was cut into cubes of approximately 1
mm3, washed once in 50 mM ABC, twice in 1:1 50 mM ABC to acetonitrile (ACN), and
once in ACN. Gel pieces were dried under reduced pressure. 1/50 (w/w) of trypsin in 50
mM ABC was added to cover all gel pieces with buffer and incubated over night at 37
°C. Supernatant was collected and peptides were extracted twice with 1:1 50 mM ABC to
ACN, and twice with 100% ACN. All supernatants were pooled and dried under reduced
pressure. For LC-MS/MS analysis samples were dissolved in 25 µl 0.1% TFA.
2.4.14 MS analysis
LC-MS analysis was performed with a Dionex 3000 nano-HPLC coupled to an LTQOrbitrap ion trap mass spectrometer (ThermoFisher). Peptides were pressure loaded onto
a home-made 75 μm diameter, 15 cm C18 reverse phase column and separated with a
gradient running from 95% buffer A (HPLC water with 0.1% formic acid) and 5% buffer
B (HPLC grade acetonitrile with 0.1% formic acid) to 55% B over 30 min, next ramping
60

to 95% B over 10 min and holding 95% B for 10 min. One full MS scan (300-2000 MW)
was followed by 3 data dependent scans of the most intense ions with dynamic exclusion
enabled. The spray voltage was set to 1.94 kV and the flow rate through the column was
set to 0.25 μL/min.
2.4.15 Data analysis
For protein identification all generated .raw files were searched using the SQUEST
search algorithm under BioWorks 3.3.1 SP1. All searches were performed against a
concatenated indexed database containing the international protein index (IPI) mouse
database

v3.49,

the

UniProtKB/Swiss-Prot

HAMAP

(http://ca.expasy.org/sprot

/hamap/SALTY.html) database for S. typhimurium LT2/SGSC1412/ATCC700720, as
well as the most common protein lab contaminants.

The database was indexed in

BioWorks 3.3.1 with carbamidomethylation as static modification, trypsin as proteolytic
enzyme, ‘fully enzymatic’ as enzyme limit, 250-5000 as MW range, and 2 missed
cleavage sites. SEQUEST searches were conducted with monoisotopic precursor and
fragment masses, 50.00 ppm peptide tolerance, 1.0 AMU fragment ion tolerance, and B
and Y ion series calculated. Carbamidomethylation was selected as static modification,
methionine/tryptophan oxidation as well as asparagines/glutamine deamindation was
selected as variable modification. The generated unified search files .srf were opened in
Scaffold 2 (Proteome Software) and further analyzed. All searches were filtered in
Scaffold 2 for 99.9% protein probability, 2 unique peptides, and 95 % peptide
probability. Data was exported into Excel and further analyzed. All identifications with
hits in the Met control sample were discarded, as well as all identified contaminations
(e.g. keratins).
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3

A phenylalanine-based orthogonal amino acid reporter3

3.1

Abstract

Orthogonal amino acid reporters (unnatural amino acids carrying an azide or alkyne
motif, which can be cell-selectively incorporated) allow the selective labeling of different
cell types in heterogenous populations through the expression of engineered aminoacyltRNA synthetases. Previously described orthogonal amino acid reporters (AOA and
ANL, see chapter 2) are limited to proteins that contain at least one methionine. Other
amino acids are present more frequently and their substitution could allow more
quantitative proteome labeling. The following chapter discusses the development of a
phenylalanine-based orthogonal amino acid reporter, which allows labeling of the
bacterial pathogen S. typhimurium during infection of mammalian cells.
3.2

Introduction

Radiolabeled or stable isotope-labeled amino acids, coupled with mass spectrometry,
allow the differentiation of newly synthesized from pre-existing proteins (Schwanhäusser
et al. 2011). Nonetheless, it is still challenging to analyze changes in protein expression
of individual cell types from heterogeneous populations since these labeled amino acids
are incorporated into all proteomes. The differentiation of individual proteomes could
significantly aid in the analysis of complex cell mixtures, such as bacterial cells during

3

This work was carried out in collaboration with Paul Dossa (The Rockefeller

Univeristy) and Emma Taylor-Salmon (Bard College). Paul Dossa and Emma TaylorSalmon conducted some of the in vitro labeling experiments.
62

host infection. Robust methodologies are thus needed to differentiate the proteomes of
individual cell types and to separate them from protein contaminations of other cell types.
Two recently introduced orthogonal amino acid reporters provide a means for cellselective labeling of newly synthesized proteins with azide or alkyne reporter groups
through the expression of mutant methionyl-tRNA synthetases (MetRS*) (Ngo et al.
2009; Grammel et al. 2010). Expression of MetRS* in S. typhimurium allows the cellselective co-translational incorporation of the orthogonal amino acid reporters
azidonorleucine (ANL, Figure 19a) and 2-amino-7-octynoic acid (AOA, Figure 19a) into
newly synthesized bacterial proteins in place of methionine (Met) during infection of
mammalian cells. Since ANL and AOA are not activated by endogenous tRNA
synthetases, they are excluded from the mammalian proteome. The incorporation of AOA
permits the subsequent visualization and proteomic analysis of AOA-labeled proteins
using the Cu(I)-catalyzed alkyne-azide cycloaddition (CuAAC) with an azido-rhodamine
fluorescence dye and azobenzene-biotin affinity tags, respectively (Y.-Y. Yang,
Grammel, et al. 2010). Here we describe the use of para-ethynylphenylalanine (PEP,
Figure 19a) for efficient cell-selective labeling of S. typhimurium during infection of host
cells (Figure 19b).
Even though the majority of proteins contain at least one Met (e.g. 96% in S.
typhimurium LT2), in addition to the initiation Met, other amino acids are present more
frequently (e.g. 2.8% Met vs. 3.9% phenylalanine) and their replacement could permit
greater penetration of the bacterial proteomes with a corresponding amino acid reporter.
We therefore explored the possibility of alternative orthogonal amino acid reporters that
would replace one of the other proteinogenic amino acids present in higher frequency
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than Met. Interestingly, an E. coli phenylalanyl-tRNA synthetase (PheRS) mutant
(A294G, PheRS*) with increased substrate tolerance has been described that activates a
wide range of para-substituted phenylalanine (Phe) derivatives (Ibba et al. 1994;
Kirshenbaum et al. 2002). One of these derivatives, PEP, contains an alkyne chemical
handle for CuAAC and could thus be used as a chemical reporter.

Figure 19 A) PEP: para-ethynylphenylalanine, AOA: aminooctynoic acid, ANL:
azidonorleucine B) Infection of mammalian cells with Salmonella typhimurium
expressing a mutant phenylalanyl-tRNA synthetase (PheRS*) allows selective metabolic
labeling of the bacterial proteome with PEP during infection.

3.3

Results

3.3.1 Development of para-ethynylphenylalanine (PEP) as an orthogonal amino
acid reporter for the analysis of the S. typhimurium proteome during
infection
To achieve incorporation of PEP into S. typhimurium, we expressed the reported mutant
E. coli alpha chain of PheRS (PheS), containing the A294G mutation (PheSA294G), under
the control of the constitutively active lac-promoter using the low-copy plasmid pWSK29
(pWSK29_PheSA294G). Due to the high sequence conservation between the pheS gene in
E. coli and S. typhimurium (98%), we anticipated that the over-expressed mutant E. coli
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alpha chain would form a hybrid hetero tetramer with the endogenous copy of the S.
typhimurium PheRS beta chain (pheT) to generate active mutant PheRS*.

Figure 20 In-gel fluorescence analysis of PEP incorporation into the S. typhimurium
proteome in M9 minimal medium. a) S. typhimurium or S. typhimurium
pWSK29_PheSA294G was labeled with PEP in M9 minimal medium. b) S. typhimurium
pWSK29_PheSA294G was labeled with PEP, S. typhimurium pWSK29_MetGNLL (see
chapter 2) was labeled with AOA or ANL, in M9 minimal medium. PheRS*: expression
of PheSA294G, az-rho: azido-rhodamine, alk-rho: alkyne-rhodamine, rho: azido-rhodamine
or alkyne-rhodamine, CB: coomassie blue.

To assess metabolic incorporation of PEP into the proteome of S. typhimurium, S.
typhimurium pWSK29_PheSA294G and S. typhimurium pWSK29 was grown in liquid
culture and incubated with different concentrations of PEP in minimal medium. Cell
lysates were reacted with an azido-rhodamine fluorescent dye (az-rho) and analyzed by
in-gel fluorescence scanning. Expression of PheSA294G facilitated incorporation of PEP
into the S. typhimurium proteome, while wild-type S. typhimurium did not incorporate
PEP (Figure 20a). Comparison of PEP with the Met-based amino acid reporters AOA and
ANL showed comparable or even increased incorporation efficiency (Figure 20b), as
anticipated owing to the higher frequency of phenylalanine in the S. typhimurium
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proteome. PEP, indeed, serves as a phenylalanine surrogate in S. typhimurium (Figure
21a) and its incorporation is dependent on active ribosomal protein synthesis, since
tetracycline inhibition abrogated the observed fluorescence signal (Figure 21b).

Figure 21 Para-enthynylphenylalanine (PEP) serves as a co-translational chemical
reporter for phenylalanine in S. typhimurium. a) S. typhimurium pWSK29_PheSA294G was
incubated with PEP and increasing concentrations of phenylalanine (Phe) in M9 minimal
medium. b) S. typhimurium pWSK29_PheSA294G was incubated with PEP in the presence
of tetracycline (Tet) in M9 minimal medium. az-rho: azido-rhodamine, CB: coomassie
blue.

To evaluate the PEP/PheRS* system for cell-selective labeling, we analyzed S.
typhimurium infections of mammalian cells. Initial PEP labeling experiments in
RAW264.7 murine macrophages with minimal media revealed low level mammalian
proteome labeling, but incubation of macrophages with PEP in full medium containing
10% fetal bovine serum did not lead to any detectable amino acid incorporation (Figure
22a). These observations suggests that PEP can be utilized by the endogenous
translational machinery of mammalian cells at low levels, but it is readily competed away
in the presence of exogenous Phe. We then proceeded with macrophage infection
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experiments using S. typhimurium pWSK29_PheSA294G. After 16 hours of infection,
infected macrophages were pulse-labeled with PEP or Phe for 1 hour in full medium. The
cell lysates were then reacted with az-rho and analyzed for PEP incorporation by in-gel
fluorescence. Infection of macrophages with S. typhimurium pWSK29_PheSA294G resulted
in PEP labeling of numerous proteins (Figure 22b), while incubation of uninfected
macrophages with PEP did not yield any significant incorporation, suggesting selective
labeling of the bacterial cells inside the infected macrophages.

Figure 22 PEP incorporation into mammalian proteomes can be suppressed. a) In-gel
fluorescence analysis of para-ethynylphenylalanine (PEP) labeling of RAW264.7 murine
macrophages. HBSS: Hank’s buffered saline solution, DMEM: Dulbecco’s Modified
Eagle Medium, FBS: fetal bovine serum. b) In-gel fluorescence analysis of PEP-labeled
S. typhimurium pWSK29_PheSA294G-infected RAW264.7 murine macrophage cell lysates.
PEP: para-ethynylphenylalanine, STM-PheRS*: S. typhimurium pWSK29_PheSA294G, azrho: azido-rhodamine fluorescence, CB: coomassie blue.

To

confirm

pWSK29_PheSA294G

selective
during

incorporation

intracellular
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infection,
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typhimurium

performed

fluorescence

microscopy following CuAAC. In this case, infected RAW264.7 or HeLa cells were
fixed after pulse labeling with PEP and reacted with az-rho. Rhodamine fluorescence was
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only observed in the samples pulsed with PEP and was absent from Phe-treated samples
(Figure 23). The rhodamine signal co-localized well with anti-S. typhimurium antibody
staining and was absent from the mammalian cytosol, which demonstrates cell-selective
labeling of bacterial proteomes using the PEP/PheRS* system. While it is possible that
these amino acid reporters alter protein function or cell viability (Beatty et al. 2005; Ngo
& Tirrell 2011), in the context of our pulse-labeling experiments we did not observe
significant defects in protein expression, recovery, or cell viability.
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Figure

23

a)

Fluorescence

pWSK29_PheSA294G-infected

microscopy

RAW264.7

of

murine

PEP-labeled

S.

typhimurium

macrophages.

b)

Fluorescence

microscopy analysis of infected PEP pulse-labeled HeLa cells. HeLa cells were infected
with S. typhimurium pWSK29_PheSA294G and pulse-labeled with PEP 16 h after infection.
PEP: para-ethynylphenylalanine, Phe: phenylalanine, az-rho: azido-rhodamine (red), aSTM Alexa488: anti-S. typhimurium antibody stain visualized with secondary Alexa488
conjugate (green), DNA TO-PRO-3: DNA stain (blue), scale bar indicates 10 µm.

69

3.3.2 Double labeling of S. typhimurium with 2-amino-7-octynoic acid (AOA) and
para-ethynylphenylalanine (PEP)
PEP and AOA (or ANL) (see chapter 2) can be selectively incorporated into bacterial
pathogens instead of phenylalanine and methionine, respectively. We have also learned
that both systems share the intrinsic limitation to the corresponding subproteome,
containing either phenylalanine or methionine. A combination of the two reporter
systems might allow wider coverage of the proteome and a higher reporter incorporation
density per protein. The concomitant expression of PheSA294G and MetRS* (more
specifically MetGNLL, see chapter 2) in the same bacterium should allow for simultaneous
incorporation of PEP and AOA (Figure 19a) into the same proteome (Figure 24a). In
addition, the exclusive nature of azides and alkynes could provide a means of targeting
individual bacterial population in the same experiment by using PEP (alkyne) in
combination with ANL (azide) (Figure 19a, Figure 24b). The expression of MetGNLL in
one population would facilitate the incorporation of ANL, while the expression of
PheSA294G in a second population would allow the incorporation of PEP.

Figure 24 Double labeling with cell-selective phenylalanine and methionine surrogates a)
Double expression of MetRS* and PheRS* allows concomitant incorporation of AOA
and PEP. b) Individually MetRS* and PheRS* expressing strains can be differentiated.
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To provide concomitant MetRS* and PheRS* activity in the same S. typhimurium
strain a bicistronic expression construct was generated. PheSA294Gwas amplified by PCR
and a N-terminal HA-tag as well as a 5’ ribosomal binding site (RBS) was introduced
with the primers. The generated fragment was cloned into the previously described
pWSK29_MetGNLL construct (see chapter 2) to generate the bicistronic dual expression
construct pWSK29_MetRSNLL_PheRSA294G (Figure 25a). This construct was transformed
into S. typhimurium and incorporation of PEP and AOA was tested in vitro. Overnight
cultures of S. typhimurium pWSK29_MetGNLL, S. typhimurium pWSK29_PheSA294G, and
S. typhimurium pWSK29_MetRSNLL_PheRSA294G were diluted 1:30 into fresh LB medium
and grown for 3 hours. Aliquots of these cultures were pelleted and resuspended in equal
volumes of M9 minimal medium with PEP, AOA, or PEP and AOA. The dual bicistronic
expression construct facilitates PEP and AOA incorporation, even though a diminished
PEP incorporation can be observed in comparison to the pWSK29_PheSA294G construct
(Figure 25b). This might be due to a reduced expression level of PheSA294G, since it is the
second ORF on the bicistronic messanger RNA. Both proteins are expressed (MetGNLL as
well as PheSA294G), as controlled for by Western blot analysis (Figure 25b). The
concomitant labeling of the S. typhimurium pWSK29_MetRSNLL_PheRSA294G strain with
AOA and PEP yields increased labeling in comparison to all mono-labeling combinations
(Figure 25b). These experiments indicate that the simultaneous labeling with PEP and
AOA in combination with dual expression of MetGNLL and PheSA294G improves the overall
labeling amount.
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Figure 25 Dual labeling with PEP and AOA for improved labeling intensity. a) A
bicistronic expression construct for dual expression of MetGNLL and PheSA294G
pWSK29_MetGNLL_PheSA294G. b) In-gel fluorescence analysis of S. typhimurium strains
labeled with PEP, AOA, or PEP/AOA in minimal medium. aaRS: aminoacyl-tRNAsynthetase, AA: amino acid, az-rho: azido-rhodamine, CB: coomassie blue, α-Stag: antiStag antibody staining, α-HA: anti-HA tag antibody staining, RBS: ribosomal biding site.
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Figure 26 Dual labeling of infected cells. RAW264.7 In-gel fluorescence analysis of
cells, infected with S. typhimurium strains and pulse-labeled with AOA, PEP, or
AOA/PEP 16 hours post-infection. AA: amino acid, STM: S. typhimurium IR715,
MetG*:

pWSK29_MetGNLL,

PheS*:

pWSK29_PheSA294G,

MetG*/PheS*:

pWSK29_MetGNLL_PheSA294G, az-rho: azido-rhodamine fluorescence, CB: coomassie
blue.

To investigate the labeling efficiency of the dual labeling system during infection,
RAW264.7 macrophages were infected with stationary phase S. typhimurium
pWSK29_MetGNLL,

S.

typhimurium

pWSK29_PheSA294G,

or

S.

typhimurium

pWSK29_MetGNLL_PheSA294G, at an MOI of 50. 16 hours post-infection, the infected
macrophages were pulse labeled with 1 mM PEP, 1 mM AOA, or 1 mM PEP/1 mM
AOA for 1 hour. Analysis of total cell lysates of infected cells, generated by SDS lysis,
by CuAAC and in-gel fluorescence analysis, revealed that the dual expression construct
yields almost equal overall labeling intensities as the mono-expression constructs (Figure
26). Dual labeling with AOA and PEP of S. typhimurium pWSK29_MetGNLL_PheSA294G
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infected cells seems to provide a slightly elevated overall labeling intensity (Figure 26),
however this result was not constantly reproducible (data not shown), indicating a large
degree of variability in the infection setting, potentially due to amino acid uptake, or
aaRS expression issues.
In addition to the simultaneous labeling of a single bacterial strain with two
alkyne reporters (AOA and PEP) for improved proteome coverage, we also explored the
individual labeling of two different bacterial strains in the same experiment with
distinguishable reporters (PEP and ANL). The expression of MetRS* in one strain should
facilitate the exclusive incorporation of ANL while the expression of PheRS* on the
other strain should exclusively allow the incorporation of PEP. For this purpose
RAW264.7 macrophages were infected with an equal ratio of S. typhimurium pWSK29
MetGNLL and S. typhimurium pWSK29_PheSA294G. 16 hours post-infection, the dually
infected cells were pulse-labeled with a 1:1 mix of 1 mM PEP and 1 mM AOA for 1
hour. Subsequently the cells were prepared for fluorescence microscopy and successively
reacted with two orthogonal fluorescent dyes by CuAAC - alk-CyFur (a 2dicyanomethylene-3-cyano-2,5-dihydrofuran based dye) (Tsou et al. 2009) and az-rho,
which allow independent visualization of the tagged species my florescence microscopy.
Since the visualization of ANL incorporation in S. typhimurium during infection with alkCyFur has never been carried out before, singly infected cells with S. typhimurium
pWSK29_MetGNLL were pulse-labeled with ANL and imaged with alk-CyFur in parallel.
ANL was selectively incorporated into S. typhimurium pWSK29_MetGNLL inside
macrophages as was demonstrated by co-localization of the alk-CyFur fluorescence
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signal with anti-Salmonella antibody staining (Figure 27a). No alk-CyFur fluorescence
signal could be observed in the methionine labeled control sample. In the double infected,

Figure 27 Visualization of two independent bacterial populations using PEP and ANL. a)
RAW264.7 cells were infected with S. typhimurium pWSK29_MetGNLL and pulse-labeled
with ANL. Infected cells were visualized with alk-Cy-Fur (Tsou et al. 2009). Blue: DNA
Sytox Orange, green: anti-Salmonella antibody stain, red: alk-CyFur. b) RAW264.7 cells
were infected with S. typhimurium pWSK29_PheSA294G and S. typhimurium
pWSK29_MetGNLL and pulse-labeled with PEP and ANL. Cells were visualized with alkCyFur and az-rho. Red: alk-CyFur, green: az-rho. (MetG*: pWSK29_MetGNLL, PheS*:
pWSK29_PheSA294G, az-rho: azido-rhodamine, alk-CyFur: alkyne-cyanofuran based dye.)
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PEP and AOA co-labeled macrophages, two distinct populations of bacteria could be
identified. The fluorescence images clearly showed alk-CyFur positive bacteria,
indicating ANL incorporation (red, Figure 27b) and therefore pWSK29_MetGNLL
identity, as well as az-rho positive bacteria (green, Figure 27b), indicating PEP
incorporation and therefore pWSK29_PheSA294G identity. No bacteria showed colocalization of both fluorescence dyes, indicating highly selective incorporation of the
two orthogonal amino acid reporters. Interestingly, most infected mammalian cells
harbored only one bacterial strain (red or green), only in a few isolated cases both strains
were present in the same macrophage (Figure 27b, blow-up). Such a scenario could arise
from a secondary infection over the course of the replication period or from two
synchronous infections during the infection period.
3.4

Materials and Methods

3.4.1 Chemical reagents
Azido-rhodamine (az-rho), alkyne-rhodamine (alk-rho), alk-CyFur, and TBTA (tris((1benzyl-1H-1,2,3-triazol-4-yl)methyl) amine) were generated by the Hang laboratory as
previously described (Charron et al. 2009; Tsou et al. 2009). PEP, AOA, and ANL were
generated as previously described ((Kirshenbaum et al. 2002; Grammel et al. 2010). All
other chemical reagents were purchased from Sigma-Aldrich.
3.4.2 Plasmids and bacterial strains
Salmonella typhimurium IR715 was transformed with pWSK29 encoding the A294G
mutant of the E. coli pheS gene. PheS was amplified from E. Coli K12 by PCR (primer 1
and primer 2) and sub-cloned into pJET1.2. The resulting fragment contained a mutation
relative to the reported UniProt sequence (P08312, D258N, GAC to AAC), which was re76

mutated to the reference sequence together with the introduction of mutation (A294G) by
use of the QuickChange Multi Site-Directed Mutagenesis Kit (Stratagene, primer 3,
primer 4). The fragment was excised from pJET1.2 and inserted into pWSK29 with SacI
and KpnI to generate pWSK29_PheSA294G.
To

generate

pWSK29_MetGNLL_PheSA264G,

PheSA264G

was

amplified

from

pWSK29_PheSA264G with the primer 5 and primer 6. The resulting fragment was cloned
into pWSK29_MetGNLL(Grammel et al. 2010) with SalI and KpnI.
Table 1 Primers for PheSA264G expression constructs.
1

GAGCTCCATGTCACATCTCGCAGAACTGG

2

GGTACCCGCATCGCTATCAATCGCC

3

GAACCTTCTGCAGAAGTGGACGTCATGGGTAAAAACG

4

GTTTACTCTGGTTTCGGCTTCGGGATGGGGATG

5

GTCGACTGAGGAAAACCATGTACCCGTACGACGTGCCGGATTACGCG
TCACA

6

GGTACCCGCATCGCTATCAATCGCCGG

3.4.3 Bacterial pulse labeling in liquid culture
Overnight cultures of bacteria were grown in full LB with 100 µg/ml Carbenicillin (Cb).
These cultures were then diluted 1:30 into fresh LB (Cb) and grown to stationary phase.
Bacteria were collected by centrifugation (10,000 rpm, 3 min) and resuspended in M9 (1x
M9 salts, 20 mM glucose, 2 mM MgSO4, 100 µM CaCl2) minimal medium (Cb). Bacteria
were grown in minimal medium for 15 min and collected by centrifugation. Bacterial
pellets corresponding to 1 ml of culture volume were resuspended in M9 minimal
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medium (Cb) containing the chemical reporter. Bacteria were labeled for 1 hour and
collected by centrifugation, washed once in PBS, and stored at -80 °C. For tetracycline
(Tet) protein synthesis inhibition, bacteria were grown for 30 min in LB (40 µg/ml Tet)
before being labeled for 30 min in M9 minimal medium (40 µg/ml Tet).
3.4.4 Infection of mammalian cells and pulse labeling
For fluorescence microscopy experiments, 3 x 105 RAW264.7 cells were split into 12
well plates 24 h before infection on round glass cover slips. For subsequent cell lysis and
in-gel fluorescence experiments, 1.5 x 106 RAW264.7 cells were split into 6 well plates
24 h before infection. An LB overnight culture of Salmonella was diluted 1:30 into fresh
LB with 100 µg/ml carbenicillin and grown to stationary phase (OD600 > 2.0). Bacteria
were collected by centrifugation and washed once with cold PBS. For a multiplicity of
infection (MOI) of 100, an appropriate volume of bacteria in PBS was added to DMEM
(10% FBS) and put on ice for 30 min. Bacteria in DMEM (10% FBS) were added to
RAW264.7 cells and centrifuged at 1000g for 5 min at 4 °C. The infection was allowed
to proceed for 25 min at 37 °C at 5% CO2. The wells were then washed 4 times with PBS
before the cells were covered in DMEM (10% FBS) with 100 µg/ml gentamicin and
incubated or 90 min at 37 °C at 5% CO2 to kill all extracellular bacteria. Subsequently,
wells were washed 2 times with PBS and filled with DMEM (10% FBS) with 12.5 µg/ml
gentamicin. The cells were further incubated for 14.5 h at 37 °C at 5% CO2. The cells
were pulse labeled with 1 mM PEP in full medium (DMEM 10% FBS) for 1 h at 37 °C at
5% CO2. After 1 h the cells were washed 4 times with cold PBS.
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3.4.5 Cell lysis, click-chemistry, and in-gel fluorescence analysis
For cell lysis, infected RAW264.7 cells were collected by scraping in ice-cold PBS and
centrifugation at 1000g for 5 min at 4 °C. Cell pellets were lysed by resuspending them in
0.1% SDS in PBS with Roche complete protease inhibitor, 1 mM PMSF, and 1 µl
benzonase/ml (Sigma E1014), and then sonicating them for 30 s in a water bath sonicator,
followed by 10 min incubation on ice. Samples were filled up with 12% SDS in PBS to a
final concentration of 4% SDS and sonicated again. Then, remaining debris was removed
by centrifugation at 20,000g for 10 min at room temperature. Protein concentrations were
determined by BSA assay (Pierce). For click-chemistry, 50 µg of cell lysate from each
sample was filled up to the smallest common volume with 4% SDS in PBS. A click
chemistry master mix was prepared and added to each sample: 100 µM azido-rhodamine
(az-rho) from a 10 mM stock solution in DMSO, 1 mM TCEP (tris(2carboxyethyl)phosphine) from a 50 mM stock solution in water (freshly prepared), 100
µM TBTA (tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine) from a 2 mM stock
solution in 4:1 n-butanol:DMSO, and 1 mM CuSO4 from a 50 mM stock solution in water
(freshly prepared).
The components were added in the order listed above to the master mix and vigorously
vortexed. Then the master mix was added to each individual protein sample to yield a
final volume of 50 µl at the final concentrations indicated. The samples were incubated
for 1 h at room temperature.
The samples were precipitated after click chemistry to remove small molecules. For this
purpose, 50 µl of water was added to each sample, followed by 400 µl of methanol, and
100 µl of chloroform. The samples were vigorously vortexed and 300 µl of water was
added. The samples were vortexed again and centrifuged at 20,000 g for 5 min at room
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temperature. The upper phase was removed carefully and 1 ml of ice-cold aetone was
added. The samples were vortexed and centrifuged at 20,000 g for 15 min at 4 °C. The
organic supernatant was discarded and the samples briefly dried on air. Then, the samples
were resuspended in 30 µl 4% SDS in PBS and briefly sonicated. 10 µl of 4 times
Laemmli buffer was added to each sample together with 2 µl of beta-mercaptoethanol,
samples were incubated at 95 °C for 5 min, and run for analysis on a 4-20% Tris-HCl
Criterion™ Precast Gel (Biorad). Protein gels were rinsed with deionized water and
incubated for multiple hours in 50% water, 40% methanol, 10% acetic acid at 4 °C.
Before in-gel fluorescence analysis, protein gels were transferred to deionized water and
incubated for at least 30 min at room temperature. Protein gels were scanned on an
Amersham Bioscience Typhoon 9400 variable mode imager (excitation 532 nm, 580 nm
filter, 30 nm band-pass). All image adjustments were done on the entire depicted image
for all samples equally in Adobe® Photoshop® CS3. After fluorescence scanning,
protein gels were stained with GelCode Blue Stain Reagent (Thermo) or Coomassie
Brilliant Blue (BioRad). Both stains are indicated as coomassie blue (CB) in all figures.
3.4.6 Sample preparation for fluorescence microscopy
For fluorescence microscopy, cells were fixed and permeabilized in 3.7%
paraformaldehyde, 0.2% Triton X-100 in PBS for 15 min at room temperature. The cells
were then washed at least 4 times for 5 min each with PBS. A click-chemistry master mix
was prepared from stock solutions listed above to yield the following final concentrations
in PBS (20 µM az-rho, 1 mM TCEP, 100 µM TBTA, 1 mM CuSO4). The cells were
covered in click chemistry master mix and incubated for 1 h at room temperature. Then,
the cells were blocked for 1 h with 2% FBS, 1% Tween 20 in PBS at room temperature.
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The cells were washed once with PBS and anti-S. typhimurium serum was added (1:250)
in 0.2% saponin in PBS for 30 min at room temperature. The cells were washed 4 times
with PBS and subsequently incubated with anti-rabbit Alexa488-conjugated antibody in
0.2% saponin in PBS for 30 min at room temperature. Cells were washed in PBS and
finally incubated with TO-PRO-3 DNA stain (1:1000) in 0.2% saponin in PBS. The cells
were washed once with 0.2% saponin in PBS and 4 times in PBS before mounting on
microscope slides in ProLong Gold (Invitrogen). The images were taken on an upright
LSM510 laser scanning confocal microscope (Zeiss) equipped with a Krypton/Argon
laser with 488 and 568 lines and a HeNe laser with a 633 line, using a 100x oil
immersion objective.
For dual labeling experiments, sample preparation was conducted equally with small
changes. After permeabilization and fixation the first CuAAC with alk-CyFur was carried
out with 200 µM alk-CyFur for 1 hours at room temperature. The samples were washed
two times with 20% methanol in PBS for 10 min to remove any un-reacted CuAAC
reagents. The samples were washed with PBS and the second CuAAC with 20 µM az-rho
was carried out. Since the emission spectrum of TO-PRO-3 overlaps with the emission
spectrum of alk-CyFur DNA was visualized with the DNA stain Sytox Orange (1:1000
dilution of a 5 mM stock).
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4

Methionine amino acid reporters based on homoserine, homocysteine, and
cysteine

4.1

Abstract

Orthogonal

amino

acid

reporters,

such

as

2-amino-7-octynoic

acid

(AOA),

azidonorleucine (ANL), or para-phenylalanine (PEP) enable the cell-selective labeling of
bacterial populations in the presence of mammalian cells. Their incorporation is
dependent on the heterologous expression of mutant E. coli aminoacyl-tRNA-synthetases
(aaRS), which requires stable transformation with a plasmid encoding the aaRS or stable
integration of the aaRS gene into the bacterial chromosome. Far from all bacterial species
are amenable to these genetic manipulations. Therefore it would be highly beneficial for
the study of bacterial pathogenesis, if amino acid reporters could be developed with
intrinsic selectivey for the bacterial translational machinery. Here, I present the initial
progress towards such an intrinsically selective amino acid reporter.
4.2

Introduction

Protein expression is a highly dynamic process that is tightly regulated by intrinsic
cellular signals as well as external environmental cues. In particular, bacterial pathogens
adapt to environmental changes during the course of a host infection by dramatically
altering their protein expression. Many pathogens produce the necessary gene products
for infection (virulence factors) just in time as they encounter different host environments
(e.g. gut, cell surface, cytosol, intracellular vacuolar compartments). Capturing these
dynamic changes is indispensable for a complete understanding of the pathogen-host
interaction and promises to be helpful in combating the incipient downturn of effective
antimicrobials.
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To this end selective labeling methods have been developed that can take snapshots of the newly synthesized bacterial proteome during infection of mammalian cells.
Orthogonal amino acid reporters (unnatural amino acids) with alkyne or azide reporter
groups can be selectively and co-translationally incorporated into the bacterial proteome
through the over-expression of engineered aminoacyl-tRNA-synthetases (aaRS). These
reporters allow tagging of newly synthesized proteins with fluorescence dyes for
visualization or affinity enrichment tags for mass spectrometry-based protein
identification by the Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC).
Two methionine surrogates, azidonorleucine (ANL) and 2-amino-7-octynoic acid
(AOA) can be activated by various E. coli methionyl-tRNA-synthetase (MetRS) mutants
(MetRS*) and selectively incorporated into E. coli or intracellularly replicating S.
typhimurium in the presence of translationally active host cells. In addition, paraethynylphenylalanine (PEP) can also be used as an orthogonal amino acid reporter, since
its activation is dependent on a mutant E. coli phenylalanyl-tRNA synthetase (PheRS*).
We have learned that the over-expression of these E. coli aaRS mutants facilitate the
required enzymatic activity in the distinct, but closely related species, S. typhimurium.
However, in an evolutionarily more distant species the heterologous E. coli aaRS might
not recognize the cognate tRNA anymore and therefore would not activate ANL or AOA.
Furthermore, various bacterial pathogens are not yet genetically tractable and would not
permit heterologous over-expression of a mutant aaRS. In our studies of alternative
alkynyl orthogonal amino acid reporters we came across a potential solution for these
problems, an intrinsically selective orthogonal amino acid reporter.
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4.3

Results

Even tough AOA provides better signal-to-noise than the isosteric azide reporter (ANL)
in S. typhimurium, the low yield of its synthetic route (<10% of L-AOA) led us to
investigate alternative reporter scaffolds for methionine. The direct alkylation of
homocysteine or homoserine with alkynyl electrophiles should provide facile synthetic
routes for the large-scale synthesis of enantiomerically pure potential amino acid
reporters for methionine, with a sulfur or oxygen at the same position as in methionine.
Therefore we synthesized (S)-2-amino-4-(prop-2-yn-1-ylthio)butanoic acid (EME) from a
N-tert-butoxycarbonyl-protected L-homocysteine thiolactone and (S)-2-amino-4-(prop-2yn-1-yloxy)butanoic acid (PHS) from N-tert-butoxycarbonyl-protected

L-homoserine.

EME constitutes an ethynyl-derivative of methionine displaying the sulfur-heteroatom at
the same position as methionine. PHC, the isoster of EME, has oxygen at the position of
sulfur. We further wanted to test whether MetRS might still accept more diverse
derivatives, with a switched sulfur-position, and therefore generated (R)-2-amino-3-(but3-yn-1-ylthio)propanoic acid (BCY) from N-acetyl-protected

L-cysteine

and (R)-2-

amino-3-(prop-2-yn-1-ylthio)propanoic acid (PCY) fom N-acetyl-protected L-cysteine.

S
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Figure 28 Potential methionine surrogates. (S)-2-amino-4-(prop-2-yn-1-ylthio)butanoic
acid (EME), (S)-2-amino-4-(prop-2-yn-1-yloxy)butanoic acid (PHS), (R)-2-amino-3(but-3-yn-1-ylthio)propanoic acid (BCY), (R)-2-amino-3-(prop-2-yn-1-ylthio)propanoic
acid (PCY).
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Figure 29 PHS and EME are incorporated into the S. typhimurium proteome. a) S.
typhimurium pWSK29, pWSK29_MetG, pWSK29_MetGL13G, pWSK29_MetGNLL, or
pWSK29_MetGPLL was incubated with PHS, BCY, PCY, or EME in M9 minimal
medium, lysed, and analyzed by SDS-PAGE and in-gel fluorescence scanning. az-rho:
azido-rhodamine, CB: coomassie blue.

Next, we tested incorporation of EME, PHC, BCY, and PCY in S. typhimurium as
a function of heterologous MetRS activity. EME, PHC, BCY, and PCY was added to S.
typhimurium, expressing different MetG mutants, grown in M9 minimal medium and
analyzed the generated cell lysates by CuAAC with azido-rhodamine (az-rho) and in-gel
fluorescence scanning. This analysis revealed that EME and PHC are incorporated into
the S. typhimurium proteome upon expression of the MetRS mutants L13G, NLL, and
PLL (Figure 29). Furthermore the mere over-expression of wild-type MetRS also sufficed
to incorporate EME or PHC. But most interestingly, EME was even accepted by wildtype S. typhimurium without the over-expression of any MetRS (Figure 29). EME serves
as an amino acid reporter for methionine, which is incorporated co-translationally.
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Provided that mammalian cells do not accept EME, it could therefore serve as an
intrinsically selective amino acid reporter for wild-type S. typhimurium and potentially
other bacterial pathogens.

Figure 30 EME serves as an amino acid reporter for wild type S. typhimurium that is cotranslationally incorporated instead of methionine. a) S. typhimurium IR715 was
incubated with increasing concentrations of methionine (Met) and EME in M9 minimal
medium. b) S. typhimurium IR715 was incubated with EME in the presence of
tetracycline (Tet) in M9 minimal medium. az-rho: azido-rhodamine, CB: coomassie blue.

To test this hypothesis we conducted infection experiments with wild-type S.
typhimurium and RAW264.7 macrophages. Before and 10 hours post-infection we pulse
labeled with 1 mM Met, 1 mM EME or 1 mM homopropargylglycine (HPG) for 1 hour.
HPG is an unselective amino acid reporter for methionine that is incorporated into
mammalian and bacterial proteomes. The infected cells were fixed, reacted with az-rho
by CuAAC and further prepared for analysis by fluorescence microscopy. EME was
selectively incorporated into bacterial cells shortly after infection (0 hours) or 10 hours
post-infection, as was indicated by the co-localization of the az-rho signal with the anti-S.
typhimurium antibody staining and the absence of az-rho signal from the mammalian
cytosol. In contrast, HPG was readily incorporated into bacterial and mammalian cells, as
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Figure 31 EME allows selective labeling of wild-type S. typhimurium during
infection of mammalian cells and visualization by fluorescence microscopy.
RAW264.7 macrophages were infected with wild-type S. typhimurium and pulse
labeled with Met, HPG, or EME 0 hours after infection (a) or 10 hours (b) postinfection. az-rho: azido-rhodamine (red), a-STM: anti-S. typhimurium antibody
staining (green), DNA: DNA staining with TO-PRO-3, Met: methionine, HPG:
homopropargylglycine.
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was expected. No az-rho signal was observed in the Met labeled samples. These data
show that EME possesses intrinsic selectively for incorporation into S. typhimurium and
exclusion from mammalian proteomes.
For a more detailed analysis of the labeled proteomes we also investigated EME
incorporation into S. typhimurium during infection of macrophages by SDS-PAGE and
in-gel fluorescence scanning. For this purpose macrophages were infected with wild-type
S. typhimurium 14028 and pulse-labeled with 1 mM EME 16 hours post-infection for 1
hour. Since we have learned previously that pulse-labeling in full growth medium can
reduce the incorporation of the orthogonal amino acid reporter into the mammalian
proteome, we tested EME incorporation in full growth medium as well as Met-depleted
growth medium. While we could clearly detect EME incorporation in the presence of S.
typhimurium, we also observed EME labeling of the mammalian proteome, which was
not diminished by the presence of Met in the growth medium. We attribute the
discrepancy between the in-gel and the fluorescence microscopy data, to the better
dynamic range of the in-gel analysis. Even though EME does most likely not provide
sufficient selectivity for the bacterial proteome for all applications (in particular mass
spectrometry based proteomics), it provides a starting point for further developments.
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Figure 32 Full medium does not reduce EME incorporation into the mammalian
proteome. RAW264.7 macrophages were infected with wild-type S. typhimurium and
pulse-labeled with EME 16 hours post-infection. Cells were lysed, reacted with az-rho by
CuAAC, and analyzed by SDS-PAGE and in-gel fluorescence scanning. az-rho: azidorhodamine, CB: coomassie blue, DMEM-Met: Dulbecco’s Modified Eagle Medium
without methionine, full medium: full DMEM with 10% fetal bovine serum.
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Figure 33 PHS and EME are incorporated into various bacterial species. S. typhimurium,
P. aeruginosa, C. violaceum, B. subtilis, and M. smegmatis were pulse-labeled with PHS
or EME in M9 minimal medium. Cell were lysed, reacted with az-rho by CuAAC, and
analyzed by SDS-PAGE and in-gel fluorescence scanning. Iden. metG: percentage
identity between individual metG genes and the metG gene of S. typhimurium. az-rho:
azido-rhodamine, CB: coomassie blue, AA: amino acid, EME: : (S)-2-amino-4-(prop-2yn-1-ylthio)butanoic acid, PHS: (S)-2-amino-4-(prop-2-yn-1-yloxy)butanoic acid.

To assess the general possibility to use these kinds of amino acid reporters in
other bacterial species, which might benefit more from an intrinsically selective amino
acid reporter than S. typhimurium, we tested EME and PHS incorporation in a variety of
other bacterial species: P. aeruginosa, C. violaceum, B. subtilis, and M. smegmatis. All of
the tested species incorporated EME and PHS, yet none of them as efficiently as S.
typhimurium. The observed fluorescence intensity (incorporation level) did not scale with
the percentage identity of the corresponding metG genes with the S. typhimurium metG
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gene (P. aeruginosa 66 %, C. violaceum 58 %, B. subtilis 29 %, M. smegmatis 26 %). In
addition to MetRS activity, differences in amino acid reporter uptake and metabolization
could also cause the observed differences in incorporation levels. These data emphasizes
the requirement for empiric determination of amino acid reporter acceptance and also the
possibility to use amino acid reporters like PHS or EME as orthogonal amino acid
reporters.
Although EME was not completely excluded from the mammalian proteome we
wanted to experimentally address the observed differences in EME incorporation
between S. typhimurium and mammalian cells. We hypothesized that the difference is
largely due to discrepant MetRS specificities. Over-expression of E. coli MetRS might
therefore rescue the mammalian EME incorporation deficiency, provided the bacterial
enzyme is able to properly interact with the mammalian tRNA. Indeed, over-expression
of E. coli MetRS in 293T cells improved EME incorporation, while HPG incorporation (a
known mammalian and bacterial amino acid reporter for Met) was not elevated to the
same extent. Over-expression of E. coli MetRS improved EME labeling almost to the
same level as the proper mammalian amino acid reporter HPG. From this preliminary
experiment we concluded that the reduced EME incorporation rate in mammalian cells
could be most likely attributed to differences in MetRS activity, rather than amino acid
reporter uptake or metabolization, parameters that should not have been changed by E.
coli MetRS heterologous expression.
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Figure 34 Over-expression bacterial methionyl-tRNA-synthetase (MetG) facilitates
increased EME incorporation into the mammalian proteome. 293T cells were transiently
transfected with a pEGFP-MetG expression construct generating a MetG-GFP protein
fusion and pulse-labeled with HPG or EME. Cells were lysed, reacted with az-rho by
CuAAC, and analyzed by SDS-PAGE and in-gel fluorescence scanning. HPG:
homopropargylglycine, EME: (S)-2-amino-4-(prop-2-yn-1-ylthio)butanoic acid, α-GFP:
anti-GFP Western Blot analysis.
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4.4

Materials and methods

4.4.1 Synthesis of (S)-2-amino-4-(prop-2-yn-1-yloxy)butanoic acid (PHS)
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Figure 35 Synthesis of (S)-2-amino-4-(prop-2-yn-1-yloxy)butanoic acid (PHS).

A 100 ml flame dried round bottom flask was charged with 25 ml anhydrous
dimethylformamide

under

argon

atmosphere.

2-((tert-butoxycarbonyl)amino)-4-

hydroxybutanoic acid (500 mg, 2.28 mmol) was added to the reaction vessel under stirring
and the reaction mix was cooled to 0 °C. Sodium hydride (137 mg, 5.70 mmol) was added
to the reaction mix under stirring. After H2 evolution had ceased propargyl bromide (339
mg, 2.85 mmol) was added under stirring and the reaction was allowed to warm up to room
temperature and was stirred for 2 h. The reaction was quenched with water and the solvents
were evaporated under reduced pressure. The resulting material was resuspended in water
and washed with ethyl acetate and diethylether. The aqueous solution was acidified with
sodium bisulfate (1 M) and extracted with 3 portions of ethyl acetate. The organic fractions
were pooled and dried over magnesium sulfate, filtered and evaporated under reduced
pressure. The resulting material was purified by column chromatography over silica gel
using 3% methanol in dichloromethane to yield (S)-2-((tert-butoxycarbonyl)amino)-4(prop-2-yn-1-yloxy)butanoic acid (43%). 1H NMR (600 MHz, CDCl3): 5.37-5.36 (d, 1H),
4.31 (s, 1H), 4.08-4.01 (m, 2H), 3.58-3.53 (m, 2H), 2.36 (s, 1H), 2.07-1.95 (m, 2H). 13C
NMR (600 MHz, CDCl3): 176.45, 155.70, 80.05, 79.3, 74.75, 66.27, 58.17, 51.46, 31.59,
28.29. Theoretical mass: 257.13, mass observed: [M+Na]+ 280.08, [M+2Na-H]+ 302.08.
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(S)-2-((tert-butoxycarbonyl)amino)-4-(prop-2-yn-1-yloxy)butanoic acid (271 mg, 1.05
mmol) was dissolved in3 ml concentrated HCl and stirred for 1.5 hours at room
temperature. The reaction mix was diluted with 15 ml water and purified over Dowex
50WX-100 to yield the final product (S)-2-amino-4-(prop-2-yn-1-yloxy)butanoic acid
(PHS) (75%). 1H NMR (600 MHz, D2O): 4.09 (s, 2H), 3.75-3.73 (m, 1H), 3.67-3.61 (m,
2H), 2.75 (s, 1H), 2.12-1.96 (m, 2H). 13C NMR (600 MHz, D2O): 173.94, 79.07, 75.76,
66.82, 57.90, 53.44, 29.65. Theoretical mass: 157.0739, mass observed: [M+H]+
158.2096.
4.4.2 Synthesis of (S)-2-amino-4-(prop-2-yn-1-ylthio)butanoic acid (EME)
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Figure 36 Synthesis of (S)-2-amino-4-(prop-2-yn-1-ylthio)butanoic acid (EME).

A flame dried 50 ml round bottom flask equipped with a condenser was charged with 10
ml anhydrous methanol and sodium methoxide (26 mg, 4.83 mmol) was added under
argon atmosphere and dissolved under stirring at room temperature. (S)-N-tertbutoxycarbonyl-homocysteine thiolactone (100 mg, 4.6 mmol) was added and the
reaction mixture was incubated for 10 min at room temperature under stirring. Propargyl
bromide (66 mg, 5.52 mmol) was added and the reaction mixture was refluxed for 3 h.
The reaction mixture was cooled to ambient temperature and quenched with water. The
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solvents were evaporated under reduced pressure. The resulting material was resuspended
in ethyl acetate and washed with concentrated sodium bicarbonate, 1 M sodium bisulfate
and brine. The organic fraction was dried over magnesium sulfate, filtered and
evaporated under reduced pressure. The resulting material was purified by column
chromatography over silica gel with 15% ethyl acetate in hexanes to yield (S)-methyl 2((tert-butoxycarbonyl)amino)-4-(prop-2-yn-1-ylthio)butanoate (63 %). 1H NMR (600
MHz, CDCl3): 5.10-5.09 (m, 1H), 4.42-4.41 (m, 1H), 3.73 (s, 3H), 3.23 (d, 2H), 2.732.70 (t, 2H) 2.21 (s, 1H), 2.15-2.12 (m, 1H), 1.95-1.91 (m, 1H), 1.42 (s, 9H). 13C NMR
(600 MHz, CDCl3): 172.71, 155.31, 80.11, 79.57, 71.30, 52.66, 52.49, 32.14, 29.72,
28.33, 27.21, 19.10.

(S)-methyl 2-((tert-butoxycarbonyl)amino)-4-(prop-2-yn-1-ylthio)butanoate (83 mg) was
dissolved in 8 ml water and acetonitrile (1:1) and stirred at room temperature. Lithium
hydroxide (6.92 mg) was dissolved in water and acetonitrile (1:1) and slowly added to the
stirred reaction mixture. The reaction mixture was stirred at room temperature for 90 min.
The organic solvent was evaporated under reduced pressure and the remaining aqueous
phase was acidified with 1 M sodium bisulfate. The aqueous phase was extracted three
times with ethyl acetate and the organic fractions were pooled, dried over magnesium
sulfate, filtered and evaporated under reduced pressure. The resulting material was
purified by column chromatography over silica gel with 5% methanol in dichloromethane
to 10% methanol in dichloromethane to yield (S)-2-((tert-butoxycarbonyl)amino)-4(prop-2-yn-1-ylthio)butanoic acid (59%). 1H NMR (600 MHz, CD3OD): 4.20-4.13 (m,
1H), 3.28 (m, 2H), 2.76-2.67 (m, 2H), 2.56 (s, 1H), 2.10-1.88 (m, 2H), 1.42 (s, 9H). 13C
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NMR (600 MHz, CD3OD): 171.62, 156.75, 79.45, 79.11, 70.94, 60.19, 52.76, 31.02,
27.37, 27.25, 17.96, 13.13. Theoretical mass: 273.10, observed mass: [M+Na]+ 296.08,
[M+2Na-H]+ 318.08.

(S)-2-((tert-butoxycarbonyl)amino)-4-(prop-2-yn-1-ylthio)butanoic acid was dissolved in
3 ml concentrated HCl and stirred for 1.5 hours at room temperature. The reaction mix
was diluted with 15 ml water and purified over Dowex 50WX-100 to yield the final
product (S)-2-amino-4-(prop-2-yn-1-ylthio)butanoic acid (EME) (45%). 1H NMR (600
MHz, D2O): 3.76-3.73 (t, 1H, J = 6.24), 3.44-3.37 (m, 2H), 2.87-2.84 (m, 2H), 2.69-2.68
(m, 1H), 2.32-2.15 (m, 2H).

13

C NMR (600 MHz, D2O): 174.06, 80.34, 72.18, 53.82,

29.84, 26.52, 18.03. Theoretical mass: 173.0510, observed mass: [M+H]+ 174.1730.
4.4.3 Synthesis of (R)-2-amino-3-(but-3-yn-1-ylthio)propanoic acid (BCY)
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Figure 37 Synthesis of (R)-2-amino-3-(but-3-yn-1-ylthio)propanoic acid (BCY).

A 50 ml flame dried round bottom flask equipped with a condenser was charged with 12
ml anhydrous ethanol under argon atmosphere. N-acetyl-cysteine (212 mg, 1.30 mmol)
was added to the reaction vessel under stirring at room temperature. Sodium ethoxide
(195 mg, 2.86 mmol) was added to the reaction mix from a 21 wt. % solution of sodium
ethoxide in ethanol and the reaction mix was stirred for 10 min at room temperature. Iodo
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butyne (281 mg, 1.56 mmol) was added and the reaction mix was refluxed for 3 h. Since
the starting material was not completely consumed (TLC) another 0.6 eq. of iodobutyne
was added and the reaction mix was refluxed for 1h, after which starting material was
completely consumed (TLC). The reaction was quenched with water and the solvents
were evaporated under reduced pressure. The resulting material was purified by column
chromatography over silica with 10% methanol, 0.5% acetic acid in ethyl acetate to yield
(R)-2-acetamido-3-(but-3-yn-1-ylthio)propanoic acid (60%). 1H NMR (600 MHz,
CD3OD): 4.61-4.59 (m, 1H), 3.11-3.08 (dd, 1H, 4.8, 13.8), 2.91-2.87 (dd, 1H, 7.8, 13.8),
2.73-2.71 (t, 2H), 2.48-2.45 (m, 2H), 2.30 (s, 1H), 2.01 (s, 3H). 13C NMR (600 MHz,
CD3OD): 170.73, 170.36, 80.35, 67.76, 50.74, 50.74, 31.57, 29.30, 19.45, 17.65.
Theoretical mass: 215.06, observed mass: [M+Na]+ 238.00, [M+2Na-H]+ 260.00.

(R)-2-acetamido-3-(but-3-yn-1-ylthio)propanoic acid (127 mg) was dissolved in 7 ml
water and the pH was adjusted to 7.8 pH with 1 M NH4OH and 1 M HCl. 1.5 mg of
acylase I was added and the reaction mix was carefully stirred over night at 37 °C. The
reaction mix was cooled to ambient temperature and 15 mg activated charcoal was added.
The reaction mix was filtered through a glasswool, sand, Celite plug, which was rinsed
with water. The aqueous solution was extracted with ethyl acetate and the observed
precipitate in the aqueous layer was removed by filtration. The aqueous solvent was
evaporated at 40 °C under reduced pressure and the resulting material was dissolved in 1
M HCl and purified over Dowex 50WX-100 to yield the final product (R)-2-amino-3(but-3-yn-1-ylthio)propanoic acid (BCY) (84%). 1H NMR (600 MHz, D2O): 3.99-3.97
(m, 1H), 3.04-3.01 (dd, 1H, 4.2, 15), 2.91-2.88 (dd, 1H, 7.2, 15), 2.56-2.54 (m, 2H), 2.33-
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2.31 (m, 2H), 2.17 (s, 1H).

13

C NMR (600 MHz, D2O): 171.11, 83.16, 70.43, 52.49,

31.29, 30.08, 18.66. Theoretical mass: 173.0510, observed mass [M+H]+ 174.2300.
4.4.4 Synthesis of (R)-2-amino-3-(prop-2-yn-1-ylthio)propanoic acid (PCY)
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Figure 38 Synthesis of (R)-2-amino-3-(prop-2-yn-1-ylthio)propanoic acid (PCY).

A 50 ml flame dried round bottom flask was charged with 6 ml anhydrous ethanol under
argon atmosphere. N-acetyl-cysteine (300 mg, 1 eq.) was added and dissolved and
sodium ethoxide in ethanol (21%) (273 mg, 2.2 eq.) was added at room temperature. The
reaction mix was incubated for 10 min at room temperature. Propargyl bromide (262 mg,
1.2 eq.) was added and the reaction mix was refluxed for 2.5 hours. The reaction mix was
cooled to ambient temperature and quenched with water. The organic solvent was
evaporated under reduced pressure and the reaction mix was acidified with 1 M HCl. The
reaction mix was extracted 3 times with ethyl acetate and the pooled organic fractions
were dried over magnesium sulfate and evaporated under reduced pressure. The resulting
material was purified by column chromatography on silica gel with 5% methanol in
dichloro methane and 0.5% acetic acid to yield the final product (R)-2-acetamido-3(prop-2-yn-1-ylthio)propanoic acid (64%). 1H NMR (600 MHz, CD3OD): 6.78-6.71 (m,
1H), 4.82-4.80 (m, 1H), 3.32-3.29 (m, 1H), 3.26-3.22 (m, 2H), 3.11-3.08 (m, 1H), 2.30
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(m, 1H), 2.06 (s, 1H). 13C NMR (600 MHz, CD3OD): 172.32, 171.99, 79.04, 71.53, 51.76,
32.51, 21.10, 18.60. Theoretical mass: 201.05, observed mass: [M+H]+ 202.10.

(R)-2-amino-3-(prop-2-yn-1-ylthio)propanoic acid (PCY) was prepared from (R)-2acetamido-3-(prop-2-yn-1-ylthio)propanoic acid in the same way as BCY (44 %). 1H
NMR (600 MHz, D2O): 3.93-3.91 (dd, J = 4.2, 3.6, 1H), 3.30-3.29 (m, 1H), 2.59 (m, 1H).
13

C NMR (600 MHz, D2O): 172.59, 79.98, 72.62, 53.27, 31.79, 18.76.

4.4.5 Amino acid reporter labeling of bacteria in liquid culture
See 2.4.6
4.4.6 Infection of RAW264.7 macrophages and pulse-labeling with amino acid
reporter
See 2.4.5
4.4.7 Analysis of amino acid reporter labeling by fluorescence microscopy
See 3.4.6
4.4.8 Analysis of amino acid reporter labeling by SDS-PAGE and in-gel
florescence scanning
See 3.4.5
4.4.9 Transfection of HEK293T cells with bacterial methionyl-tRNA synthetase
and pulse-labeling with EME
E. coli MetG (methionyl-tRNA-synthetase) was cloned into pEGFP-N1 (pEGFP-MetG)
by amplifying metG from pWSK29_MetG with the primers: GAGCTCATGACTCA
AGTCGCGAAGAAAATTCTGG and GGTACCAGTTTCACCTGATGACCCGGTTT
AGC, by PCR and cloning the resulting fragment into pEGFP-N1 with SacI and KpnI.
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This cloning strategy, however, introduced a frame shift in the GFP protein fusion, which
was corrected by site-directed mutagenesis using the QuikChange Site-Directed
Mutagenesis

Kit

and

the

primers:

CTAAACCGGGTCATCAGGTGAAA

TGGTACCGCGGGC and GCCCGCGGTACCATTTCACCTGATGACCCGGTTTAG.
pEGFP-N1 was transfected into 293T cells using the X-tremeGENE (Roche) transfection
reagent, following the supplied protocol with a ratio of 2:1 between DNA and
transfection reagent. MetG expression was analyzed by epifluorescence visualization of
the GFP fluorescence and by Western Blot analysis (Living Colors anti-GFP antibody JL8, Clonetech).
Transfected cells were pulse-labeled with 1 mM EME or 1 mM HPG 24 hours posttransfection in fresh Dulbecco’s Modified Eagle Medium (DMEM) growth medium
without methionine.
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5

Exploring orthogonal amino acid reporter labeling of S. typhimurium effector
proteins

5.1

Abstract

Intracellular pathogens are able to live and replicate within a mammalian cell without
clearance of the hosts immune system. A very specialized set of virulence factors enables
them to survive in this environment and escape from bactericidal mechanisms the host
cell imposes on them. Various virulence factors are secreted into the host cytosol
(effector proteins) were they modify host functions and pathways. Both the identification
of these factors and the analysis of their function are central to the understanding of the
pathogen-host-interaction. Previous proteomic approaches to detect effector proteins have
been extremely difficult, due to the complexity of the mixed pathogen host proteome and
low abundance of secreted bacterial effector proteins. This section discusses our attempts
to use orthogonal amino acid reporters for the proteomic detection of S. typhimurium
effector proteins during infection.
5.2

Introduction

A highly specialized subset of symbiotic or pathogenic bacteria has evolved to invade
and replicate within different host cell types. These bacteria are taken up either by
phagocytic cell populations or actively invade non-phagocytic cells, such as epithelial
cells. The first step in both processes - adherence to the plasma membrane - is mediated
by various adherence structures. These structures comprise a plethora of bacterial
proteins, ranging from rather simple structured adhesins, like fibronectin binding
proteins, to multimeric complexes such as pili and fimbria (Pizarro-Cerdá & Cossart
2006). In the second step, the actual invagination takes place, which can be either
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achieved by interaction with cognate membrane bound host receptors, or by remodeling
mammalian signaling pathways from within the cell. The latter requires the concerted
expression, activation, and delivery of effector proteins into the mammalian host cell by
means of protein secretion systems (Zhou & Galán 2001; DiGiuseppe Champion & J. S.
Cox 2007; Coburn et al. 2007). Once in the mammalian cytosol, these effector proteins
can modulate crucial host pathways - often by mimicking mammalian protein activities leading to the uptake of the bacterial cell (Bhavsar et al. 2007). Upon cell entry the
bacterium finds itself encompassed by vesicular membrane structures, derived from the
host membranes. Bacteria such as S. typhymurium or M. tuberculosis remain within these
vesicular structures, replicate, and remodel them to their benefit. Other bacteria however,
such as L. monocytogenes, egress from these compartments and adopt a cytosolic
lifestyle. In both cases, the bacterium will adjust to the given environment as well as
modulate it to guarantee its survival (Bhavsar et al. 2007; Coombes et al. 2004).
Each step during the above outlined infection process requires the expression and
activity of specific bacterial proteins - concerted in time and space. Indeed bacterial
protein expression changes upon superficial contact with mammalian host cells, e.g. in S.
typhimurium (B B Finlay et al. 1989). The application of microarray technologies to
dissect changes in gene expression during various stages of the intracellular life cycle
bears valuable information about necessary virulence factors (Coombes et al. 2004;
Rohde et al. 2007). However, analysis of gene expression on the transcript level has its
inherent limitations, especially if taken as a surrogate for protein levels, since protein
levels and activity – the general effectors of biological function – are determined by
many other parameters in addition to mRNA levels (J. Cox & Mann 2007). Furthermore
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the analysis of transcript level does not provide information about protein secretion
activity.
Recent data in S. typhimurium emphasizes the role of posttranscriptional
regulation in bacteria and shows poor correlation of transcript and protein levels (Ansong
et al. 2009). The advent of modern mass spectrometry based proteomic technologies gave
biological researcher excess to an immediate representation of proteome composition and
hence cellular function (Aebersold & Mann 2003). Several studies explored the
proteomic composition of pathogens under established culture conditions (Rosenkrands
et al. 2000; C. G. Zhang et al. 2005). While these studies give a general list of bacterial
proteins, they reveal only limited information about necessary virulence factors and
dynamic proteome changes. Therefore, several in vivo and in vitro studies aimed at the
analysis of the bacterial proteome under relevant infection conditions. In traditional in
vitro experiments bacteria are cultivated under conditions that mimic intracellular
conditions, such as high pH and low magnesium, which are known to induce the
expression and secretion of certain virulence factors. This approach has been widely used
for the identification of secreted effector proteins (Kodama et al. 2008; Yahr et al. 1997).
Even though these experiments contribute to the understanding of bacterial virulence they
do not truly reflect the native situation within the host cell. More elaborate experiments
have tried to measure bacterial protein expression in cell culture infection experiments or
in vivo. A recent study investigated S. typhimurium proteome changes upon infection of
murine macrophages either expressing or lacking the host resistance regulator Nramp1
(natural resistance-associated macrophage protein 1) (Shi et al. 2006). Another study
used GFP-expressing S. typhimurium to infect mice (Becker et al. 2006). This allowed for
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flow cytometric sorting of S. typhimurium containing cells isolated from organs of
infected mice and subsequent proteomic analysis. The overwhelming amount of host
proteins impedes the analysis of less abundant bacterial proteins (Rodland et al. 2008)
and none of the above-mentioned studies was able to detect secreted effector proteins in
the context of the host cell.
Salmonellae are Gram-negative enterobacteria with a broad host range, in which
they can cause either systemic disease in the form of enteric (typhoid) fever, or
gastroenteritis (Ohl & S I Miller 2001). S. typhimurium in particular infects cattle, pigs,
chickens, and humans. In these hosts it usually causes a self-limiting gastroenteritis.
However, in certain mouse strains it causes a typhoid fever-like systemic disease, the
susceptibility to which is greatly determined by Nramp1 (Jones & Falkow 1996; Plant &
Glynn 1979). This mouse model has been widely used for the analysis of systemic
Salmonella infection (Ohl & S I Miller 2001; Fields et al. 1986).
Salmonella spp. possesses a number of virulence factors, such as virulence
plasmids, toxins, fimbriae, and importantly Salmonella pathogenicity islands (SPI) (van
Asten & van Dijk 2005). SPIs are thought to be acquired through horizontal gene transfer
between species, indicated by an anomalous GC content and the presence of fragments of
transposable elements (Groisman & Ochman 1996). Even though more than five SPIs
have been described in the literature, the focus has been greatly on SPI-1 and SPI-2
(Hansen-Wester & M Hensel 2001; Schlumberger & Hardt 2006). Both SPIs encode,
amongst other proteins, for a type III secretion system (TTSS), which is a multicomponent secretion machinery for the purpose of protein effector delivery into the host
cell cytosol (Mueller et al. 2008). So far, more than 30 effector proteins have been
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identified, whose secretion depends on the activity of these two SPI encoded secretion
systems (McGhie et al. 2009). Conventionally, SPI-1 effectors and SPI-2 effectors are
associated with very distinct functions. SPI-1 effectors are necessary for the invasion of
non-phagocytic cells and the establishment of the Salmonella containing vacuole (SCV),
which is a vesicular structure that harbors S. typhimurium upon cellular invasion. In the
typhoid fever model SPI-1 TTSS (TTSS1) deficient S. typhimurium show attenuated
infectivity when administered orally, but not when given intravenously (Ohl & S I Miller
2001). Furthermore, TTSS1 is implicated in the molecular etiology of S. typhimurium
induced enteritis. These results indicate the importance of TTSS1 in the interaction and
penetration of the intestinal epithelium.
Later during the infection process SPI-2 effectors promote intracellular replication
and systemic dissemination. It has been shown that SPI-2 TTSS (TTSS2) is necessary for
systemic infection in the mouse model and for replication in tissue culture. In epithelial
cells and macrophages, TTSS2 is responsible for the formation of membrane structures
called Salmonella-induced filaments (Sif) – Sif protrude from SCVs and are possibly
involved in vesicular trafficking (Haraga et al. 2008). However, contrary to the current
model, recent data suggest an unappreciated interaction between SPI-1 and SPI-2
effectors, as classical SPI-1 effectors like SopB have been implicated in late SCV
positioning functions (Wasylnka et al. 2008). Despite the above-mentioned focus on
TTSS1/2, other secretion systems have been discovered in S. typhimurium and have been
implicated in its virulence. One of them is the sci-encoded (Salmonella enterica
centisome 7 genomic island) type VI secretion system, which when ablated attenuates
infectivity in various model systems (Filloux et al. 2008). The list of secreted effector
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proteins is constantly growing and it is likely that more effector proteins are to be
discovered, especially considering the vast number of non-annotated ORFs. Even tough
some progress has been made in predicting bacterial effector proteins using
bioinformatics (Y. Wang et al. 2011; McDermott et al. 2011), it is still desirable to
develop a robust proteomics strategy that would allow global analysis of effector
production and secretion in the infected host, since some effectors might always elude the
bioinformatics prediction and an empiric determination and analysis of the dynamics of
this concerted process is invaluable for its complete understanding. All previous
proteomic studies of effector proteins or bacterial infection have failed to achieve this
goal.
The orthogonal amino acid reporters presented in the preceding chapters (AOA,
ANL, PEP) could help to isolate secreted bacterial effector proteins from the mammalian
cytosol or membrane fraction and therefore could allow the proteomic detection of
secreted bacterial effector proteins. In the following we present our efforts to use
orthogonal amino acid reporters for this purpose and describe the current limitations of
the orthogonal amino acid system.
5.3

Results
Initially we wanted to test whether the orthogonal amino acids AOA and ANL

can be generally incorporated into secreted bacterial effector proteins. To address this
question we investigated the incorporation of AOA and ANL into secreted bacterial
effector proteins in liquid culture. S. typhimurium SPI-1 or SPI-2 dependent protein
secretion can be induced in liquid culture (Ellermeier & Slauch 2003; Yu et al. 2010). S.
typhimurium pWSK29_MetGPLL IR715 was grown in full LB medium over night and
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diluted into fresh LB medium. After 2 or 3 hours of growth 1 mM ANL, AOA, or Met
was added to the growth medium until 4 hours of growth were completed. The culture
supernatant was separated from the bacteria and the containing proteins were precipitated
with trichloroacetic acid. The precipitated proteins were reacted with az-rho or alk-rho by
CuAAC and analyzed by SDS-PAGE and in-gel fluorescence analysis (Figure 39). AOA
and ANL were incorporated into the secreted effector proteins (identity of these proteins
was determined under similar conditions by other members of the Hang laboratory).
Interestingly, earlier addition of the orthogonal amino acid reporter (2 h) impaired protein
secretion in comparison to the methionine control and the 1 h sample. This speaks for a
detrimental effect on protein secretion upon longer incubation times with AOA or ANL.
Both amino acid reporters showed this effect. The smaller effect observed by
fluorescence could be due to an increased labeling intensity in the 2 h sample compared
to the 1 h sample, which is able to balance out some of the signal loss due to impaired
protein secretion. Repeating the same experiment with S. typhimurium 14028
pWSK29_MetGPLL and S. typhimurium 14028 ΔSPI-1 pWSK29_MetGPLL, a TTSS-1
inactive mutant, pulse-labeling for 1 hour, confirmed that most of the labeled protein
species indeed are secreted SPI-1 effector proteins (Figure 40). So, generally AOA or
ANL-labeled effector proteins can be secreted through the TTSS.
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Figure 39 AOA and ANL are incorporated into secreted S. typhimurium proteome. SPI-1
dependent protein secretion of S. typhimurium IR715 pWSK_MetGPLL was induced in full
LB growth medium. S. typhimurium IR715 pWSK_MetGPLL was pulse-labeled with
AOA, ANL, or Met and the proteins in the culture supernatant were reacted with az-rho
or alk-rho by CuAAC and analyzed by SDS-PAGE and in-gel fluorescence. Fluor.: azrho or alk-rho fluorescence, CB: coomassie blue, AA: amino acid, az-rho:azidorhodamine, alk-rho: alkyne-rhodamine.
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Figure 40 AOA and ANL are incorporated into SPI-1 effector proteins. SPI-1 dependent
protein secretion of S. typhimurium IR715 pWSK_MetGPLL and S. typhimurium IR715
ΔSPI-1 pWSK_MetGPLL was induced in full LB growth medium. S. typhimurium was
pulse-labeled with AOA, ANL, or Met and the proteins in the culture supernatant were
reacted with az-rho or alk-rho by CuAAC and analyzed by SDS-PAGE and in-gel
fluorescence. Fluor.: az-rho or alk-rho fluorescence, CB: coomassie blue, AA: amino
acid, az-rho:azido-rhodamine, alk-rho: alkyne-rhodamine.
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For previous proteomics experiments (see chapter 2) we pulse-labeled infected
macrophages around 16 hours post-infection. Before moving into large-scale proteomics
experiments for the detection of secreted bacterial effector proteins we wanted to assess
whether known bacterial effector proteins are actually expressed at this time during
infection. Eriksson et al published a microarray study profiling S. typhimurium gene
expression during infection of macrophages and compared it to S. typhimurium grown in
mammalian growth medium (Eriksson et al. 2003). Their data revealed that the
transcription of numerous known effector proteins, amongst them SseJ and SifA, is upregulated in comparison to the control population 12 hours post-infection (Figure 41).

Figure 41 Relative expression level of selected known effector proteins in S.
typhimurium during infection of macrophages. Relative expression level: relative
expression compared to opsonized S. typhimurium in mammalian growth medium. (Data
from Eriksson et al 2003).
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SseJ, one of the most strongly up-regulated effector proteins in the microarray
study by Eriksson and colleagues, is known to take part in the formation of Salmonellainduced filaments (Sifs) and as a SPI-2 regulated effector proteins plays an important role
in the establishment of the intracellular infection (Lossi et al. 2008). We analyzed its
expression dynamics during infection of RAW264.7 macrophages by fluorescence
microscopy. Macrophages were infected with S. typhimurium IR715 pWSK29_SseJ,
expressing a HA-tagged SseJ, regulated by the endogenous SseJ promoter. SseJ cannot be
detected 2 hours post-infection, but can be detected after 7 hours and is most strongly
expressed at the 20-hour time point.

Figure 42 SseJ is expressed during infection of RAW264.7 macrophages. RAW264.7
cells were infected with S. typhimurium pWSK29_HASseJ and analyzed by fluorescence
microscopy. Blue: DNA stain TO-PRO-3, green: anti-Salmonella antibody stain, red:
anti-HA antibody stain. Bar indicated 10 µm.

As a final step towards establishing orthogonal amino acid incorporation into
bacterial effector proteins during infection, in preparation of large-scale proteomics
experiments, we analyzed the incorporation of the amino acid reporter EME (see chapter
4) into SseJ during infection of macrophages. Macrophages were infected with S.
typhimurium IR715 pWSK29_SseJ and pulse labeled with EME 16 hours post-infection.
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SseJ was immunoprecipitated, reacted with az-rho by CuAAC, and analyzed by SDSPAGE and in-gel fluorescence scanning. EME was incorporated into SseJ during
infection of mammalian cells (Figure 43). Based on the mild Brij detergent lysis we
concluded that the immunoprecipitated SseJ population should be largely of mammalian
cytosolic origin, hence secreted. These data demonstrate that amino acid reporters can be
incorporated into SPI-1 and SPI-2 effector proteins in S. typhimurium and that this
incorporation does not preclude effector secretion. Furthermore, known effector proteins,
such as SseJ, are expressed between 7 and 20 hours of infection of macrophages, the time
window we have been conducting our proteomics studies.

Figure 43 SseJ is labeled with the amino acid reporter EME during infection of
RAW264.7 macrophages.

The identification of secreted effector proteins by mass spectrometry-based
proteomics requires the separation of intact bacterial cells from the mammalian proteome.
The mammalian cytosolic, membrane, and even nucleic fraction should contain any
secreted bacterial effector proteins. It is therefore indispensable to lyse the infected
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mammalian cell without also lysing the containing bacterial cell bodies since any
contamination of the mammalian fraction with non-secreted bacterial proteins impedes
the assignment of an identified bacterial protein to the secreted proteome fraction.
The literature is filled with a wide range of different selective lysis conditions that
have been used for the analysis of secreted effector proteins. Initially we tested a standard
fraction fractionation procedure based on an initial lysis with 0.2% saponin, followed by
a 0.1% Triton X-100 lysis (Kuhle & Michael Hensel 2002). RAW264.7 cells were
infected with S. typhimurium pWSK29_MetGPLL and pulse-labeled with AOA 16 hours
post-infection for 1, 2, or 3 hours. Subsequently the infected cells were fractionated with
0.2% saponin and 0.1% Triton X-100 into a cytosolic (0.2% saponin), a membrane (0.1%
Triton X-100), and a pellet fraction, which should contain the nucleus and the intact
bacteria. The resulting proteome fractions were reacted with az-rho by CuAAC and
analyzed by SDS-PAGE, in-gel fluorescence scanning, and Western blot. The S-tag
epitope tag of MetGPLL expressed only in the bacterial cells served as a bacterial cytosolic
marker. Fluorescence signal was detected in all three fractions. The mammalian cytosolic
fraction differed qualitatively from the membrane and the pellet fraction, while the latter
two were highly similar. MetGPLL was detected in all three fractions, indicating that a
major portion of bacterial cells is lysed during cell lyses or prior to that, during infection.
This data indicated that these lysis conditions were not selective enough and resulted in
bacterial contaminations in the mammalian cytosol, provided post-labeling cell lysis was
the reason for the contamination.
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Figure 44 AOA can be detected in various proteome fractions. RAW264.7 cells were
infected with S. typhimurium pWSK29_MetGPLL and pulse-labeled with 1 mM AOA
for different times 16 hours post-infection. Cells were fractionated with 0.2% saponin
(cytosol) and 0.1% Triton X-100 (membrane). az-rho: azido-rhodamine, CB: coomassie
blue,

Due to the high background lysis observed in the first fractionation experiment
(Figure 44), we investigated various lysis procedures for their selectivity for mammalian
cells. Blotting for MetG in the isolated mammalian proteome fraction served as the readout for bacterial co-lysis. Infected RAW264.7 cell were infected with S. typhimurium
pWSK29_MetGPLL and lysed by different procedures 16 hours post-infection. Cells were
either lysed by mechanical disruption in sucrose and imidazole (N1) or triethanolamine
(N2) or by detergents (Triton X-100, saponin). Western blot analysis of MetGPLL as a
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marker for bacterial integrity revealed the mechanical lysis (N1) as the most selective,
while the traditional 0.1% Triton X-100 lysis seemed to be the least selective (Figure 45).

Figure 45 Analysis if differential lysis procedures. N1: mechanical lysis in sucrose and
imidazol, N2: mechanical lysis in triethanolamine, 0.1TX: 0.1% Triton X-100, 0.01TX:
0.01% Triton X-100, 0.2Sp: 0.2% saponin, 0.02Sp: 0.02% saponin, α-S-tag: anti-S-tag
(MetGPLL) Western blot analysis.

Based on these results we conducted an infection and fractionation experiment.
RAW264.7 cells were infected with S. typhimurium pWSK29_MetGPLL and pulse-labeled
with AOA 16 hours post-infection for 2 hours. Subsequently the cells were lyzed by
method N1, 0.01% Triton X-100, or 0.02% saponin. The resulting fractions were
analyzed by CuAAC with az-rho, SDS-PAGE, and in-gel-fluorescence scanning as well
as Western blot. Compared to the precious experiment (Figure 44) the improved selective
fractionation conditions caused less bacterial lysis, since no MetGPLL signal was detected
in the supernatant fractions (mammalian cytosol). In addition, the total fluorescence
intensity in the supernatant fraction seemed to be reduced, indicating reduced levels of
bacterial proteins in these fractions. This might speak for a reduced level of bacterial
contaminants.
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Figure 46 Improved fractionation conditions. RAW264.7 cells were infected with S.
typhimurium pWSK29_MetGPLL and pulse-labeled with AOA for 2 hours 16 hours
post-infection. N1: mechanical lysis in sucrose and imidazol, 0.01TX: 0.01% Triton X100, 0.02Sp: 0.02 % saponin, az-rho: azido-rhodamine, CB: coomassie blue.

With these fractionation conditions in hand we decided to approach the first largescale proteomics experiment. For the initial experiment we decided for the most selective
fractionation condition N1, even tough this condition also provides the least fluorescence
signal, which suggested very little protein retrieval by affinity enrichment of AOAlabeled proteins. Since the expected protein amount was very small we choose to use an
in-solution digest protocol to minimize protein loss during the sample preparation for
mass spectrometry (Wiśniewski et al. 2009). RAW264.7 cells were infected with S.
typhimurium pWSK29_MetGPLL and pulse-labeled with AOA 16 hours post-infection for
2 hours. Cells were washed, harvested, and frozen in liquid nitrogen. Cells were lysed
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and fractionated by the N1 procedure and the resulting protein fractions were precipitated
by methanol/chloroform precipitation and resuspended in SDS buffer for CuAAC with
azide-azo-biotin. Clicked protein samples were precipitated again and bound to
streptavidin beads. The protein bound beads were washed and finally the selectively
bound proteins were eluted with sodium dithionite. Protein reduction, alkylation, and
digestion with Lys-C and trypsin was carried out on Microcon YM-10 filters (Wiśniewski
et al. 2009). Resulting peptides were purified on StageTips and analyzed by LC-MS/MS.

Table 2 Identified proteins in the N1 supernatant fraction by Filter Aided Sample
Preparation (FASP).
#	
  
1	
  
2	
  
3	
  
4	
  
5	
  
6	
  
7	
  
8	
  
9	
  
10	
  
11	
  
12	
  
13	
  

Identified	
  Protein	
  
mouse	
  
mouse	
  
mouse	
  
60	
  kDa	
  chaperonin	
  
Elongation	
  factor	
  G	
  
Elongation	
  factor	
  Tu	
  
Spermidine/putrescine-‐binding	
  periplasmic	
  prot	
  
Chaperone	
  protein	
  htpG	
  
Enolase	
  
Chaperone	
  protein	
  dnaK	
  
Chaperone	
  protein	
  clpB	
  
30S	
  ribosomal	
  subunit	
  protein	
  S1	
  
Pyruvate	
  formate	
  lyase	
  I,	
  induced	
  anaerobicall	
  	
  

Accession	
  Number	
  
IPI:IPI00319992.1	
  
IPI:IPI00407130.4	
  
IPI:IPI00886297.1	
  
P0A1D3|CH60_SALTY	
  
P0A1H3|EFG_SALTY	
  
P0A1H5|EFTU_SALTY	
  
P0A2C7|POTD_SALTY	
  
P58480|HTPG_SALTY	
  
P64076|ENO_SALTY	
  
Q56073|DNAK_SALTY	
  
Q7CQ01|CLPB_SALTY	
  
Q7CQT9|Q7CQT9_SALTY	
  
Q7CQU1|Q7CQU1_SALTY	
  

Not surprisingly, given the low fluorescence intensity in the N1 supernatant
fraction (Figure 46), the total number of proteins was very low (Table 2). Three proteins
were mouse proteins, the remaining ten were S. typhimurium proteins, presenting an
overall enrichment of S. typhimurium proteins similar what was observed in previous
AOA labeling studies (Grammel et al. 2010). The identified S. typhimurium proteins did
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not contain any known or previously described potential effector proteins and almost all
of them were previously identified from intact bacteria infecting RAW264.7
macrophages (see chapter 1). We concluded that none of these proteins are in fact
effector proteins.
Due to the low overall protein retrieval from the N1 supernatant fraction we
turned to the Triton X-100 fractionation method, resulting in an increased fluorescence
signal in the supernatant fraction (Figure 46). The RAW264.7 cell infection experiment
was carried out as before, however cells were lysed in 0.1% Triton X-100. The resulting
fractions were precipitated by methanol/chloroform precipitation and reacted with azidoazo-biotin for affinity enrichment. Since we expected higher protein recovery upon Triton
X-100 lysis, compared to the N1 lysis, samples for LC-MS/MS analysis were prepared by
in-gel digestion, providing a means of sample complexity reduction. Captured proteins
were selectively eluted by sodium dithionite and separated by SDS-PAGE (Figure 47).
SDS-PAGE analysis already indicated that the major protein components retrieved from
the supernatant and the pellet fraction could be identical. LC-MS/MS and data analysis
was carried out as previously (Grammel et al. 2010). 55 S. typhimurium proteins were
identified in the supernatant fraction (Table 5), all of which were also detected in the
bacterial pellet fraction, which comprised 140 identified S. typhimurium (Table 6). None
of the identified proteins in the supernatant or pellet fraction was a known and
characterized effector proteins (e.g. SifA, SseJ), which should be expressed 16 hours
post-infection (Figure 41, Figure 42, Figure 43). In addition, non of the recently predicted
putative effector proteins were among the identified proteins (Samudrala et al. 2009;
Arnold et al. 2009). In conclusion, neither the highly selective N1 mechanical lysis nor

119

the harsher Triton X-100 lysis resulted in the proteomic identification of a known or
putative effector protein. The reduction in general fluorescence recovery in the
supernatant fraction only was accompanied by a reduction in dynamic range of bacterial
protein detection, since the top protein hits in both, the N1 and the Triton X-100, lysis are
the same. These proteins are highly abundant chaperones and translational components.

Figure 47 In-gel sample preparation enriched bacterial proteins from infected RAW264.7
cells, fractionated by 0.1% Triton X-100 lysis.

5.4

Materials and Methods

5.4.1 Labeling effector proteins in liquid culture with AOA or ANL
An overnight culture of S. typhimurium IR715 pWSK29_MetGPLL , S. typhimurium 14028
pWSK29_MetGPLL, or S. typhimurium 14028 ΔSPI-1 pWSK29_MetGPLL was centrifuged
and resuspended in fresh LB medium with 100 µg/ml carbenicillin. For secretion assays
the cultures were grown in 15 ml plastic culture tubes at 37 °C with aeration (2 ml culture
volume). For amino acid labeling, 2 mM AOA, ANL, or Met was added either 2 or 3
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hours afterwards. Bacteria were harvested by centrifugations, twice. To the culture
supernatant trichloroacetic acid was added to a final concentration of 10% an the sample
was incubated over night at 4 °C. The sample was centrifuged for 30 min at 20,000g at 4
°C. The resulting pellet was carefully rinsed with ice-cold acetone three times. The
resulting pellets were resuspended in 20 µl 4% SDS, 50 mM TEA, 150 mM NaCl. To this
solution 5 µl click-chemistry master mix was added (see 3.4.5). The samples were
precipitated by methanol/chloroform precipitation after CuACC to remove all small
molecules and finally completely loaded on a SDS-PAGE for separation and in-gel
fluorescence scanning.
5.4.2 Cloning of SseJ into pWSK29
Initially a pWSK29_HA plasmid was generated by annealing two primers
(TCGAGTTATGCATAATCAGGAACATCATAAGGATAG

and

AATTCTATCCTTATGATGTTCCTGATTATGCATAAC), digesting them with EcoRI
and XhoI, and ligating them in pWSK29, also cut with EcoRI and XhoI. SseJ was
amplified

from

S.

typhimurium

IR715

(GAATTCTTCAGTGGAATAATGATGAGCTATAAAAC

by

PCR
and

TCTAGAGATAGCAGTCAGATAATATGTACCAGGC). The resulting PCR product
was digested with EcoRI and XbaI and ligated into pWSK29_HA, also cut with EcoRI
ans XbaI.
5.4.3 Imaging of SseJ during infection by fluorescence microscopy
For infection see 3.4.4, for fluorescence microscopy see 3.4.6.
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5.4.4 Pulse-labeling with EME and immunoprecipitation of SseJ during infection
Confluent 6 well dishes of RAW264.7 cells were infected with S. typhimurium IR715
pWSK29_HASseJ grown in LB medium to stationary phase at an MOI of 10 (see 3.4.4).
16 hours post-infection cells were washed with PBS and incubated with methionine free
DMEM and 1 mM EME or 1 mM Met for 1 hour. Cells were washed with PBD and lysed
in Brij-97 buffer (M. M. Zhang et al. 2010). Immunoprecipitation, CuAAC on beads, and
analysis was carried out as reported previously (M. M. Zhang et al. 2010).
5.4.5 Fractionation of infected RAW264.7 macrophages
For detergent based lysis, infected cells were resuspended in ice-cold 50 mM TEA buffer
pH 7.4 containing 1 mM PMSF, 1 RocheComplete protease inhibitor tablet per 25 ml,
and different concentrations of detergent (0.1% Triton X-100, 0.01% Triton X-100, 0.2%
saponin, or 0.02% saponin). Cells were lysed on ice for 10 min and centrifuged at 20,000
g for 5min at 4°C to yield the supernatant and pellet fraction.
For mechanical lysis, cells were resuspended in either 250 mM sucrose, 3 mM imidazole,
0.5 mM EDTA, 1 mM PMSF, and 1 RocheComplete protease inhibitor tablet per 25 ml
(N1) or 50 mM TEA pH 7.4, 1 mM PMSF, and 1 RocheComplete protease inhibitor
tablet per 25 ml (N2). Cells were pushed trough a 21.5 gauge needle 20 times. Lysates
were centrifuged at 20,000 g for 5min at 4 °C to yield the supernatant and pellet fraction.
5.4.6 Sample preparation for LC-MS/MS analysis
Sample preparation by in-gel digestion, LC-MS/MS and data analysis was carried out as
in 2.4.11, 2.4.12, 2.4.13, 2.4.14, and 2.4.15.
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5.4.7 Filter aided sample preparation (FASP)
Sample preparation by filter aided sample preparation (FASP) was strictly carried out as
published previously (Wiśniewski et al. 2009).
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6

A chemical reporter for protein AMPylation4

6.1

Abstract

Protein AMPylation is an emerging posttranslational modification, which plays key roles
in bacterial pathogenesis and cell biology. Enzymes with AMPylation activity, referred to
as AMPylators, have been identified in several bacterial pathogens and eukaryotes. To
facilitate the study of this unique modification, we developed an alkynyl chemical
reporter for detection and identification of protein AMPylation substrates. Covalent
functionalization of AMPylation substrates with the alkynyl reporter in lieu of adenylyl
5’-monophosphate (AMP) allows their subsequent bioorthogonal labeling with azidefluorescent dyes or affinity enrichment tags. We show that this chemical reporter is
transferred by a range of AMPylators onto their cognate protein substrates and allows
rapid detection and identification of AMPylated substrates.
6.2

Introduction

Protein AMPylation refers to the covalent modification of protein side chain hydroxyl
groups with adenylyl 5’-monophosphate (AMP) through a phosphodiester bond. This
posttranslational modification is installed by the enzymatic transfer of AMP from
adenosine-5’-triphosphate (ATP) to the substrate hydroxyl group. This catalytic activity
was initially described for E. coli glutamine synthetase (GS) adenylyl transferase, which
tightly regulates GS activity (Kingdon et al. 1967; Shapiro & Stadtman 1970). Additional
proteins with AMPylation activity (AMPylators) have been identified that contain either

4

This work was carried out in collaboration with Phi Luong (UT Southwestern) and Kim

Orth (UT Southwestern). Phi Luong conducted all cloning and expression experiments.
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the filamentation induced by cAMP (fic) domain or the adenylyl transferase (ATase)
domain, which confer AMPylation activity (Woolery et al. 2010; Lisa N Kinch et al.
2009). Many of these characterized AMPylators serve as bacterial virulence factors that
are secreted into the mammalian host cell during infection. There, they AMPylate
mammalian host proteins to alter their function for the benefit of the pathogen. In
particular, secreted bacterial AMPylators, such as VopS (Vibrio parahaemolyticus), IbpA
(Legionella pneumophila), and DrrA (Legionella pneumophila) have been shown to
target mammalian small GTPases, like RhoA, Rac1, Cdc42, and Rab1 (Melanie L
Yarbrough, Yan Li, et al. 2009; Worby et al. 2009; Müller et al. 2010). Another bacterial
effector protein has been identified that selectively deAMPylates a GTPase, indicating
the dynamic nature of this modification (Tan & Luo 2011; Neunuebel et al. 2011). The
AMPylation of small GTPases, on threonine or tyrosine residues, interferes with their
proper function, either by sterically blocking the interaction with downstream signaling
components or GTPase activating proteins (GAPs). Interestingly, fic and ATase domains
are not limited to bacterial effector proteins, but have been identified in archaea and
eukaryotes as well. Most eukaryotic genomes appear to contain a fic domain protein.
AMPylation activity has been observed for the human protein HYPE and the Drosophila
protein dFic (Lisa N Kinch et al. 2009; Worby et al. 2009). The widespread presence of
these domains suggests a ubiquitous role for protein AMPylation as a regulated and
reversible posttranslational modification. While radioactive ATP, targeted mass
spectrometry, and specific antibodies, can be used to detect AMPylated substrates, more
general and efficient analytical tools are still needed for the unbiased identification of
new AMPylated substrates and the analysis of their regulation. We therefore developed
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an alkynyl chemical reporter for bioorthogonal detection, enrichment and identification
of AMPylated proteins (Figure 48).

Figure 48 N6pATP – N6-propargyl adenosine-5’-triphosphate; N6pAMP – N6-propargyl
adenosine-5’-monophosphat; PPi – pyrophosphate; CuAAC – Cu(I)-catalyzed azidealkyne cycloaddition; Tag – rhodamine fluorescence dye or cleavable biotin enrichment
tag .

6.3

Results

Alkynyl chemical reporters allow Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC)
of labeled substrates with azide-functionalized detection and enrichment reagents. This
technology has facilitated the analysis of various posttranslational modifications and
nucleic acid biogenesis (Sletten & Bertozzi 2009). Recent structural studies of
AMPylators and previous studies of fluorescent AMP analogs, suggested that a
modification of the N6 position of the adenine ring could be tolerated (Chock et al. 1973;
Rhee et al. 1981; Xiao et al. 2010; Luong et al. 2010a; Palanivelu et al. 2011). Thus, we
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synthesized the ATP analog N6-propargyl adenosine-5’-triphosphate (N6pATP) as a
potential chemical reporter for AMPylation.
To assess the activity of N6pATP as a possible chemical reporter for AMPylation,
we used a well-established in vitro system, based on the recently identified AMPylator
VopS and its cognate mammalian target Cdc42 (M. L. Yarbrough, Y. Li, L. N. Kinch, et
al. 2009). Cdc42(Q61L), subsequently referred to as Cdc42, was incubated with VopS in
the presence of increasing concentrations of N6pATP under previously reported in vitro
AMPylation conditions (Luong et al. 2010b). N6pAMP transfer was analyzed by CuAAC
with azido-rhodamine (az-rho) dye and in-gel fluorescence scanning (Charron et al.
2009). Increasing concentrations of N6pATP yielded dose-dependent increase in
fluorescence labeling of Cdc42 (Figure 49). The chemical reporter proved to be
transferred only in the presence of VopS and appeared to be highly selective for the
native substrate Cdc42, as judged by the lack of concomitant BSA labeling (Figure 49).

Figure 49 VopS labeled its native substrate with the chemical reporter N6pATP. Cdc42
(0.5 µg) was incubated with VopS (1 ng) with increasing concentrations of N6pATP for 1
hour at 30°C in reaction buffer and analyzed by CuAAC and in-gel fluorescence. az-rho:
azido-rhodamine, CB: coomassie blue.
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To investigate the selectivity of N6pATP, we made use of substrate and
AMPylator mutants. When VopS was incubated with the T35A mutant of Cdc42, in
which the target threonine residue of VopS was mutated to an alanine, no transfer was
observed (Figure 50b) (M. L. Yarbrough, Y. Li, L. N. Kinch, et al. 2009). In addition, a
catalytic inactive mutant of VopS, H348A, failed to transfer the chemical reporter (Figure
50b) (M. L. Yarbrough, Y. Li, L. N. Kinch, et al. 2009). The dependence on this
previously described catalytic histidine suggests that N6pAMP is transferred by the same
catalytic mechanism as the native AMP group. These data emphasize the distinct
selectivity of N6pATP, which was further demonstrated by competitive inhibition with
ATP (Figure 50c). N6pATP appears to be a general cofactor for AMPylation, since it was
also utilized by VopS to modify its alternative substrates RhoA and Rac1 (Figure 50d). It
should be noted that labeling of Cdc42(T35S) by VopS was also observed (Figure 50e),
supporting the notion that AMPylation may occur on serine residues. Moreover, it served
as a chemical reporter for another fic domain AMPylator, IbpA (Fic2, Figure 51a). Like
VopS, Fic2 modifies Cdc42, however, it transfers AMP onto tyrosine residue Y32
(Worby et al. 2009) (Figure 51b). We also tested the ATase domain AMPylator DrrA for
its ability to utilize N6pATP. Indeed, DrrA accepted N6pATP as cofactor and labeled the
reported protein substrate Rab1 (Figure 51c) (Worby et al. 2009). These experiments
demonstrate the versatile nature of N6pATP as a chemical reporter for all known
AMPylator families, namely fic domain and ATase domain AMPylators. N6pATP
labeling appears to be independent of the target protein substrate and could also allow the
identification of serine-modified AMPylation substrates.
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Figure 50 In vitro analysis of VopS activity, using N6-propargyl adenosine-5’triphosphate (N6pATP) as a chemical reporter, by click-chemistry and in-gel fluorescence
scanning. All AMPylation reactions were carried out in 15 µl total volume for 1 h at 30°C
. A) Cdc42 (0.5 µg) was incubated with VopS (1 ng) and increasing concentrations of
N6pATP. B) Cdc42 (0.5 µg) or Cdc42(T35A) (0.5 µg) was incubated with VopS (1 ng) or
VopS(H348A) (1 ng) and N6pATP. C) Analysis of Cdc42 labeling by VopS, using N6propargyl-adenosine-5’-triphosphate (N6pATP) as a chemical reporter, with increasing
concentrations of adenosine-5’-triphosphate, by click-chemistry and in-gel fluorescence
scanning. VopS (1 ng) was incubated with Cdc42 (0.5 µg), N6pATP (100 µM) and
increasing concentrations of ATP in a total volume of 15 µl for 1 h at 30°C. D) RhoA
(0.5 µg) was incubated with VopS (10 ng). Rac1 (0.5 µg) was incubated with VopS (10
ng) in the presence of N6pATP (100 µM) in a total volume of 15 µl for 1 h at 30°C. E)
Cdc42(T35S) (0.5 µg) was incubated with VopS (10 ng). az-rho: azido-rhodamine
fluorescence; CB: coomassie blue.
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Figure 51 N6pATP is used by all known AMPylation enzyme families. a) Cdc42 (0.5 µg)
was incubated with increasing amounts of Fic2 (IbpA) in the presence of N6pATP in
reaction buffer. b) Cdc42 (0.5 μg) or Cdc42(Y32A) (0.5 μg) was incubated with Fic2 (10
ng) or Fic2(H3717A) (10 ng) and N6pATP in a total volume of 15 μl for 1 h at 30°C. c)
Increasing amounts of DrrA were incubated with Rab1a (0.5 μg) and N6pATP (100 μM)
in a total volume of 15 μl for 1 h at 30°C. az-rho: azido-rhodamine, CB: coomassie blue.
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We next analyzed the ability of VopS, Fic2, and DrrA to modify their substrates
with N6pATP in mammalian cell lysates. It has been reported that addition of purified
VopS or Fic2 to HeLa cell lysates in the presence of 32P-a-ATP results in the labeling of
one distinct band in the molecular weight range of small GTPases, as assessed by
autoradiography (Melanie L Yarbrough et al. 2009; Worby et al. 2009). We incubated
purified VopS, Fic2, and DrrA with Triton X-100 lysed HeLa cell lysates and N6pATP
(100 µM). As previously observed for

32

P-a-ATP labeled cell lysates, VopS and Fic2

labeled one distinct protein or protein population at the corresponding molecular weight
of small GTPases (Figure 52a, b). Addition of DrrA also resulted in the modification of
one distinct protein or protein population at ~21 kDa (Figure 52c), although more
recombinant DrrA was needed to observe similar levels of labeling. In the absence of
recombinant enzyme, the reporter did not significantly label the cell lysate. All three
enzymes displayed auto-AMPylation activity as evidenced by a specific fluorescent
signal at the corresponding molecular weight (Figure 52a, b, c). These results corroborate
previous findings, underscoring the distinctive selectivity of these effector proteins for
small host GTPases (Melanie L Yarbrough et al. 2009; Worby et al. 2009).
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Figure 52 Detection of endogenous AMPylation substrates in cell lysates. AMPylation
reactions (a-c) were carried out in 15 µl for 1 h at 30°C. a) VopS (100 ng) was added to
HeLa cell lysate (10 mg) in the presence of N6pATP (100 µM). b) Fic2 (300 ng) was
added to HeLa cell lysate (10 mg) in the presence of N6pATP (100 µM). c) DrrA (4 µg)
was added to HeLa cell lysate (10 mg) in the presence of N6pATP (100 µM).

132

To explore the utility of N6pATP for the unbiased identification of AMPylated
substrates, we incubated HeLa cell lysate (1 mg) with N6pATP (100 µM) in the presence
or absence of VopS (88µg). The bulk of the samples was then reacted with a cleavable
biotin enrichment tag (ortho-hydroxy-azidoethoxy-azo-biotin) and incubated with
Streptavidin beads for affinity capture of labeled proteins (Y.-Y. Yang et al. 2010).
Captured proteins were digested on beads and the resulting peptides were collected and
subjected to protein identification by tandem mass spectrometry. For data analysis, all
protein hits of the negative control were subtracted from the VopS containing sample,
which revealed two final protein identifications: VopS and Cdc42, with VopS peptides
representing the majority of the identified peptides (Figure 53b, c). The dominant VopS
fraction correlates well with the observed fluorescence profiling of the same samples
(Figure 53a). This data demonstrates that N6pATP can be used to identify substrates of
individual AMPylators in complex cellular protein samples and confirms Cdc42 as an
endogenous VopS target.
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Figure 53 Proteomic analysis of endogenous VopS substrates in Hela cell lysates
confirms Cdc42. a) 1 mg HeLa cell lysates was incubated with VopS (88 µg) and
N6pATP (100 µM). b) Proteomic analysis of VopS substrates in HeLa cell lysate
identified two proteins above background, VopS and Cdc42. c) Identified Cdc42
peptides. # TS – number of total spectra, # UP – number of unique peptides, XCorr –
SEQUEST Xcorr score, DCn – SEQUEST DCn score, az-rho - azido-rhodamine
fluorescence; CB, coomassie blue; asterisk indicates auto-AMPylation and recombinant
AMPylator.

134

6.4

Materials and Methods

6.4.1 General methods and materials
All chemical reagents were purchased from Sigma-Aldrich. Analytical and preparative
HPLC was conducted on a Waters 1525 Binary HPLC Pump system with a XBridge Prep
C18 5 µm OBD, 19 x 150 mm, column or a Xbridge C18 5µm, 4.6 x 150 mm, analytical
column. Compounds were eluted with a linear gradient of 100% acetonitrile and 20 mM
triethylammonium bicarbonate, 2% acetonitrile, adjusted to pH 7.4 with acetic acid. 31P
NMR analysis was done on a Bruker Avance DPX400 and 1H analysis on a Bruker
Avance DMX600 system. HRMS analysis was conducted by the Proteomics Resource
Center of The Rockefeller University on a LTQ-Orbitrap (Thermo Scientific). Azidorhodamine (az-rho) and TBTA (tris((1-benzyl-1H-1,2,3-triazol-4-yl)methyl) amine) was
generated by the Hang laboratory as previously described (Charron et al. 2009).
6.4.2 Chemical synthesis
6.4.2.1 6-propargyl-adenosine
6-propargyl-adenosine was synthesized as previously reported (Jiang et al. 2009). Briefly,
6-Choropurine nucleoside (1 eq.), calcium carbonate (2 eq.) and propargylamine (5 eq.)
were added to absolute ethanol and refluxed under argon for 12 hours. The reaction
mixture was filtered and the filtrate was kept at -20 °C over night. The white precipitate
was collected by filtration, washed with ether and dried under vacuum to afford the pure
product. 1H NMR (DMSO): δ 8.36 (s, 1H), 8.24 (s, 1H), 8.20 (br, 1H), 5.86 (d, 1H, J =
6.1 Hz), 5.4 (d, 1H, J = 6.2 Hz), 5.28 (dd, 1H, J = 4.7, 2.3 Hz), 5.14 (d, 1H, J = 4.7 Hz),
4.56 (dd, 1H, J = 6.0, 5.2 Hz), 4.21 (br, 2H), 4.11 (dd, 1H, J = 4.7, 3.3 Hz), 3.92 (dd, 1H,
J = 3.5, 3.4 Hz), 3.63 (m, 1H), 3.51 (m, 1H).
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6.4.2.2 N6-propargyl-adenosine-5’-triphosphate
N6-propargyl-adenosine-5’-triphosphate

was

synthesized

using

the

Yoshikawa

(Yoshikawa et al. 1967) reaction for selective phosphorylation of the 5’-hydroxyl group,
generally following the method of Ludwig (Ludwig 1981). Trimethyl phosphate was
dried for 18 h over molecular sieves (3A) and under argon atmosphere. 0.5 ml trimethyl
phosphate was transferred into a flame dried round bottom flask and 6-propargyladenosine (61 mg, 0.2 mmol) was added. Phosphoryl chloride (39.8 mg, 0.26 mmol) was
added to the stirred suspension with a syringe and the reaction mix was stirred for 1.5 h at
0 °C until it cleared. To this solution tributylammonium pyrophosphate (549 mg, 1
mmol), in 2 ml anhydrous dimethylformamide, was added and stirred for 20 min at 0 °C.
The reaction mix was further stirred for 5 min at room temperature, before 2 ml of
triethylammonium bicarbonate (1M) was added. Solvent was evaporated under reduced
pressure and half of the resulting material was purified by reverse phase HPLC using a
gradient of 20 mM triethylammonium bicarbonate (pH 7.4, acetic acid, 2% acetonitrile)
and 100 % acetonitrile. Fractions that contained the desired product were lyophilized to
afford 54 mg of N6-propargyl-adenosine-5’-triphosphate as a triethylammonium salt
(54% extrapolated yield).
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P NMR (D2O): 1.74 (s), -9.63 (m), -10.27 (m); 1H NMR

(D2O): δ 8.55 (m, 1H), 8.34 (m, 1H), 6.16 (m, 1H), 4.56 (m, 1H), 4.40 (m, 3H), 4.30 (m,
1H), 4.22 (m, 1H), 4.07 (m, 1H), 2.63 (s, 1H). HRMS calcd. for C13H18N5O13P3 [(M+H)+]
546.0187, obsd. 546.0247.
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6.4.3 Cloning and expression
VopS (31-387) pGEXTEV and His6-Cdc42-(1-179)-(Q61L) pPROEXHTa were
expressed and purified as described previously (Luong et al. 2010). GST-Fic2
pGEXTEV, GST-Fic2-(H3717A) pGEXTEV, Rab1a (Canis) pet28a, DrrA (1-339)
pet28a,

RacV12

pet28a,

RhoApGEX-KG,

His6-Cdc42-(1-179)-(Q61L,

T35S)

pPROEXHTa, His6-Cdc42-(1-179)-(Q61L, T35A) pPROEXHTa and His6-Cdc42-(1-179)(Q61L, Y32A) pPROEXHTa were expressed and transformed in BL21 (DE3) cells.
Protein expression was performed overnight at room temperature with 0.4 mM IPTG.
Protein pellets were purified using glutathione-agarose (Sigma) or immobilized metal ion
affinity chromatography (Sigma). Proteins were buffer exchanged in 20 mM Tris pH 8.0,
100 mM NaCl, 10% glycerol, 1 mM DTT with an Amicon 10K concentrator and stored
at -80 °C. Protein concentrations were assayed by the Bradford method (Bio-Rad) and
purity by SDS-PAGE analysis.
6.4.4 AMPylation reactions
In vitro AMPylation reactions were carried out at 30 °C for 1 hour, if not indicated
otherwise, in a total volume of 15 µl. For in vitro AMPylation reactions with purified
substrates, protein substrates (0.5 µg) and AMPylation enzymes (VopS 1-10 ng, Fic2 1100 ng, DrrA 1-1000 ng) were incubated with N6pATP (100 µM, unless indicated
otherwise) in 20 mM Hepes pH 7.4, 100 mM NaCl, 5 mM MgCl2, 0.1 mg/ml BSA and
1mM DTT. For the ATP competition experiment, increasing concentrations of ATP from
a dilution series was added to the assay mix.
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For in vitro AMPylation reactions with cell lysates, AMPylation enzymes (100 ng VopS,
300 ng Fic2, 4 µg DrrA) were incubated with 10 µg cell lysate in 20 mM Hepes pH 7.4,
100 mM NaCl, 5 mM MgCl2, and 1mM DTT.
HeLa cells were grown in DMEM medium supplemented with 10% fetal bovine serum.
HeLa cell lysates were generated from 1 P15 dish of 80% confluent HeLa cells. Cells
were harvested by trypsinization, collected by centrifugation, and washed once in PBS.
The cell pellet was lysed with 1 ml 20 mM Tris, pH 8.0, 150 mM NaCl, 0.5% Triton X100, 1 mM EDTA and Roche complete EDTA-free protease inhibitors (1 tablet/25 ml)
for 20 min on ice. Cell lysate was cleared by centrifugation at 23,000 g, 4 °C, for 15 min.
Protein concentration was determined using the BCA assay. The resulting protein
concentration was 5 µg/µl.
6.4.5 Click-chemistry and in-gel fluorescence analysis
The AMPylation reaction was stopped by methanol/chloroform precipitation. To 15 µl
assay volume, 85 µl water, 400 µl methanol and 100 µl chloroform was added and
samples were vortexed; 300 µl water was added, samples were vortexed again and
centrifuged at 23,000 g, at room temperature, for 5 min. The upper phase was carefully
discarded and 1 ml ice-cold acetone was added. Samples were vortexed and centrifuged
at 23,000g, at 4 °C, for 10 min. The supernatant was discarded and pellets were dried for
5 min. Subsequently, pellets were dissolved in 15 µl 4% SDS, 150 mM NaCl, 50 mM
triethanolamine, pH 7.5 (4ST).
For in-gel fluorescence detection of N6pATP modified substrate proteins, resolubilized
protein pellets from AMPylation reactions were reacted with azido-rhodamine (az-rho).
For this purpose a click-chemistry master mix was prepared with 7.5 µl 4ST, 0.25 µl 10
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mM az-rho, 0.5 µl 50 mM TCEP (tris(2-carboxyethyl)phosphine), 1.25 µl 2 mM TBTA
(tris((1-benzyl-1H-1,2,3-triazol-4-yl)methyl) amine) in 1:4 DMSO:n-butanol and 0.5 µl
CuSO4 per individual sample. 10 µl click-chemistry master mix was added to each
individual protein sample to yield a total volume of 25 µl with 0.1 mM az-rho, 1 mM
TCEP, 0.1 mM TBTA and 1 mM CuSO4. Click-chemistry was carried out for 1 hour at
room temperature. Click-chemistry was stopped by addition of 8.3 µl 4x Laemmli buffer
and 1.6 µl 2-mercaptoethanol. Samples were incubated at 95 °C for 5 min and run for
analysis on a 4-20% Tris-HCl Criterion™ Precast Gel (Biorad).
Protein gels were rinsed with deionized water and incubated for multiple hours in 50%
water, 40% methanol, 10% acetic acid at 4 °C. Before in-gel fluorescence analysis
protein gels were transferred to deionized water and incubated for at least 30 min at room
temperature. Protein gels were scanned on a Amersham Bioscience Typhoon 9400
variable mode imager (excitation 532 nm, 580 nm filter, 30 nm band-pass). All image
adjustments were done on the entire depicted image for all samples equally in Adobe®
Photoshop® CS3. Subsequent to fluorescence scanning, protein gels were stained with
GelCode Blue Stain Reagent (Thermo) or Coomassie Brilliant Blue (BioRad). Both stains
are indicated as coomassie blue (CB) in all figures.
6.4.6 AMPylation reaction and sample preparation for proteomic analysis
For large-scale proteomic analysis, 1 mg of HeLa cell lysate (preparation see above) was
incubated with 100 µM N6pATP in the presence or absence of VopS (88 µg) for 1.5 h at
30 °C in a total volume of 1.5 ml of 20 mM Hepes pH 7.4, 100 mM NaCl, 5 mM MgCl2,
and 1mM DTT. The reaction mix was precipitated by methanol chloroform precipitation,
adding 6 ml methanol, 1.5 ml chloroform, and 4.5 ml water in a 15 ml falcon tube.
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Samples was vigorously vortexed and centrifuged for 30 min at 5200g at 4 °C. The upper
phase was discarded and 10ml ice-cold acetone was added and mixed. Samples were
centrifuged for 30 min at 5200g at 4 °C and the supernatant was discarded and the pellets
were dried on air.
Protein pellets were resuspended in 400 µl 4 % SDS in PBS. A click-chemistry master
mix was prepared with 21 µl of a 10 mM solution of ortho-hydroxy-azidoethoxy-azobiotin (compound 5 in Yang et al. 2010), 42 µl of a 50 mM TCEP (tris(2carboxyethyl)posphine; freshly prepared in water) solution, 105 µl of a 2 mM TBTA
(tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine; in 4:1 n-butanol and DMSO)
solution, 42 µl of a 50 mM CuSO4 solution, and 1050 µl of 4 % SDS in PBS. 600 µl of
the master mix was added to each sample and each sample was incubated for 1.5 h at
room temperature. Click-chemistry was ended by methanol/chloroform precipitation (4
ml methanol, 1 ml chloroform, 3 ml water). The resulting pellet was rinsed 3 times with
ice-cold methanol and vigorously vortexed each time. The pellets were dried on air. The
resulting protein pellets were dissolved in 1 ml 6M urea/2M thiourea in 10 mM Hepes pH
8.0. Proteins were reduced by addition of DTT to 1mM (from 500 mM DTT stock) for 45
min at room temperature. Then, proteins were alkylated by addition of iodoacetamide to
5.5 mM from a 500 mM stock. Samples were incubated for 30 min at room temperature
in the dark. High-capacity streptavidin beads (Thermo) were equilibrated with 6M
urea/2M thiourea in 10 mM Hepes pH 8.0. The reduced and alkylated protein samples
were directly loaded onto the equilibrated beads and incubated on a nutator mixer for 1.5
h at room temperature. The beads were washed 3 times with 6M urea/2M thiourea in 10
mM Hepes pH 8.0, 3 times with 0.2% SDS in PBS, 3 times with PBS, and 1 time in 4.5
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M urea/1.5 M thiourea in 10 mM Hepes pH 8.0. Beads were drained and 200 µl 4.5 M
urea/1.5 M thiourea in 10 mM Hepes pH 8.0 was added with 2 µg Lys-C. Samples were
incubated in shaker (1000 rpm) for 4 h at room temperature. Samples were diluted by
addition of 600 µl 10 mM Hepes pH 8.0 and 2 µl trypsin was added to each sample (2
µl/5 µl in 50 mM acetic acid stock). Samples were incubated over night at 1000 rpm at
room temperature. Beads were spun down (2000g for 1 min) and the supernatant was
collected for mass spectrometry analysis. The supernatant was then purified by Zip-Tip
Pipette tips (Millipore).
6.4.7 Mass spectrometry
LC-MS analysis was performed at the Rockefeller Proteomics Resource Center, with a
Dionex 3000 nano-HPLC coupled to an LTQ-Orbitrap ion trap mass spectrometer
(ThermoFisher). Peptides were pressure loaded onto a home-made 75 μm diameter, 15
cm C18 reverse phase column and separated with a gradient running from 95% buffer A
(HPLC water with 0.1% formic acid) and 5% buffer B (HPLC grade acetonitrile with
0.1% formic acid) to 55% B over 30 min, next ramping to 95% B over 10 min and
holding 95% B for 10 min. One full MS scan (300-2000 MW) was followed by 3 data
dependent scans of the most intense ions with dynamic exclusion enabled. The spray
voltage was set to 1.94 kV and the flow rate through the column was set to 0.25 μL/min.
6.4.8 Data analysis
For protein identification all generated .raw files were searched using the SQUEST
search algorithm under BioWorks 3.3.1 SP1. All searches were performed against a
indexed database containing the international protein index (IPI) human database v3.86,
the sequence of VopS, and the sequence of streptavidin. The database was indexed in
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BioWorks 3.3.1 with carbamidomethylation as static modification, trypsin as proteolytic
enzyme, ‘fully enzymatic’ as enzyme limit, 250-7000 as MW range, and 2 missed
cleavage sites. SEQUEST searches were conducted with monoisotopic precursor and
fragment masses, 50.00 ppm peptide tolerance, 1.0 AMU fragment ion tolerance, and B
and Y ion series calculated. Carbamidomethylation was selected as static modification,
methionine/tryptophan oxidation as well as asparagine/glutamine deamindation was
selected as variable modification. The generated unified search files .srf were opened in
Scaffold 3 (Proteome Software) and further analyzed. All searches were filtered in
Scaffold 2 for 99.9% protein probability, 2 unique peptides, and 95% peptide probability.
Data was exported into Excel and further analyzed. All identifications with hits in the
control sample were discarded, as well as all identified contaminations (e.g. keratins).
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7

Chemical reporters for RNA synthesis and mRNA polyadenylation5

7.1

Abstract

Modern array and sequencing technologies have tremendously improved our capabilities
for transcriptome analysis. In parallel metabolic labeling approaches have been taken to
label newly synthesized mRNAs with chemical reporters, which allow analysis of mRNA
synthesis and degradation. In this chapter we present a new adenosine based chemical
reporter for RNA synthesis that is incorporated into newly transcribed mRNA and into
mRNA polyadenylation tails.
7.2

Introduction

Understanding the mechanisms of gene expression requires a thorough knowledge of the
balance between the biogenesis of an mRNA and its degradation. While advances in
transcriptome profiling methods have enabled the large-scale analysis of RNA steadystate levels, monitoring the synthesis, processing and decay rates of specific transcripts
remains technically challenging. The application of nucleoside analogs such as 4thiouridine (4-sU) has recently enabled metabolic labeling and enrichment of nascent
transcripts to monitor RNA dynamics in mammalian cells (Rabani et al. 2011). Thiolselective labeling allows the capture and enrichment of RNA but is incompatible with
cellular imaging due to competing free thiols in cells. Alternatively, metabolic labeling
with 5-ethynyluridine (EU) is compatible with fluorescence imaging of nascent

5

This work was carried out in collaboration with Nicholas K. Conrad (UT Southwestern).

Nicholas K. Conrad conducted all experiments pertaining to Figure 55, Figure 56, and
Figure 57.
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transcripts in cells, tissues and model organisms following copper (I)-catalyzed azidealkyne cycloaddition (CuAAC or “click chemistry”) with azide-functionalized
fluorescent dyes (Jao & Salic 2008). Here we report N6-propargyl adenosine (N6pA;
Figure 54a) is efficiently incorporated into RNA in mammalian cells and can be used for
CuAAC-mediated fluorescence imaging and affinity enrichment of nascent transcripts.
We also demonstrate how “clickable” nucleosides can be employed to monitor
polyadenylate [poly(A)] tail dynamics in cells.
7.3

Results

To determine whether N6pA labels cellular RNA, we analyzed metabolic incorporation of
N6pA into mammalian cells by fluorescence microscopy. HeLa cells were incubated in
complete medium containing a range of N6pA concentrations (1.0 µM - 1 mM). After 12
hours, the cells were washed, permeabilized, fixed, reacted with azido-rhodamine via
CuAAC and visualized by fluorescence microscopy (Figure 54b). The majority of N6pAspecific fluorescence signal localized to distinct substructures of the nucleus, most likely
nucleoli, in accordance with the dominant transcriptional activity of RNA polymerase I
(pol I). Incorporation of N6pA was observed with as little as 10 µM of N6pA and
appeared to reach its maximum between 10 µM and 100 µM. To distinguish between
DNA and RNA labeling, we examined N6pA incorporation in the presence of
hydroxyurea, a ribonucleotide reductase inhibitor, or actinomycin D, a transcription
inhibitor (Figure 54c). While the addition of hydroxyurea had no effect, actinomycin D
completely abolished fluorescence, demonstrating that N6pA is incorporated into RNA,
but not DNA. We conclude that, similar to EU, N6pA is efficiently incorporated into
rRNA by pol I in cells.
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Figure 54 N6pA is incorporated by pol I in cells. a) Structure of N6pA and N6pATP. b)
Cells were incubated for 12 hours in media containing the indicated concentrations of
N6pA. After fixation and permeabilization, rhodoamine-azide was conjugated via click
chemistry. Top panels are rhodamine signal and the bottom panels are nuclei
counterstained with TO-PRO-3. c) Cells were incubated with 1 mM N6pA in the presence
of actinomycin D or hydroxyurea as indicated; fluorescent assay performed as in b).
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In contrast to EU, N6pA is a potential substrate for incorporation into poly(A) tails by
cellular poly(A) polymerases. To test this, we performed in vitro polyadenylation
reactions with HeLa nuclear extracts, a uniformly
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P-labeled RNA substrate and N6-

propargyl adenosine-5´-triphosphate (N6pATP; Figure 54a) (Grammel et al. 2011).
Incubation of the substrate in nuclear extract under polyadenylation conditions leads to
the addition of a poly(A) tail of ~150-250 nt, as previously observed (Wilusz & Shenk
1988) (Figure 55a, lanes 1 and 2). Inclusion of N6pATP in the reaction at various
concentrations (Figure 55a, lanes 3-5) had no apparent effect on polyadenylation
efficiency, as judged by the intensity and lengths of the polyadenylated products (Figure
55a, lanes 2-5). However, when ATP was replaced completely with N6pATP, no poly(A)
extension was observed (Figure 55a, lane 6). To show incorporation of N6pA into
poly(A) tails, polyadenylation products were biotinylated using CuAAC with biotin-azide
and captured on streptavidin beads. Polyadenylated RNAs generated in the presence of
N6pATP were retained by streptavidin beads, whereas those generated in its absence were
not (Figure 55a, compare lanes 9-11 to lane 8). In principle, incorporation of only one
N6pATP and its subsequent biotinylation should be sufficient for binding. However, the
recovery of the polyadenylated substrates correlated with higher N6pATP:ATP ratios.
This may indicate that N6pATP is not utilized by poly(A) polymerase as efficiently as
ATP or that any one of the downstream steps (i.e. biotinylation, binding or retention on
the column) requires more than one modified residue for maximal recovery. Interestingly,
while N6pATP alone did not support processive polyadenylation, this substrate was
recovered more efficiently than the control (Figure 55a, lane 12 versus lane 7). It is
therefore likely that a few N6pATP molecules were incorporated into the substrate, but

146

the tail could not be further extended. Perhaps natural adenosines in the poly(A) tail are
required to promote processive polyadenylation or ATP may be necessary for the activity
of putative ATP-dependent enzymes (e.g. helicases) involved in polyadenylation in
extract. In either case, these data clearly show that N6pA is utilized by a poly(A)
polymerase in vitro.

Figure 55 N6pA is incorporated into poly(A) tails in vitro and in vivo. a) In vitro
polyadenylation assays with a 32P-labeled “pre-cleaved” substrate in HeLa nuclear extract
(Wilusz & Shenk 1988). The substrate is a 247-nt in vitro transcribed RNA derived from
the 3´ end of PANΔ79 RNA (Conrad et al. 2007) that contains the AAUAAA
polyadenylation signal and terminates at the natural cleavage site. As a result,
polyadenylation is uncoupled from the endonucleolytic cleavage step of 3´-end
formation. The concentrations of N6pATP and ATP in the reaction are shown above each
lane. Lanes 1-6 contain the products of the polyadenylation reaction (20% of the total
reaction), while lanes 7-12 are the streptavidin-bound transcripts. b) N6pA is incorporated
into poly(A) tails in vivo. 10% of the RNase T1-treated RNA (Input) or 100% of the
streptavidin-bound RNA was analyzed by northern blot using an oligo dT probe to detect
poly(A) tails. The experimental flow is shown to the right.

Next we tested whether N6pA is incorporated into poly(A) tails in mammalian
cells. To do this, we labeled HEK293 cells with 200 µM EU or N6pA for 12 hr, harvested
cells, and extracted RNA. To degrade total RNA but leave poly(A) tails intact, we treated
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the RNA with RNase T1, a G-specific endonuclease, prior to biotinylation and selection.
Heterogeneous poly(A) tails are observed in each of the input samples (Figure 55b).
However, only the poly(A) tails from cells labeled with N6pA bound the streptavidin
column (Figure 55b), while the EU-treated or control (DMSO) poly(A) tails did not.
These results demonstrate that N6pA is incorporated into poly(A) tails by at least one
poly(A) polymerase in cells. While several poly(A) polymerases are expressed in cells,
our results are consistent with the conclusion that we are monitoring incorporation by the
“canonical” poly(A) polymerase, PAPα (PAPOLA) (Eckmann et al. 2011). PAPα is
responsible for the polyadenylation of cellular mRNAs that contain a typical AAUAAA
poly(A) signal. Both our in vitro substrate (Figure 55a) and the majority of the “bulk”
poly(A) tails (Figure 55b) fall into this category, so it seems likely that this is the poly(A)
polymerase responsible for the activity we are monitoring. Further studies are necessary
to determine whether the “noncanonical” poly(A) polymerases involved in a variety of
alternative polyadenylation pathways (Schmidt & Norbury 2010) can also utilize N6pA.
We next examined whether pol II and pol III utilize N6pA. For pol II, we needed
to experimentally distinguish between pol II and PAPα activity in cells. To do so, we
tested whether the histone mRNAs, which are non-polyadenylated pol II transcripts
(Marzluff et al. 2008), were labeled with N6pA. Total RNA from N6pA-treated cells was
biotinylated, selected, and recovered transcripts were analyzed by semi-quantitative RTPCR (Figure 56, top). H2A mRNA was efficiently recovered from N6pA-treated cells as
well as from positive control (EU) cells. In contrast, minimal H2A mRNA was observed
in the negative control (DMSO). Similar results were obtained for histone HIST3H2BB
mRNA (data not shown). Additionally, the pol III-transcribed 7SK RNA was detected
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among the selected transcripts from EU and N6pA-treated cells (Figure 56, bottom). From
these results and those presented above, we conclude that N6pA is incorporated into RNA
by pol I, II, III and PAPα.

Figure 56 N6pA is incorporated into pol II and pol III transcripts in vivo. RNA harvested
from cells treated with DMSO, 200 μM EU, or 200 μM N6pA for 12 hr was subject to
click chemistry with biotin-azide and selected on a streptavidin column. 10% of the input
and 100% of the bound RNA was analyzed by semi-quantitative RT-PCR using primers
specific for the histone H2A mRNA or the 7SK small noncoding RNA. Negative controls
lacking reverse transcriptase are also shown (-RT).

The general pathway for destruction of cytoplasmic mRNAs begins with a slow
distributive deadenylation of the transcript, which is followed by nearly coincident
decapping, processive deadenylation, and transcript decay (Parker & Song 2004;
Yamashita et al. 2005). In most cases, distributive deadenylation has been observed using
specific reporter transcripts driven from inducible promoters, but has not been
demonstrated at the bulk level. Changes in bulk poly(A) lengths have been limited to
steady-state observations primarily due to the lack of simple approaches for global pulsechase analysis of poly(A) tail lengths. While steady-state analysis can be informative
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(Apponi et al. 2010), interpreting poly(A) tail length differences in a pool of transcripts
that contains both newly synthesized transcripts and older transcripts can be difficult. We
therefore developed a pulse-chase strategy using EU or N6pA to study bulk poly(A) tail
dynamics in cells. HEK293 cells were pulse-labeled with 200 µM EU or N6pA for 2 hr,
washed, and chased with media lacking modified nucleoside. Cytoplasmic RNA was
extracted from cells at given time intervals following the chase. Metabolically labeled
transcripts were biotinylated by CuAAC, captured on streptavidin columns, and digested
with RNase T1. Northern blot analysis of the resulting poly(A) tails showed that after a 2hr pulse (t=0), the cytoplasmic poly(A) tails were ~150-200 nt long (Figure 57).
Importantly, the tails shortened over time and decreased in their abundance, consistent
with the model that most cytoplasmic mRNAs are gradually deadenylated prior to their
destruction. This assay has the advantage of observing RNAs transcribed from
endogenous promoters in the absence of general transcription inhibitors, which often
have pleiotropic effects (Loflin et al. 1999). The ability to detect bulk poly(A) tails after a
short labeling pulse allows us to examine poly(A) dynamics of transcripts that were
synthesized within a 2-hr window, thereby limiting the heterogeneity of poly(A) tail
length that arises over time. We conclude that alkyne-nucleosides and click chemistry can
be employed to examine poly(A) tail dynamics in cells. In principle, this approach could
be extended to examine poly(A) tail dynamics of specific cellular mRNAs using
previously described RT-PCR techniques to detect poly(A) tail length (Sallés et al. 1999).
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Figure 57 Pulse-chase assay to analyze poly(A) tail dynamics. a) Experimental flow.
Cells were labeled for two hours with EU or N6pA and chased for 2, 4, or 6 hr prior to
cytoplasmic RNA extraction. Poly(A) tails of captured transcripts were then analyzed by
northern blot using an oligo dT probe. b) Data from an in vivo poly(A) tail dynamics
assay.

In summary, we report N6pA is incorporated by all three cellular RNA polymerases
(pol I, pol II, pol III) in mammalian cells. Moreover, N6pA is added to poly(A) tails in
vitro and in vivo, demonstrating that this chemical reporter is utilized by poly(A)
polymerase. Furthermore, we showed that clickable nucleosides can be employed to
monitor cellular poly(A) tail dynamics. These alkyne-adenosine reporters should provide
new tools to monitor RNA metabolism in vitro and in vivo using bioorthogonal chemistry
(Boyce & Bertozzi 2011) and Raman microscopy (Yamakoshi et al. 2011).
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7.4

Materials and methods

7.4.1 Metabolic labeling of HeLa cells and visualization by fluorescence
microscopy
For metabolic labeling experiments in mammalian cell culture, 5 x 104 HeLa cells were
split into 12 well plates on glass cover slips 24 hours before the experiment. HeLa cells
were cultured in Dulbecco’s Modified Eagle Medium (DMEM) with 10 % fetal bovine
serum (FBS). Cells were washed once with phosphate-buffered saline (PBS) and then
incubated with N6pA in culture media for 12 hours at 37 °C at 5% CO2. Actinomycin D
(Sigma Aldrich) or hydroxyurea (Fisher Scientific) was added to the growth medium
together with N6pA at 2 µM or 10 mM, respectively.

After metabolic labeling, the cells were washed three times with PBS and subsequently
fixed and permeabilized with 3.7% formaldehyde in PBS with 0.2% Triton X-100 for 30
min at room temperature. Then, cells were washed three times for 5 min each with PBS.

To detect incorporation of N6pA, fixed cells were reacted with an azide-rhodamine (azrho) fluorescence dye. For this purpose, click chemistry master mix (300 µl) was added
to each well for a 1 h incubation period at room temperature. The master mix was
prepared in PBS by addition of azido-rhodamine (Charron et al. 2009) (N-(9-(2-(4-(6azidohexanoyl)piperazine-1-carbonyl)phenyl)-6-(diethylamino)-3H-xanthen-3-ylidene)N-ethylethanaminium chloride, from a 10 mM stock solution in DMSO) to a final
concentration of 20 µM, TCEP (tris(2-carboxyethyl)phosphine, from a 50 mM freshly
prepared aqueous solution) to a final concentration of 1 mM, TBTA (tris[(1-benzyl-1H1,2,3-triazol-4-yl)methyl]amine, from a 2 mM solution in 4:1 n-butanol:DMSO) to a final
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concentration of 100 µM, and CuSO4 (from a 50 mM freshly prepared aqueous solution)
to a final concentration of 1 mM. The components were added in the order listed and the
mix was vigorously vortexed after the addition of each component. After click chemistry,
the cells were washed three times for 5 min each. Cells were incubated with TO-PRO-3
DNA dye (1:1000 in PBS) for 30 min at room temperature. Cells were washed three
times for 5 min each. Cover slips were mounted on glass slides in ProLong Gold
Mounting medium (Invitrogen). The images were taken on an upright LSM510 laser
scanning confocal microscope (Zeiss) equipped with a Krypton/Argon laser with 488 and
568 lines and a HeNe laser with a 633 line, using a 100x oil immersion objective.
7.4.2 CuAAC reaction and streptavidin selection of alkyne-modified RNA
Modified transcripts were selected using the Click-iT Nascent RNA Capture Kit
(Invitrogen) with several alterations to the manufacturer’s protocol. Primarily, we scaled
down the procedure to cost-effectively accommodate the number of samples required for
pulse-chase analyses. Additionally, the elution and detection schemes were experimentspecific. A typical click reaction contained from 100 ng - 3 µg RNA, 10 µl of Click-iT
EU Buffer, 2 mM CuSO4, 250 nM biotin-azide, 0.5 µl of Click-iT reaction additive 1, and
0.5 µl of Click-iT reaction additive 2 in a total volume of 20 µl. As per the
manufacturer’s instructions, the Click-iT reaction additives were added last; additive 2
was added 3 min after additive 1. Generally, we used the higher range of RNA
concentrations (~1-3 µg) from cells treated for shorter times with ethynyluridine (EU,
Invitrogen) or N6pA. The reaction proceeded for 30 min, and was mixed tapping the tube
every ~10 min. Subsequently, 20 µl of 10M NH4OAc, 15 µg of GlycoBlue (Ambion),
and 350 µl of ethanol were added and the RNA was precipitated overnight at -20 °C.
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Dynabeads streptavidin beads were washed three times in an equal volume of Wash
Buffer 2; 10 µl of slurry was used per click reaction. After the final wash, the beads were
resuspended in 20 µl of Wash Buffer 2. Precipitated RNA from the click reaction was
washed with 70% ethanol and resuspended in 5 µl H2O. 25 µl of 2X binding buffer
supplemented with 10 U RNase inhibitor (Promega) was mixed with the RNA suspension
and heated to 65 °C for 5 min prior to the addition of 20 µl bead suspension. The
resulting 50 µl binding reactions were incubated at room temperature for 60 min with
gentle vortexing every ~10 min to keep beads from settling. The beads were subsequently
washed three times with 100 µl of Click-iT reaction wash buffer 1 and then three times
with 100 µl of Click-iT reaction wash buffer 2. Selected RNAs were eluted in an
experiment-specific manner.
7.4.3 In vitro polyadenylation
In vitro polyadenylation reactions were performed using pre-cleaved substrates based on
previously described protocols (Wilusz & Shenk 1988). The gel-purified, uniformly 32Plabeled substrate contains the 3´-most 247 nt of PANΔ79 RNA (Conrad et al. 2007)
including the AAUAAA hexamer and ends at the natural poly(A) addition site. Substrates
were generated by in vitro transcription with bacteriophage T7 RNA polymerase using
general laboratory protocols. The template was made by PCR amplification of PANΔ79
with primers NC137 (5´-cgtaatacgactcactatagggcagctgggagcgctctttcaatg-3´) and NC138
(5´-tatggattaaacattgacctttatttatgttgtaagttgc-3´). Excluding contributions from nuclear
extract, each 25 µl polyadenylation reaction contained ~25 fmol of substrate, 20 mM
creatine phosphate, 1 mM DTT, 2% (v/v) polyvinyl alcohol, 1 mM MgCl2, 20 µg/ml
tRNA, 20 U RNase Inhibitor, and 45% HeLa nuclear extract. The nuclear extract
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contained 20 mM HEPES (pH 7.9), 20% glycerol, 50 mM KCl, 0.2 mM EDTA, and 0.5
mM DTT (Dignam et al. 1983). ATP and N6pATP was added as indicated in Figure 2.
After 60 min at 30 °C, reactions were stopped by the addition of 200 µl of 0.1 mg/ml
proteinase K, 0.1% (v/v) SDS, 15 µg GlycoBlue, 20 µg torula yeast RNA (Sigma), and
incubated for an additional 30 min at 37 °C. RNAs were phenol-chloroform extracted and
ethanol precipitated using standard laboratory techniques.

After precipitation, the entire reaction was subjected to click chemistry and streptavidin
selection as described above. After washing, the bound transcripts were eluted in two
steps. First, the beads were heated to 90 °C in 50 µl of a solution of 98% formamide and
10 mM EDTA. Second, after removal of the eluted formamide solution, the beads were
stripped by incubation for 60 min at 50 °C in 250 µl of a solution containing 0.1% SDS,
0.1 mg/ml proteinase K, 20 mM Tris-HCl (pH 6.8), and 22.5 µg of GlycoBlue. The
formamide and proteinase K elutions were combined, 30 µl of 3M NaOAc was added,
and the samples were phenol-chloroform extracted and ethanol precipitated using
standard laboratory techniques. Input and eluted RNAs were run on 6% urea-PAGE, the
gel was dried, and substrate was detected by Phosphorimager (Molecular Dynamics).
7.4.4 Metabolic labeling of poly(A) tails in vivo
To determine whether N6pA was incorporated into poly(A) tails in vivo, HEK293 were
grown in DMEM supplemented with 10% fetal bovine serum, 1X penicillin-streptomycin
(Sigma), 2 mM L-glutamate, and 200 µM of EU, N6pA, or DMSO as a control. After
overnight incubation, a slightly lower confluence of cells treated with N6pA was
observed, suggesting a minor growth defect compared to the DMSO control. Total RNA
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was extracted using Tri-Reagent (Molecular Research Center) following the
manufacturers protocol and treated with RQ1 DNase (Promega). One µg total RNA was
digested in 10 µl reactions containing 10 mM Tris-HCl (pH 7.5), 200 U RNase T1
(Ambion), 20 U RNase Inhibitor for 30 min at 37 °C. This treatment is sufficient to
completely digest the RNA as a 5-fold range of RNase T1 concentrations yielded similar
digestion products (data not shown). After digestion, the reaction was stopped by the
addition of 190 µl of 300 mM NaOAc, 0.1 mg/ml proteinase K, 0.25% SDS, 2 mM
EDTA, 20 mM Tris-HCl (pH 7.0) for 30 min at 37 °C. The RNA was then phenolchloroform extracted and ethanol precipitated using standard lab techniques. 10% of the
RNA was set aside as “Input” samples and the remaining RNA was selected using click
chemistry and streptavidin as described above. Elution protocol was the same as used for
the in vitro poly(A) selection.
7.4.5 Metabolic labeling and detection of histone mRNAs and 7SK RNA
Labeling and extraction of RNA was performed as described for the in vivo poly(A)
labeling assay. One µg of total RNA was used for click chemistry and streptavidin
selection as described above. After selection and washing, the selected RNA was reverse
transcribed on the beads. To the washed pellets, we added 25 µl of a solution containing
100 ng random hexamers (Sigma) and 10 mM solution of all four dNTPs. The mix was
heated for 5 min at 65 °C, briefly chilled on ice. To this solution, 8 µl of 5X first strand
buffer (Invitrogen), 4 µl of 100 mM DTT and 40 U RNase Inhibitor were added for a
total of 38 µl. Half of this mix was added to 1 µl (200 U) of M-MuLV reverse
transcriptase (New England Biolabs) while the other half was mixed with 1 µl H2O as a
“no-RT” control. Reverse transcription proceeded at 25 °C for 15 min and then at 42 °C
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for 1 hr. After the reverse transcription, 1 U of RNase H (Promega) and 5 ng RNase A
(Sigma) was added to the reaction for 30 min at 37 °C. The reaction was stopped by the
addition of 180 µl of a solution containing 300 mM NaOAc, 0.25% SDS, 2 mM EDTA,
20 mM Tris-HCl (pH 7.0) and 15 µg GlycoBlue. The cDNA was then phenol-chloroform
extracted and ethanol precipitated using standard lab techniques. PCR was performed
using 1/100th of the cDNA as template in a standard 20 µl PCR reaction with primers:
NC996 (5´ gtctggtcgtggcaaacaag-3´) and NC997 (5´-tgcgcgtcttcttgttgtcc-3´) for histone
H2A, NC998 (5´ atgccagacccgtccaaatc-3´) and NC999 (5´-tggtggagcgcttgttgtag-3´) for
histone HIST3H2BB and ID15 (5´- taagagctcggatgtgagggcgatctg -3´) and ID16 (5´cgaattcggagcggtgagggaggaag -3´) for 7SK RNA.
7.4.6 In vivo poly(A) tail dynamics assay
HEK293 cells were grown to ~80% confluency in 6-well plates and 200 µM EU, 200 µM
N6pA, or DMSO was added directly to the media. After 2 hr, the cells were washed twice
with PBS containing calcium and magnesium (Sigma); cells were harvested at time
intervals shown in Figure 4. To collect cytoplasmic RNA, cells were resuspended in
Buffer I (0.32 M sucrose, 3mM CaCl2, 2 mM MgCl2, 0.1 mM EDTA, 10 mM Tris-HCl
(pH 8.0), 1 mM DTT, 0.04 U/µl RNase Inhibitor, 0.5% Triton X-100), incubated on ice
for 5 min, centrifuged at 500 x g for 3 min at 4 °C, and RNA in the supernatant was
extracted using TriReagent followed by an additional phenol-chloroform extraction. One
µg of cytoplasmic RNA was used for click chemistry and streptavidin selection as
described above. After binding and washing, the beads were treated with 30 µl RNase T1
solution (20 mM Tris-HCl (pH 6.8), 8U RNase Inhibitor, 150 U RNase T1) for 15 min at
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37°. Subsequently, RNA was eluted as for the in vitro poly(A) selection assay and
poly(A) tails were detected by northern blotting.
7.4.7 Northern blot analysis
To examine bulk poly(A) tails by northern blot, the RNA was run on 1.8% formaldehydeagarose gels using standard laboratory techniques and transferred to Zeta-Probe nylon
membranes (Bio-Rad). An RNA marker (0.1-2kb; Invitrogen) was run as a size standard.
The blots were probed 3hr to overnight at 42 °C in ExpressHybe (Clontech) with a 5´
end-labeled oligonucleotide dT40 probe. The membranes were washed twice in 2X salinesodium citrate buffer, 0.1% SDS, twice in 1X SSC, 0.1% SDS at room temperature and
detected by Phosphorimager.
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8

Discussion and future outlook

In the past decade bioorthogonal chemistries and the resulting idea of chemical reporters
has effectively shaped the modern field of chemical biology. The strategy of using highly
selective non-perturbing, or at least selectively perturbing, chemistry to investigate basic
biological phenomena, develop new pharmacophores, and identify drug targets was truly
invigorated or maybe even completely new defined by a set of new chemical
transformations. This thesis work set out to contribute to this still growing field by
investigating the possibilities chemical reporters provide to analyze pathogen-host
interactions. While I recognize the current limitations of these approaches, some of the
discoveries I have made during my thesis work have strong potential to contribute to the
current line of investigation and transcend the topic of bacterial pathogenesis. Most
notably, various other laboratories are already applying the chemical reporters I have
developed for protein AMPylation and RNA synthesis to identify new AMPylation
substrates and investigate mRNA polyadenylation. Other explorations, as for example the
serendipitous discovery of a somewhat intrinsically cell-selective amino acid reporter (i.e.
EME), on the other hand, are only first steps towards more valuable research tools.
8.1

Development of cell-selective amino acid reporters for the investigation of
bacterial protein synthesis and secretion during infection

Bacterial pathogens dramatically change their gene expression pattern during the course
of an infection (Eriksson et al. 2003; Shi et al. 2006). It is believed that many genes that
are selectively expressed during infection, contribute to disease. The identification of
these genes or proteins has been a major interest in the field of bacterial pathogenesis,
especially in face of more rapidly emerging multi-resistant strains and the growing need
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for new antibiotics. Many bacterial pathogens, such as S. typhimurium, secrete effector
proteins into the mammalian host cell, which are important factors of infectivity, through
elaborate and complex secretion apparatuses. These secretion systems and their substrates
are of major interest for the development of new antibiotics. Proteomics has the theoretic
potential to identify bacterial proteins, selectively expressed or secreted during infection
and their respective posttranslational modifications. Proteomic interrogation of the
mammalian cytosol should reveal secreted bacterial effector proteins. Modern mass
spectrometry-based proteomics also has the potential to allow a quantitative and dynamic
analysis of these processes (J. Cox & Mann 2007). However, the confounding problem of
the direct proteomic interrogation of the bacterial proteome during infection is the
abundance and complexity of the mammalian proteome, which, by today’s dynamic
range standards of mass spectrometry, makes robust detection of the bacterial proteome,
especially of the secreted fraction, very difficult or even impossible (C. G. Zhang et al.
2005).
To address this issue we developed a cell-selective labeling strategy, based on
previous work of the Tirell group (Tanrikulu et al. 2009; Ngo et al. 2009) that allows
selective labeling of the S. typhimurium proteome during infection with alkyne (AOA) or
azide (ANL) bearing amino acids (Grammel et al. 2010). These amino acids are cotranslationally incorporated into the bacterial proteome upon expression of a mutant
methionyl-tRNA synthetase (MetRS) and replace methionine (Met) throughout the
bacterial proteome. The incorporated alkyne or azide groups serve chemical reporters that
allow visualization or enrichment of newly synthesized bacterial proteins. However, this
approach bears two intrinsic limitations; first, only cells in which the described MetRS
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mutant is active can be targeted with AOA or ANL, second only proteins that possess
Met residues can be labeled.
The first limitation will likely preclude the application in many more distantly
related (from E. coli) bacteria, even though sometimes striking cross reactivity has been
observed (Ripmaster et al. 1995). It will be interesting to see, whether these E. coli
derived MetRS mutants will be active in eukaryotic cells. This thesis presented some
experimental evidence that this is the case. The translation of the E. coli MetRS/AOA
system to eukaryotes could allow labeling of individual cell populations in multi-cellular
organisms (e.g. C. elegans) in the future. Towards this goal, it has been recently shown
that multi-cellular organisms, such as the zebrafish, can be labeled with methionine
amino acid reporters that do not depend on mutant MetRS activity (Hinz et al. 2012). If
the inhere used E. coli MetRS mutants do not possess activity in other model systems,
similar approaches of protein engineering, as the one used for the identification of the
current E. coli MetRS mutants, could be applied to the corresponding MetRS (Dieterich
et al. 2006).
The second limitation was addressed in this thesis by developing paraethynylphenylalanine (PEP) as a cell-selective amino acid reporter (Grammel et al.
2012). Since phenylalanine (Phe) is present at higher frequencies in many proteomes than
Met, the replacement of Phe with PEP could provide better coverage of the proteome.
Indeed we could detect better overall incorporation of PEP compared to AOA. A
combination of AOA and PEP provided even further improved labeling intensity.
Unfortunately, these results did not translate to the infection setting. Suboptimal PEP
incorporation upon dual bicistronic expression of MetRS and phenylalanyl-tRNA-
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synthetase (PheRS) should be overcome by generating a non-bicistronic expression
system for PheRS. In general, however, this proofs that the strategy that was initially
applied to ANL and E. coli MetRS could be also applied to other aminoacyl-tRNAsynthetases (aaRS). In fact, Met is one of the least frequent amino acids, while some
other amino acids, such as alanine, can make up 10% of a proteome or more
(http://www.pasteur.fr/~tekaia/aafreq.html) (Tekaia et al. 2002; Tekaia & Yeramian
2006). The engineering of an orthogonal amino acid reporter aaRS pair of one of these
aaRSs could dramatically increase labeling efficiencies.
While exploring alternative alkynyl amino acid reporters of Met we discovered
that EME has a certain intrinsic selectivity for S. typhimurium over mammalian cells.
Whereas its selectivity is currently not sufficient for proteomics studies, it provides a
mode for bacterial visualization during infection. In a first attempt to improve the
selectivity by extending the alkyl chain by one methylene unit, our laboratory tried to
improve the selectivity for S. typhimurium. However, this amino acid is still incorporated
into the mammalian proteome. Nevertheless, these observations at least demonstrated that
the differential intrinsic affinity of aaRSs of different organisms for an amino acid
reporter could be exploited to achieve cell-selective labeling.
Our proteomics studies revealed that cell-selective (orthogonal) amino acid
reporters can be used to enrich bacterial proteins from infected mammalian cells and
identify them by mass spectrometry. Yet, even though this method provides a facile way
to separate these two proteomes the dynamic range of amino acid reporter incorporation
is still not completely represented by the dynamic range of the subsequent enrichment
and mass spectrometry detection. Many of the identified bacterial proteins are proteins of
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high abundance, such as components of the translational machinery. This became
particularly clear when looking at the mammalian cytosolic fractions, which should
contain secreted bacterial effector proteins. Whereas we could show that the SPI-2
effector protein SseJ is labeled with amino acid reporter during infection and effector
proteins can be generally secreted by the type three secretion system (TTSS) after they
have incorporated amino acid reporters, we could not detect any effector proteins in the
mammalian cytosolic fraction by mass spectrometry. In these fractions we only detected
the most abundant bacterial proteins also detected in the pellet fraction, even with the
most selective lysis conditions.
The aim of enriching and detecting secreted effector proteins from infected
mammalian cells by mass spectrometry is pushing the boundaries of the theoretical
detection limit of current mass spectrometry based proteomics work-flows. Estimates for
secreted bacterial effector proteins range from a few hundred to a few thousand
molecules per cells, in some cases this number might even be lower (Winnen et al. 2008).
Other data suggest that in a typical cell the abundance of proteins ranges from a few
dozen to more then 106 molecules (Ghaemmaghami et al. 2003). This dynamic range has
to be compared with the current dynamic range of modern mass spectrometers, that is the
range of the least abundant and the most abundant molecule detected in a single
experiment, which is currently 4 to 5 orders of magnitude under optimal conditions (de
Godoy et al. 2008). The dynamic range of a particular mass spectrometry run is however
dependent on countless factors that all have to be optimized (Andrews et al. 2011). These
numbers show, that even under optimal conditions, the robust and reproducible detection
of secreted bacterial effector proteins is a daunting task. The complexity of the current
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workflow, that consists of the infection experiment, amino acid reporter pulse-labeling,
lysis, CuAAC, affinity enrichment, proteomics sample preparation, mass spectrometry,
leaves plenty of room for improvements. However, quantitative analysis of the
bottlenecks in the future will be indispensable, before addressing the current
shortcomings.
8.2

A chemical reporter for protein AMPylation

Protein AMPylation is emerging as an important posttranslational modification (PTM),
especially in the context of pathogen-host interactions. Genome data suggest that protein
AMPylation could be a ubiquitous PTM in prokaryotes as well as eukaryotes. To
determine its prevalence in different organisms we have developed an alkynyl chemical
reporter (N6pATP) for protein AMPylation that can be used by all known classes of
AMPylation enzymes and allows unbiased detection of substrates in cell lysates at
endogenous levels (Grammel et al. 2011). We demonstrated its utility by detecting the
known VopS substrate Cdc42 in Hela cell lysates by mass spectrometry. Addition of
recombinant AMPylation enzyme and N6pATP to cell lysates allows the enzyme specific
identification of substrates, an approach that our lab has also applied to other PTMs, such
as acetylation (Y.-Y. Yang et al. 2011). A general draw back of cofactor analogs as
N6pATP is its charged character and the resulting lack of cell permeability. Caged
cofactor analogs could circumvent this issue in the future (Ellis-Davies 2007). Caging
charged phosphate groups with esters results in a neutral net charge and enhances cell
permeability (Schultz et al. 1993). Such caging strategies could allow metabolic labeling
with cofactor analogs in the future. In addition to the current application in cell lysates,
N6pATP can be used for enzyme specific substrate identification with protein arrays. Our
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collaborators are currently establishing a screening assay for AMPylation substrates using
N6pATP and a nucleic acid programmable protein array (NAPPA)(Ramachandran et al.
2008). This assay provides the opportunity to screen thousands of proteins in highthroughput as potential AMPylation substrates using a combination of NAPPA and
CuAAC for substrate detection by fluorescence. Preliminary data has show that this
approach can be used to detect VopS substrates (RhoA, Rac3, Cdc42) and auto
AMPylation (HYPE) in array format. This approach is independent of the individual
expression patterns of cell lines and its reduced complexity might allow the detection of
substrates that would go undetected in cell lysates.
8.2.1 An adenosine based chemical reporter
Numerous alkynyl chemical reporters for nucleic acid biosynthesis have been introduced
in recent years (Salic & Mitchison 2008; Jao & Salic 2008; Neef & Luedtke 2011; Guan
et al. 2011). This thesis work has shown that N6-propargyl-adenosine (N6pA) also serves
as a chemical reporter for RNA biosynthesis, which is metabolically incorporated by
RNA polymerase I, II, and III (pol I, II, or III). In contrast to previous chemical reporters
of RNA biosynthesis, N6pA is also incorporated into polyadenylation (polyA) tails of
mRNA molecules. In the absence of transcriptional activity of pol I, II, and III polyA
modification of mRNA could be selectively studied with N6pA. However, the activated
triphosphate N6pATP does not seem to be an adequate substrate for polyA polymerase in
vitro.
As is indicated by its incorporation into RNA, N6pA is intracellularly transformed into its
triphosphate N6pATP, most likely, by the purine ribonucleoside salvage pathway. In
addition to nucleic acid biosynthesis, N6pATP could also be used as a co-factor/co165

substrate in other transformations. As we have seen, isolated AMPylation enzymes in
vitro as well as in cell lysates use N6pATP to modify their substrates. Hence,
intracellularly formed N6pATP might serve as a chemical reporter for potential
AMPylation enzymes. Indeed, in addition to the labeling of RNA, we have also observed
labeling of the proteome in mammalian and bacterial cells, when incubated with N6pA
(data not shown). However, these observed protein modifications could also be of
different origin, e.g. ADP-ribosylation. Provided the intracellularly formed N6pATP is
integrated into nicotinamide adenine dinucleotide (NAD), the co-substrate for ADPribosyl transferases and poly ADP-ribose polymerases, by the enzyme NAD
pyrophosphorylase, N6pA could potentially serve as chemical reporter for protein ADPribosylation.
This shows that N6pA is a facile chemical reporter for RNA biosynthesis and
polyA mRNA modification, but potentially also for protein posttranslational
modifications. This is particularly interesting due to the limited applicability (lack of cellpermeability) of the cofactor based chemical reporters N6pATP and alkyne-modified
NAD (Du et al. 2009; Jiang et al. 2010), for protein AMPylation and ADP-ribosylation,
respectively.
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9
9.1

Appendix
Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC)
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Figure 58 Current stepwise model of the Cu(I)-catalyzed azide-alkyne cycloaddition
(Himo et al. 2005; Bock et al. 2006; Rodionov et al. 2005; Rostovtsev et al. 2002b).
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9.2

Proteomics data

Table 3 S. typhimurium proteins identified from infected RAW264.7 cells (red – only
detected from infected RAW264.7 cells and not from in vitro labeled S. typhimurium). #
SC: number of spectral counts.
#
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
17
16
18
19
20
22
23
21
24
25
27
26
29
28
30
31
32
33
34
36
35
37
38
39
40
41

UniProt
P0A1D3
Q56073
P0A1H5
P0A1P0
P64076
P0A1E3
P0A1H3
P58480
Q8ZNN4
Q7CQ01
Q7DAP2
P14146
Q7CR42
Q7CPX8
P64052
Q9L6N1
P0A1D5
Q8ZP03
Q8ZRT0
Q7CPE2
P02936
P0A7W4
O30911
P26976
P77983
P62405
P0A251
Q8ZRT2
Q7CQV9
Q7CPE1
Q93DX3
P06173
P66932
Q7CPK0
P65702
P16657
P0A7Z7
Q8ZRU0
P25077
P60446
Q7CQT9

Name
60 kDa chaperonin
Chaperone protein dnaK
Elongation factor Tu
Glyceraldehyde-3-phosphate dehydrogenase
Enolase
Cysteine synthase A
Elongation factor G
Chaperone protein htpG
Methionyl-tRNA synthetase
Chaperone protein clpB
Putative carbonic anhydrase
Virulence transcriptional regulatory protein p
Putative thiol-alkyl hydroperoxide reductase
Fur regulated Salmonella iron transporter
Elongation factor Ts
5-methyltetrahydropteroyltriglutamate--homocys
10 kDa chaperonin
Mannose-specific enzyme IIAB
Dihydrolipoyl dehydrogenase
ATP synthase subunit beta
Outer membrane protein A
30S ribosomal protein S5
ATP-dependent hsl protease ATP-binding subunit
Non-specific acid phosphatase
Pyruvate kinase I
50S ribosomal protein L5
Alkyl hydroperoxide reductase subunit C
Pyruvate dehydrogenase, decarboxylase componen
DNA protection during starvation protein
ATP synthase subunit alpha
Putative LysR family transcriptional regulator
DNA-directed RNA polymerase subunit beta
Trigger factor
sn-glycerol-3-phosphate-binding periplasmic pr
Phosphoglycerate kinase
Enoyl-[acyl-carrier-protein] reductase [NADH]
DNA-directed RNA polymerase subunit alpha
Cell division protein ftsZ
Malate dehydrogenase
50S ribosomal protein L3
30S ribosomal subunit protein S1
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# SC
763
271
261
152
132
122
109
74
71
69
57
56
51
50
49
46
46
45
44
43
41
41
41
41
41
40
40
39
39
36
34
32
31
31
30
30
29
29
28
28
26

#
42
44
43
45
46
47
48
49
50
51
52
54
55
53
58
56
57
63
60
59
61
62
64
69
65
66
67
68
73
70
72
71
74
78
77
75
76
79
80
81
82
83
84
85
86
87
88
92

UniProt
Q9XCS1
Q7CQU1
P0A7K0
P0A2R4
Q8ZN59
P0A1S2
P66541
P67093
P0A2A3
Q8ZRB9
Q8ZQS2
Q8ZRT1
Q93DX1
P0A7V6
Q7CQN4
P0A295
Q7CPU6
Q8ZP45
P28354
P0A2B3
P33321
P66593
Q8ZPZ0
Q8ZLM1
P0A249
P0A2C9
P26219
Q7CPZ4
P65977
P0A297
P26982
P14846
Q8ZQE3
Q7CPL5
P60726
P0A2E1
P19480
Q8ZS18
P37430
P61179
Q8ZLD5
Q8ZRC0
O54297
P0A283
P67904
Q8ZK71
Q9F2E0
Q7CPF1

Name
Fur regulated Salmonella iron transporter
Pyruvate formate lyase I, induced anaerobicall
50S ribosomal protein L11
DNA-directed RNA polymerase subunit beta'
Inosine-5'-monophosphate dehydrogenase
DNA-binding protein H-NS
30S ribosomal protein S2
Universal stress protein G
50S ribosomal protein L1
ATP-dependent protease La
2,3-bisphosphoglycerate-dependent phosphoglyce
Pyruvate dehydrogenase
Putative acetyl-CoA hydrolase
30S ribosomal protein S3
Major outer membrane lipoprotein 1
Transcription termination factor rho
Fructose-bisphosphate aldolase
Iron-dependent alcohol dehydrogenase of the mu
Lysyl-tRNA synthetase
30S ribosomal protein S7
Translation initiation factor IF-3
30S ribosomal protein S6
Isocitrate dehydrogenase [NADP]
30S ribosomal protein S13
Phosphoenolpyruvate-protein phosphotransferase
3-oxoacyl-[acyl-carrier-protein] reductase
CDP-diacylglycerol pyrophosphatase
Protein grpE
Protein recA
50S ribosomal protein L10
Protease do
Carbamoyl-phosphate synthase large chain
ATP-binding subunit of serine protease
50S ribosomal protein L14
50S ribosomal protein L4
Serine hydroxymethyltransferase
Alkyl hydroperoxide reductase subunit F
Threonine synthase
Transcription elongation protein nusA
50S ribosomal protein L22
Putative phosphatase
ATP-dependent Clp protease ATP-binding subunit
30S ribosomal protein S4
Glucose-specific phosphotransferase enzyme IIA
30S ribosomal protein S10
Peptide methionine sulfoxide reductase msrA
GTP-binding elongation factor family protein
Small heat shock protein ibpA
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# SC
26
25
25
24
24
22
21
21
20
20
19
18
18
18
17
17
17
16
16
16
16
16
16
15
15
15
15
15
14
14
14
14
14
13
13
13
13
13
12
12
12
12
11
11
11
11
11
10

#
93
90
89
91
94
98
102
95
101
100
96
97
99
103
110
112
104
108
105
106
107
109
111
113
114
117
119
122
123
115
125
116
118
120
121
124
126
127
132
137
133
134
135
136
131
128
129
130

UniProt
Q8ZLT3
P0A1Z2
O84944
Q7CP63
Q8ZRJ5
Q08016
Q8ZK80
P0A1P6
Q7CQV2
Q7CQU5
P0A2B1
P63411
Q7CPJ3
Q8ZN40
Q7CPL7
Q8ZKI4
O68883
P64222
P27237
P63557
P63923
Q7CP96
Q7CR87
Q8ZRP0
Q93GL9
P53636
P66869
Q8ZMM8
Q8ZND6
P0A1S4
Q8ZPG8
P40732
P65882
Q8ZKP7
Q8ZL96
Q8ZNW0
Q8ZRB8
Q8ZRP4
P41033
Q8ZM63
Q7CQM5
Q8ZKW4
Q8ZL03
Q8ZLT4
P37411
P0A1F6
P0A7X0
P14062

Name
Polyribonucleotide nucleotidyltransferase
Chaperone protein skp
Secretion system effector
Response regulator
Aminoacyl-histidine dipeptidase
Ornithine carbamoyltransferase
50S ribosomal protein L9
Glutamine synthetase
Arginine 3rd transport system
Thioredoxin reductase
30S ribosomal protein S20
Acetate kinase
Putative inner membrane lipoprotein
Cysteine desulfurase
50S ribosomal protein L17
Glucose-6-phosphate isomerase
Citrate synthase
Aminomethyltransferase
Oligopeptidase A
Acetylglutamate kinase
Phosphopentomutase
Component of modulator for protease specific f
Chaperone surA
Outer membrane protein assembly factor yaeT
Conjugative transfer: surface exclusion
Superoxide dismutase [Cu-Zn] 1
Succinyl-CoA ligase [ADP-forming] subunit beta
Effector protein pipB2
Phosphotransacetylase
DNA-binding protein stpA
Putative hydrolase
Acetylornithine/succinyldiaminopimelate aminot
Adenylosuccinate synthetase
Triosephosphate isomerase
Glycyl-tRNA synthetase beta subunit
Pyruvate kinase II
Peptidyl prolyl isomerase
2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N
Phosphoenolpyruvate carboxykinase [ATP]
Transketolase 1 isozyme
Secretion system regulator: transcriptonal act
Aspartate--ammonia ligase
Small heat shock protein ibpB
Cysteine sulfinate desulfinase
DNA gyrase subunit A
Uridine phosphorylase
30S ribosomal protein S8
6-phosphogluconate dehydrogenase, decarboxylat
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# SC
10
10
10
10
10
9
9
9
9
9
9
9
9
9
8
8
8
8
8
8
8
8
8
8
8
7
7
7
7
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6

#
138
139
140
147
141
142
143
144
145
146
148
149
150
151
152
154
157
158
163
153
167
155
156
159
160
161
162
164
165
166
175
176
168
172
177
179
173
174
169
170
171
178
182
181
180
183
184
185

UniProt
Q8ZM69
P0A1D7
P0A2M5
Q7CQ97
P43019
P66409
P66738
P66764
Q7CPC8
Q7CPY9
Q8XFG8
Q8ZKN5
Q8ZMF5
Q8ZPT7
Q9ZF31
P15111
P65692
P66313
Q8ZKA4
P0A263
Q8ZP57
P26978
P60428
Q7CPE7
Q7CPH6
Q7CPM0
Q7CQ36
Q8ZKN4
Q8ZLT0
Q8ZNV2
Q04873
Q8ZLX5
O33921
P64046
Q8ZPC9
Q9ZFV8
P64394
P67557
P0A2I3
P0AA19
P15434
Q8ZQ76
Q8ZPQ3
P65215
P14845
Q8ZQT5
Q8ZRT7
Q9X523

Name
D-3-phosphoglycerate dehydrogenase
ATP-dependent Clp protease proteolytic subunit
Uracil phosphoribosyltransferase
3-oxoacyl-[acyl-carrier-protein] synthase I
Superoxide dismutase [Mn]
30S ribosomal protein S14
Ribosome-recycling factor
S-adenosylmethionine synthetase
Putative enzyme
Transcriptional repressor of emrAB operon
Peptidyl-prolyl cis-trans isomerase
Cystathionine gamma-synthase
Sulfate adenylyltransferase subunit 1
Putative enzyme
Translation initiation factor IF-2
NADP-specific glutamate dehydrogenase
6-phosphofructokinase
50S ribosomal protein L6
Component of modulator for protease specific f
Outer membrane protein C
Putative inner membrane protein
Bifunctional purine biosynthesis protein purH
50S ribosomal protein L2
Regulatory gene for high affinity phosphate up
Putative rhodanese-related sulfurtransferases
Acetyl CoA carboxylase
3-oxoacyl-[acyl-carrier-protein] synthase I
Aspartokinase II
Argininosuccinate synthase
Aspartyl-tRNA synthetase
UDP-glucose 6-dehydrogenase
Ribosomal RNA large subunit methyltransferase
Glucose-1-phosphatase
Elongation factor P-like protein
Gamma-aminobutyraldehyde dehydrogenase
NADP-dependent malic enzyme
Integration host factor subunit beta
Glucans biosynthesis protein G
DNA gyrase subunit B
Transcriptional regulatory protein ompR
Phenylalanyl-tRNA synthetase beta chain
Aminopeptidase N
Putative transport protein
2-dehydro-3-deoxyphosphooctonate aldolase
Carbamoyl-phosphate synthase small chain
Protein tolB
Protein translocase subunit secA
Periplasmic dipeptidase
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# SC
6
5
5
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2

Table 4 S. typhimurium proteins identified from in vitro culture conditions in MgM
medium. # SC: numer of spectral counts.
#
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
17
16
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
38
37
40
39
41
42
43
44
45

UniProt
Q8ZQE3
P64076
Q7CPE2
P66932
Q8ZRT0
Q7CPA1
Q8ZRU0
Q8ZM07
Q8ZQS2
Q8ZRC0
Q8ZKP3
P14146
Q8ZM88
P40732
P63557
Q7CP63
P00929
Q8ZJZ3
Q8ZRB9
P77983
Q7CR62
P0AA19
Q8ZMB8
P27237
Q7CQ00
P38039
Q7DAP2
Q7CQ10
Q8ZRJ5
Q8ZMF5
P0A2E5
Q8ZQT9
P0A1F6
P58661
P06202
Q8ZQW9
P37430
P15434
Q8ZJU9
Q7CQP3
Q8ZLZ4
Q7CPE7
Q8ZPM0
Q8ZQ40
P00905

Name
ATP-binding subunit of serine protease
Enolase
ATP synthase subunit beta
Trigger factor
Dihydrolipoyl dehydrogenase
Aspartate ammonia-lyase
Cell division protein ftsZ
Putative alcohol dehydrogenase
2,3-bisphosphoglycerate-dependent phosphoglyce
ATP-dependent Clp protease ATP-binding subunit
Glycerol kinase
Virulence transcriptional regulatory protein p
Putative periplasmic protein
Acetylornithine/succinyldiaminopimelate aminot
Acetylglutamate kinase
Response regulator
Tryptophan synthase alpha chain
Putative NAD-dependent aldehyde dehydrogenase
ATP-dependent protease La
Pyruvate kinase I
Prolyl-tRNA synthetase
Transcriptional regulatory protein ompR
Amino-acid acetyltransferase
Oligopeptidase A
Ribosome associated factor
Sulfite reductase [NADPH] flavoprotein alpha-c
Putative carbonic anhydrase
HTH-type transcriptional regulator iscR
Aminoacyl-histidine dipeptidase
Sulfate adenylyltransferase subunit 1
RNA polymerase sigma factor rpoS
Cytochrome d terminal oxidase, polypeptide sub
Uridine phosphorylase
Aspartate aminotransferase
Periplasmic oligopeptide-binding protein
Phosphoglucomutase
Transcription elongation protein nusA
Phenylalanyl-tRNA synthetase beta chain
Putative transport protein
Transcriptional activator of ntrL gene
Outer membrane channel
Regulatory gene for high affinity phosphate up
Putative oxidoreductase
Flavoprotein wrbA
Anthranilate synthase component II
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# SC
138
136
105
96
95
89
83
76
73
73
70
68
66
63
61
60
60
55
54
52
52
49
48
47
46
45
45
44
44
43
42
42
41
40
39
38
36
36
35
35
33
32
32
32
31

#
47
48
46
52
51
50
53
49
55
54
56
57
58
59
60
61
66
62
67
63
64
65
69
68
70
72
71
77
79
78
76
75
80
74
73
81
82
83
86
85
84
87
88
89
93
96
90
97

UniProt
P16657
Q8ZPM7
P0A2C9
Q8ZL96
Q7CQ36
P0A2F4
Q8ZQL1
P0A1V4
Q8ZLT0
Q7CPU6
Q8ZPZ0
O54297
P0A283
Q8ZNW8
Q8ZP21
Q8ZRP4
Q8ZLL6
P09384
Q8ZP60
P33321
P67366
Q7CR64
P66409
P0A249
Q8ZP10
Q8ZLX9
P66764
Q7CP68
Q9F2E0
Q8ZL72
P20753
P0A2T6
Q9ZF31
P0A2E1
P00910
P0AA02
P22037
Q8ZNV2
Q8ZK81
P40860
P02910
Q8ZP52
Q8ZQT5
Q8ZQU2
P26264
Q8ZKB4
P0A273
Q8ZKL9

Name
Enoyl-[acyl-carrier-protein] reductase [NADH]
Glutathionine S-transferase
3-oxoacyl-[acyl-carrier-protein] reductase
Glycyl-tRNA synthetase beta subunit
3-oxoacyl-[acyl-carrier-protein] synthase I
Superoxide dismutase [Fe]
D-alanyl-D-alanine carboxypeptidase penicilli
Adenylate kinase
Argininosuccinate synthase
Fructose-bisphosphate aldolase
Isocitrate dehydrogenase [NADP]
30S ribosomal protein S4
Glucose-specific phosphotransferase enzyme IIA
Putative inner membrane protein
Putative homolog of glutamic dehydrogenase
2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N
Peptidyl-prolyl cis-trans isomerase
Chemotaxis protein cheA
Phage shock protein
Translation initiation factor IF-3
UPF0227 protein ycfP
UPF0325 protein yaeH
30S ribosomal protein S14
Phosphoenolpyruvate-protein phosphotransferase
Cell division inhibitor
Putative methyl-accepting chemotaxis protein
S-adenosylmethionine synthetase
Hyperosmotically inducible periplasmic protein
GTP-binding elongation factor family protein
Aldehyde dehydrogenase B
Peptidyl-prolyl cis-trans isomerase A
Catabolite gene activator
Translation initiation factor IF-2
Serine hydroxymethyltransferase
Tryptophan biosynthesis protein trpCF
Transcription antitermination protein nusG
Protein mgtC
Aspartyl-tRNA synthetase
30S ribosomal protein S18
Sulfate/thiosulfate import ATP-binding protein
Histidine-binding periplasmic protein
Aconitate hydratase 1
Protein tolB
Succinate dehydrogenase iron-sulfur subunit
3'(2'),5'-bisphosphate nucleotidase cysQ
Fumarate reductase
LexA repressor
Acetylornithine deacetylase
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# SC
31
31
31
30
30
30
30
30
29
29
29
28
28
28
28
28
27
27
27
27
27
27
26
26
26
25
25
24
24
24
24
24
24
24
24
23
23
23
22
22
22
22
22
22
21
21
21
21

#
91
94
98
95
99
92
100
103
104
105
101
102
106
108
110
109
107
111
112
113
114
115
117
122
123
124
118
120
119
125
116
126
121
138
131
134
129
137
130
127
139
135
136
132
133
128
143
147

UniProt
P0A2B3
P60659
Q8ZM76
P69936
Q8ZPV9
P14846
O30911
Q7CPI5
Q8ZLQ5
Q8ZNC8
P55900
P66738
Q8ZS18
P61179
Q8ZNW0
Q7CQW0
P0A251
P65921
Q8ZN40
Q8ZQ76
Q8ZR95
Q8ZS19
P0A295
Q8ZK29
Q8ZKF6
Q8ZKP7
P0A7V6
P66692
P10370
Q8ZP02
P00898
Q8ZPS9
P67270
Q9L6M9
P66073
Q8ZLR6
P17845
Q9F5L2
P26398
P06179
Q9ZNM2
Q8ZNZ7
Q8ZPS3
Q7CQT1
Q8XFG8
P0A1G5
P26219
Q8ZL68

Name
30S ribosomal protein S7
Biosynthetic arginine decarboxylase
Glycine dehydrogenase [decarboxylating]
NADP-dependent L-serine/L-allo-threonine dehyd
Putative enzyme related to aldose 1-epimerase
Carbamoyl-phosphate synthase large chain
ATP-dependent hsl protease ATP-binding subunit
Putative outer membrane lipoprotein
Stringent starvation protein A
Putative sugar nucleotide epimerase
Phosphoserine aminotransferase
Ribosome-recycling factor
Threonine synthase
50S ribosomal protein L22
Pyruvate kinase II
Glutamine high-affinity transporter
Alkyl hydroperoxide reductase subunit C
CTP synthase
Cysteine desulfurase
Aminopeptidase N
Copper-exporting P-type ATPase A
Aspartokinase I
Transcription termination factor rho
Probable cytosol aminopeptidase
Acetyl-coenzyme A synthetase
Triosephosphate isomerase
30S ribosomal protein S3
Ribose-5-phosphate isomerase A
Histidinol dehydrogenase
Mannose-specific enzyme IID
Anthranilate synthase component 1
Threonyl-tRNA synthetase
UPF0135 protein ybgI
Putative carboxymethylenebutenolidase
50S ribosomal protein L15
Sigma cross-reacting protein 27A
Sulfite reductase [NADPH] hemoprotein beta-com
Putative serine/threonine protein kinase
Lipopolysaccharide biosynthesis protein rfbH
Flagellin
FliY
Putative IclR family transcriptional repressor
Phosphoenolpyruvate synthase
Putative cytoplasmic protein
Peptidyl-prolyl cis-trans isomerase
DnaK suppressor protein
CDP-diacylglycerol pyrophosphatase
Putative glutathione S-transferase
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# SC
21
21
21
21
21
21
20
20
20
20
20
20
20
19
19
19
19
18
18
18
18
18
17
17
17
17
17
17
17
17
17
17
17
16
16
16
16
16
16
16
16
16
16
16
16
16
15
15

#
148
145
140
146
141
142
144
158
159
154
155
151
160
161
150
156
162
152
149
163
164
157
153
171
170
169
172
174
173
175
165
166
167
176
168
189
182
181
184
186
187
190
188
177
183
178
191
179

UniProt
Q8ZLI7
Q7CPU8
P0A1N0
Q7CPZ4
P0A1W4
P0A2D1
P37426
Q8ZJV7
Q8ZJV8
P65748
Q7CP94
P0A2F6
Q8ZKL6
Q8ZLQ1
P0A2E3
Q7CPY9
Q8ZN59
P14062
P02941
Q8ZNW2
Q8ZNW4
Q7CR25
P15875
Q7CPD8
P64036
P63365
Q7CPL6
Q8ZM69
Q7CQ04
Q8ZNE6
P0A1Q0
P0A2K1
P37439
Q8ZR22
P60217
Q8ZKR6
P43019
P37419
P67904
Q7CPQ3
Q7CPU7
Q8ZML4
Q7CQ54
P0A1R2
P60317
P0A2I1
Q8ZPD4
P0A2S0

Name
Fe/S biogenesis protein nfuA
Putative periplasmic immunogenic protein
Surface presentation of antigens protein spaK
Protein grpE
GTP-binding protein lepA
Oxidoreductase ucpA
Ribonucleoside-diphosphate reductase 1 subunit
Purine nucleoside phosphorylase deoD-type
Deoxyribose-phosphate aldolase
Inorganic pyrophosphatase
Putative exoribonuclease
Single-stranded DNA-binding protein
Argininosuccinate lyase
Serine endoprotease
RNA polymerase sigma factor rpoD
Transcriptional repressor of emrAB operon
Inosine-5'-monophosphate dehydrogenase
6-phosphogluconate dehydrogenase, decarboxylat
Methyl-accepting chemotaxis protein II
Glucose-6-phosphate 1-dehydrogenase
2-keto-3-deoxygluconate 6-phosphate aldolase
Morphogene putative regulator of murein genes
2-isopropylmalate synthase
UPF0438 protein yifE
Elongation factor P
Phosphate import ATP-binding protein pstB
50S ribosomal protein L18
D-3-phosphoglycerate dehydrogenase
Putative tRNA/rRNA methyltransferase
Putative chemotaxis signal transduction protei
Alpha,alpha-trehalose-phosphate synthase [UDPTryptophan synthase beta chain
PTS system glucose-specific EIICB component
Periplasmic disulfide isomerase, thiol-disulph
5'-methylthioadenosine/S-adenosylhomocysteine
Response reguator in two-component regulatory
Superoxide dismutase [Mn]
Putative 8-amino-7-oxononanoate synthase/2-ami
30S ribosomal protein S10
Putative ABC superfamily transport protein
Putative membrane protein
Putative inner membrane protein
Putative acyltransferase
Imidazole glycerol phosphate synthase subunit
ProP effector
DNA topoisomerase 1
Putative NADP-dependent oxidoreductase
Leucine-responsive regulatory protein
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# SC
15
15
15
15
15
15
15
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
13
13
13
13
13
13
13
13
13
13
13
13
12
12
12
12
12
12
12
12
12
12
12
12
12

#
192
185
193
180
195
201
207
203
212
197
208
196
199
202
209
194
210
200
211
204
205
206
198
220
215
214
221
222
217
223
213
224
216
225
218
227
226
219
230
238
239
240
241
242
234
233
235
236

UniProt
Q8ZRB1
Q56062
Q8ZRP0
P14845
P0A2A3
P63923
Q8ZJZ8
Q7CP78
Q9F173
P0A2H9
Q8ZKX9
P0A2A5
P50335
P69066
Q8ZN71
P06185
Q8ZNF3
P58663
Q8ZNM0
Q7CQE8
Q7CQK9
Q7CQP4
P0A6B1
Q8ZJU7
P60829
P0A2I3
Q8ZL67
Q8ZL95
Q7CPN9
Q8ZM41
P0A1Y6
Q8ZNN5
Q04866
Q8ZNS0
Q7CQF9
Q9X523
Q8ZPE8
Q7CR43
P0A299
Q8ZK71
Q8ZKI5
Q8ZKM0
Q8ZKN4
Q8ZKX1
Q02755
P77980
Q7CPR8
Q7CPR9

Name
Glycoprotein/polysaccharide metabolism
Methylisocitrate lyase
Outer membrane protein assembly factor yaeT
Carbamoyl-phosphate synthase small chain
50S ribosomal protein L1
Phosphopentomutase
Isoaspartyl dipeptidase
Putative translation initiation inhibitor
DNA polymerase I
Thiol:disulfide interchange protein dsbA
Putative oxidoreductase
50S ribosomal protein L28
Protein yhjJ
Chaperone protein sicA
Dihydrodipicolinate synthase
Outer membrane protease E
UDP-4-amino-4-deoxy-L-arabinose--oxoglutarate
Capsular synthesis regulator component B
Cytidine deaminase
Putative GTP-binding protein
Putative glutaredoxin protein
Putative oxidoreductase
Acyl carrier protein
Transcriptional regulator
UPF0307 protein yjgA
DNA gyrase subunit B
Mannitol-1-phosphate 5-dehydrogenase
Glycyl-tRNA synthetase alpha subunit
Putative ABC superfamily transport protein
Putative cytoplasmic protein
NADH-quinone oxidoreductase subunit C/D
Putative ATP-binding protein
Chain length determinant protein
AMP nucleosidase
Putative cytoplasmic protein
Periplasmic dipeptidase
NAD-dependent malic enzyme
Response regulator in two-component regulatory
50S ribosomal protein L7/L12
Peptide methionine sulfoxide reductase msrA
Aspartokinase
Phosphoenolpyruvate carboxylase
Aspartokinase II
Glucosamine--fructose-6-phosphate aminotransfe
Methyl-accepting chemotaxis citrate transducer
3-dehydroquinate synthase
Putative SH3 domain protein
Bifunctional protein hldE
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# SC
12
12
12
12
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
10
10
10
10
10
10
10
10
10
10
10
10
10
10
10
9
9
9
9
9
9
9
9
9
9

#
228
243
244
245
231
246
247
248
229
249
253
250
232
252
237
251
259
256
264
271
268
257
272
266
267
273
274
255
269
270
262
263
254
260
261
275
276
265
277
278
258
279
280
281
282
286
300
301

UniProt
O68838
Q8ZN45
Q8ZN60
Q8ZND4
P16328
Q8ZNZ5
Q8ZP37
Q8ZPL8
O84944
Q8ZPT7
Q9L328
Q8ZQ14
P58696
Q935S7
Q7CQY3
Q8ZQX5
P26978
P0AA28
P65882
Q8ZKN5
Q7CPH6
P17215
Q8ZLK3
P67347
P68684
Q8ZM21
Q8ZME2
P0A2A9
Q7CQ05
Q7CQ15
P60802
P63411
O52325
P37592
P40676
Q8ZPN7
Q8ZPP1
P67341
Q8ZQL2
Q8ZQX7
P19480
Q8ZR92
Q8ZRA7
Q8ZRJ9
Q8ZRT7
P0A1R6
Q8ZJY6
Q8ZK31

Name
Glutamate--cysteine ligase
Putative sulfurtransferase
GMP synthase [glutamine-hydrolyzing]
Putative transketolase
Flagellar hook-associated protein 2
Putative GAF domain-containing protein
Nitrate reductase 1, alpha subunit
Putative periplasmic protein
Secretion system effector
Putative enzyme
Catalase
3-oxoacyl-[acyl-carrier-protein] synthase II
Asparaginyl-tRNA synthetase
Chromosome partition protein mukB
Transcriptional repressor of iron-responsive g
Glutaminyl-tRNA synthetase
Bifunctional purine biosynthesis protein purH
Thioredoxin-1
Adenylosuccinate synthetase
Cystathionine gamma-synthase
Putative rhodanese-related sulfurtransferases
Leu/Ile/Val/Thr-binding protein
Membrane protein
UPF0190 protein yedY
30S ribosomal protein S21
Putative glutathione S-transferase
(P)ppGpp synthetase I
30S ribosomal protein S16
Autonomous glycyl radical cofactor
Putative inner membrane protein
Erythronate-4-phosphate dehydrogenase
Acetate kinase
Bifunctional polymyxin resistance protein arnA
Outer membrane porin protein ompD
Transcriptional regulator slyA
N-ethylmaleimide reductase
Riboflavin synthase, alpha chain
UPF0189 protein ymdB
Putative glutathione S-transferase
Glucosamine-6-phosphate deaminase
Alkyl hydroperoxide reductase subunit F
Putative thioredoxin protein
RND family, acridine efflux pump
Homolog of sapA
Protein translocase subunit secA
DNA-binding protein HU-alpha
Putative cobalamin synthesis protein
Valyl-tRNA synthetase
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# SC
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
7
7
7

#
290
294
302
303
292
295
289
296
297
304
305
306
293
307
288
308
287
284
309
310
298
283
311
312
299
313
291
314
285
339
324
317
323
329
330
321
325
319
326
327
328
322
331
316
332
315
333
334

UniProt
P26976
Q7CPI1
Q8ZL99
Q8ZLD5
P67686
Q7CPJ6
P0A2P2
Q7CPM0
Q7CPM2
Q8ZLQ6
Q8ZLR3
Q8ZM16
Q56026
Q8ZN42
P0A2K3
Q8ZND5
P0A1Y4
P06614
Q8ZPA8
Q8ZPL7
Q7CQK7
O85139
Q8ZQF0
Q8ZQX6
Q7CQY5
Q8ZQZ2
P63223
Q8ZRT5
P0A1G7
Q9L9I6
Q56121
P0A2L1
P74861
Q8ZLK4
Q8ZLR4
P63343
Q7CPQ6
P58537
Q7CQ27
Q7CQ39
Q7CQ71
P65363
Q8ZPC4
P0A1A9
Q8ZPY6
O30916
Q8ZQC4
Q8ZR27

Name
Non-specific acid phosphatase
PTS family, mannitol-specific enzyme IIABC com
Putative periplasmic or exported protein
Putative phosphatase
Universal stress protein B
Putative ATPase involved in cell division
Tryptophanyl-tRNA synthetase
Acetyl CoA carboxylase
Putative oxidoreductase
N-acetylneuraminate lyase
Glutamate synthase, small subunit
Hydrogenase-2, large subunit
Cell invasion protein sipD
Chaperone protein hscA
Glutamyl-tRNA synthetase
Putative transketolase
NADH-quinone oxidoreductase subunit G
HTH-type transcriptional regulator cysB
Alcohol dehydrogenase class III
Fumarate hydratase class II
Tyrosyl-tRNA synthetase
3-oxoacyl-[acyl-carrier-protein] synthase 3
Pyruvate dehydrogenase/oxidase FAD and thiamin
Sugar Specific PTS family, n-acetylglucosamine
Putative phosphatase in N-acetylglucosamine me
Putative cytoplasmic protein
Phosphoheptose isomerase
GMP reductase
Chaperone protein dnaJ
Regulator of sigma D
Peptide chain release factor 3
UPF0047 protein yjbQ
Aromatic-amino-acid aminotransferase
D-ribulose-5-phosphate 3-epimerase
Glutamate synthase, large subunit
Cell division protease ftsH
Putative periplasmic protein
Inositol-1-monophosphatase
Putative iron-dependent peroxidase
Putative aspartate-semialdehyde dehydrogenase
50S ribosomal protein L25
Cell division topological specificity factor
Putative outer membrane lipoprotein
Exodeoxyribonuclease III
Putative molecular chaperone
Inositol phosphate phosphatase sopB
Cytidylate kinase
Putative glycerol dehydrogenase
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# SC
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6

#
320
335
336
337
338
318
380
363
364
354
348
356
365
359
341
366
367
345
368
369
353
349
370
381
358
350
340
347
371
352
357
360
361
372
373
342
355
362
374
375
376
351
343
346
377
378
344
379

UniProt
P58688
Q8ZR86
Q8ZRA6
Q8ZRB2
Q8ZRB8
P37412
Q9L6L5
Q8ZJY1
Q8ZK42
P66593
P36936
P67651
Q8ZL52
Q7CPJ3
P05415
Q8ZLJ1
Q8ZLJ4
P0A7X0
Q8ZLN3
Q8ZLP6
P66431
P58580
Q8ZMD2
Q9XCS1
P74881
P58671
O52765
P33901
Q8ZNM5
P63905
P74871
Q7CQG1
Q7CQG2
Q8ZP85
Q8ZPD7
P06204
P67563
Q8XG72
Q8ZQQ4
Q8ZR26
Q8ZRC1
P63603
P0A277
P32200
Q8ZRS0
Q8ZRU8
P0A2B1
Q93GL9

Name
Bifunctional protein folD
HTH-type transcriptional repressor allR
Acridine efflux pump
Acyl-CoA thioesterase II
Peptidyl prolyl isomerase
3-isopropylmalate dehydrogenase
Fatty acid oxidation complex subunit alpha
Putative PTS permease
Putative periplasmic protein
30S ribosomal protein S6
Peptidase E
Regulator of ribonuclease activity A
L-threonine 3-dehydrogenase
Putative inner membrane lipoprotein
Glucose-1-phosphate adenylyltransferase
Putative RNase R
33 kDa chaperonin
30S ribosomal protein S8
Putative ferripyochelin binding protein
Putative outer membrane protein
30S ribosomal protein S15
Glutathione synthetase
Putative nucleotide binding
Fur regulated Salmonella iron transporter
Phosphoribosylformylglycinamidine synthase
4-hydroxy-3-methylbut-2-en-1-yl diphosphate sy
Histidyl-tRNA synthetase
NADH-quinone oxidoreductase subunit F
Putative oxidoreductase
Deoxycytidine triphosphate deaminase
Arginyl-tRNA synthetase
Putative translation factor
Putative oxoacyl-(Acyl carrier protein) reduct
Putative Smr domain protein
Putative cytoplasmic protein
Dihydroorotase
Seryl-tRNA synthetase
Arginine transport system
UvrABC system protein B
Putative aminotransferase
Putative lipoprotein
Shikimate kinase 2
Xanthine phosphoribosyltransferase
Acyl-[acyl-carrier-protein]--UDP-N-acetylgluco
Carbonic anhydrase
S-adenosyl-L-methionine-dependent methyltransf
30S ribosomal protein S20
Conjugative transfer: surface exclusion
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# SC
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5

#
391
403
404
405
397
406
407
408
394
398
409
399
385
392
382
383
410
387
411
400
388
396
384
412
413
414
386
393
415
416
390
425
417
418
419
420
395
421
389
401
422
402
423
424
440
430
434
435

UniProt
P40810
Q8ZJX0
Q8ZK11
Q8ZK78
Q7CP96
Q8ZKB1
Q8ZKE2
Q8ZKH9
P66008
Q7CPC8
Q8ZL36
Q7CPK0
P0A1F8
P60428
O54296
P0A1B3
Q8ZLQ2
P0AA13
Q8ZLR0
Q7CPQ5
P17853
Q56019
P0A1B5
Q8ZMW8
Q8ZMX7
Q8ZN19
P0A9Z4
P65889
Q8ZN82
Q8ZNC2
P37604
Q9RM66
Q8ZP20
Q8ZP34
Q8ZP42
Q8ZPF0
P67197
Q8ZQR7
P22715
Q7CQX4
Q8ZRD1
Q7CR87
Q93GQ7
Q93GS8
Q8ZK91
P51066
P67912
Q7CPP7

Name
Dihydroxy-acid dehydratase
Putative cytoplasmic protein
Putative ATPase involved in DNA repair
Putative cell envelope opacity-associated prot
Component of modulator for protease specific f
Phosphatidylserine decarboxylase proenzyme
Fumarase B
Glycerol-3-phosphate acyltransferase
Soluble pyridine nucleotide transhydrogenase
Putative enzyme
Putative inner membrane protein
sn-glycerol-3-phosphate-binding periplasmic pr
Aspartate-semialdehyde dehydrogenase
50S ribosomal protein L2
30S ribosomal protein S11
Arginine repressor
Putative periplasmic protein
50S ribosomal protein L13
Putative cytosine deaminase
Putative intracellular proteinase
Phosphoadenosine phosphosulfate reductase
Cell invasion protein sipB
Phospho-2-dehydro-3-deoxyheptonate aldolase, T
Putative lipoprotein
ATP-dependent RNA helicase
Pyridoxine 5'-phosphate synthase
Nitrogen regulatory protein P-II 1
Phosphoribosylaminoimidazole-succinocarboxamid
Transketolase 2 isozyme
Amidophosphoribosyltransferase
D-alanyl-D-alanine carboxypeptidase dacD
Universal stress protein C
Periplasmic trehalase
Response regulator in two-component regulatory
Formyltetrahydrofolate hydrolase
Putative alpha amylase
Putative phosphotransferase ydiA
Molybdate transporter
UDP-glucose 4-epimerase
2-oxoglutarate dehydrogenase
1-deoxy-D-xylulose-5-phosphate synthase
Chaperone surA
Plasmid partition protein B
DNA replication
Putative hydrolase of the alpha/beta superfami
Isocitrate lyase
ADP-L-glycero-D-manno-heptose-6-epimerase
50S ribosomal protein L21
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# SC
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3

#
436
441
437
426
431
442
427
432
429
443
438
444
445
449
446
439
433
447
428
448
450
461
462
454
453
457
465
466
472
467
463
458
451
460
455
452
456
459
468
469
470
471
464

UniProt
Q7CPS3
Q8ZM45
Q7CPZ7
P0A1W2
P63423
Q8ZN89
P0A1Y8
P64209
P26397
Q8ZP18
Q7CQF3
Q8ZP75
Q8ZPF1
Q9Z5Z2
Q8ZQY0
Q7CQY7
P65792
Q8ZRM7
P21267
Q8ZRW0
P0A2Q4
Q7CP84
Q7CP91
P37413
P17750
P41789
Q8ZKV4
Q8ZL61
Q93IN1
Q8ZLD4
Q7CPJ7
P65510
P0A7S6
Q56020
P37431
P10372
P37600
Q06399
Q8ZPC0
Q8ZPU3
Q8ZR02
Q8ZR16
Q7CR52

Name
Putative cytoplasmic protein
Nucleoside-triphosphatase rdgB
4.5S-RNP protein
Signal peptidase I
Acetyltransferase ypeA
DNA ligase
NADH-quinone oxidoreductase subunit E
GTP cyclohydrolase 1
CDP-glucose 4,6-dehydratase
Putative resistance protein MccF
Thymidine kinase
Putative cytoplasmic protein
Putative glycosyl hydrolase
Oxygen-insensitive NADPH nitroreductase
Asparagine synthetase B
Putative phosphate starvation-inducible protei
Glutamate 5-kinase
2,5-diketo-D-gluconic acid reductase B
Glutamate-1-semialdehyde 2,1-aminomutase
LPS-assembly protein lptD
HTH-type transcriptional regulator metR
Putative peptide maturation protein
Peptidyl-prolyl cis-trans isomerase
Homoserine O-succinyltransferase
Catalase-peroxidase
Nitrogen regulation protein NR(I)
Protein for a late step of protoheme IX synthe
L-lactate dehydrogenase [cytochrome]
Cyclic di-GMP-binding protein
Glutathione oxidoreductase
RNA polymerase sigma factor
Glutathione-regulated potassium-efflux system
30S ribosomal protein S12
Cell invasion protein sipC
3-demethylubiquinone-9 3-methyltransferase
1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino
Thiosulfate reductase
Uncharacterized lipoprotein yedD
Acetyl transferase
PTS family sugar specific enzyme III for cello
D-alanyl-D-alanine carboxypeptidase, penicilli
RNase I
Sigma factor-binding protein crl
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# SC
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2

Table 5 Identified S. typhimurium proteins in the Triton X-100 supernatant fraction upon
in-gel digestion.
UniProt	
  
P0A1H5
Q56073
P58480
Q7CQ01
P0A1H3
P64052
P0A249
P0A1P0
O30911
P64076
P0A1D5
Q7CPK0
Q7CR42
Q7CQ36
Q8ZS18
P65702
P26976
P14062
Q8ZPZ0
Q8ZP49
Q8ZL96
P0A7Z7
Q8ZRU0
Q8ZRS8
Q7CPE1
P14146
P0A2C9
Q8ZM63
Q7CR87
Q7CQ11
P77983
P66738
P65977
P40732
P0A1E3
Q9F2E0
Q8ZNV2
Q7CPU6
P66764
P64281
P25077
P0A2E1
Q7CPE2
P37430

Name	
  
Elongation factor Tu
Chaperone protein dnaK
Chaperone protein htpG
Chaperone protein clpB
Elongation factor G
Elongation factor Ts
Phosphoenolpyruvate-protein phosphotransferase
Glyceraldehyde-3-phosphate dehydrogenase
ATP-dependent hsl protease ATP-binding subunit
Enolase
10 kDa chaperonin
sn-glycerol-3-phosphate-binding periplasmic pr
Putative thiol-alkyl hydroperoxide reductase
3-oxoacyl-[acyl-carrier-protein] synthase I
Threonine synthase
Phosphoglycerate kinase
Non-specific acid phosphatase
6-phosphogluconate dehydrogenase, decarboxylat
Isocitrate dehydrogenase [NADP]
UPF0259 membrane protein yciC
Glycyl-tRNA synthetase beta subunit
DNA-directed RNA polymerase subunit alpha
Cell division protein ftsZ
Aconitate hydratase 2
ATP synthase subunit alpha
Virulence transcriptional regulatory protein p
3-oxoacyl-[acyl-carrier-protein] reductase
Transketolase 1 isozyme
Chaperone surA
NifU homolog
Pyruvate kinase I
Ribosome-recycling factor
Protein recA
Acetylornithine/succinyldiaminopimelate aminot
Cysteine synthase A
GTP-binding elongation factor family protein
Aspartyl-tRNA synthetase
Fructose-bisphosphate aldolase
S-adenosylmethionine synthetase
Transcription elongation factor greA
Malate dehydrogenase
Serine hydroxymethyltransferase
ATP synthase subunit beta
Transcription elongation protein nusA
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# SC	
  
66
64
34
33
15
14
14
13
13
12
12
11
9
9
8
8
8
8
7
7
7
7
6
6
6
6
6
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
3
3

UniProt	
  
P0A7W4
P0A7K0
O85140
Q9L6N1
Q8ZQT5
Q8ZQS4
Q8ZPG8
Q7CQ22
P65692
P14846
P0A9X6

Name	
  
30S ribosomal protein S5
50S ribosomal protein L11
Malonyl CoA-acyl carrier protein transacylase
5-methyltetrahydropteroyltriglutamate--homocys
Protein tolB
Putative ABC transport protein
Putative hydrolase
Putative PerM family permease
6-phosphofructokinase
Carbamoyl-phosphate synthase large chain
Rod shape-determining protein mreB
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# SC	
  
3
3
3
2
2
2
2
2
2
2
2

Table 6 Identified S. typhimurium proteins in the Triton X-100 pellet fraction upon in-gel
digestion.
UniProt
Q56073
Q7CQ01
P06173
P0A2R4
P0A1H3
P0A1H5
P58480
Q8ZRT1
Q8ZRT2
Q8ZQT9
P0A1P0
P64076
Q8ZNN4
P0A1S2
P63343
Q7DAP2
P0A7W4
P02936
Q8ZP45
P64052
Q7CQT9
P0A1D5
P0A7K0
P14846
P0A7V6
Q8ZLT3
P0A1S4
P0A2A3
Q8ZND6
P0A7Z7
Q7CQU1
Q8ZRB9
O30911
P40732
P60446
P66541
P66593
Q9L6N1
P26976
P65702
Q7CR42
Q7CPE2
Q8ZL96
Q8ZRS8
P37411

Name
Chaperone protein dnaK
Chaperone protein clpB
DNA-directed RNA polymerase subunit beta
DNA-directed RNA polymerase subunit beta'
Elongation factor G
Elongation factor Tu
Chaperone protein htpG
Pyruvate dehydrogenase
Pyruvate dehydrogenase, decarboxylase componen
Cytochrome d terminal oxidase, polypeptide sub
Glyceraldehyde-3-phosphate dehydrogenase
Enolase
Methionyl-tRNA synthetase
DNA-binding protein H-NS
Cell division protease ftsH
Putative carbonic anhydrase
30S ribosomal protein S5
Outer membrane protein A
Iron-dependent alcohol dehydrogenase of the mu
Elongation factor Ts
30S ribosomal subunit protein S1
10 kDa chaperonin
50S ribosomal protein L11
Carbamoyl-phosphate synthase large chain
30S ribosomal protein S3
Polyribonucleotide nucleotidyltransferase
DNA-binding protein stpA
50S ribosomal protein L1
Phosphotransacetylase
DNA-directed RNA polymerase subunit alpha
Pyruvate formate lyase I, induced anaerobicall
ATP-dependent protease La
ATP-dependent hsl protease ATP-binding subunit
Acetylornithine/succinyldiaminopimelate aminot
50S ribosomal protein L3
30S ribosomal protein S2
30S ribosomal protein S6
5-methyltetrahydropteroyltriglutamate--homocys
Non-specific acid phosphatase
Phosphoglycerate kinase
Putative thiol-alkyl hydroperoxide reductase
ATP synthase subunit beta
Glycyl-tRNA synthetase beta subunit
Aconitate hydratase 2
DNA gyrase subunit A
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#SC
143
107
91
83
76
73
65
57
39
37
34
32
31
27
27
27
26
25
25
23
23
22
22
21
19
19
18
18
18
17
17
17
16
16
16
16
16
16
15
15
14
13
13
13
12

Q7CPK0
Q7CPL7
Q7CQ36
Q9ZF31
P0AA13
P14146
Q8ZNV2
Q8ZP03
P0A1G7
P26219
P60726
P65977
Q8ZK80
Q8ZM76
P0A297
P0A2B3
P26353
P62405
Q7CQV9
Q8ZM63
Q8ZQE3
P0A1E3
P0A9X6
P15111
P22036
Q7CPE4
Q7CR87
Q9F2E0
Q9ZFV8
P0A1X0
P0A295
P37586
P60428
Q7CP96
Q8ZK31
Q8ZQ17
Q8ZRT7
Q8ZRZ0
P0A251
P15434
P25077
P65882
P66313
P74881
Q8ZKA4
Q8ZPZ0
Q8ZQZ6
Q8ZRB8
Q8ZRC0

sn-glycerol-3-phosphate-binding periplasmic pr
50S ribosomal protein L17
3-oxoacyl-[acyl-carrier-protein] synthase I
Translation initiation factor IF-2
50S ribosomal protein L13
Virulence transcriptional regulatory protein p
Aspartyl-tRNA synthetase
Mannose-specific enzyme IIAB
Chaperone protein dnaJ
CDP-diacylglycerol pyrophosphatase
50S ribosomal protein L4
Protein recA
50S ribosomal protein L9
Glycine dehydrogenase [decarboxylating]
50S ribosomal protein L10
30S ribosomal protein S7
Flavohemoprotein
50S ribosomal protein L5
DNA protection during starvation protein
Transketolase 1 isozyme
ATP-binding subunit of serine protease
Cysteine synthase A
Rod shape-determining protein mreB
NADP-specific glutamate dehydrogenase
Magnesium-transporting ATPase, P-type 1
ATP synthase subunit b
Chaperone surA
GTP-binding elongation factor family protein
NADP-dependent malic enzyme
Outer membrane lipoprotein slyB
Transcription termination factor rho
Methionine synthase
50S ribosomal protein L2
Component of modulator for protease specific f
Valyl-tRNA synthetase
RNase E
Protein translocase subunit secA
Isoleucyl-tRNA synthetase
Alkyl hydroperoxide reductase subunit C
Phenylalanyl-tRNA synthetase beta chain
Malate dehydrogenase
Adenylosuccinate synthetase
50S ribosomal protein L6
Phosphoribosylformylglycinamidine synthase
Component of modulator for protease specific f
Isocitrate dehydrogenase [NADP]
Leucyl-tRNA synthetase
Peptidyl prolyl isomerase
ATP-dependent Clp protease ATP-binding subunit
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12
12
12
12
11
11
11
11
10
10
10
10
10
10
9
9
9
9
9
9
9
8
8
8
8
8
8
8
8
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6

O54297
P0A2C9
P0A2E3
P65692
P66932
Q8ZKM0
Q8ZLM1
Q8ZN40
Q8ZRP0
Q935S7
Q93DX3
P0A1Y6
P16657
P63923
Q7CPE1
Q7CQU5
Q7CQV8
Q7CQW9
Q8ZLK3
Q8ZM69
Q8ZPG8
Q9F173
Q9XCS1
O84944
P0A2E1
P0AA19
P65215
P66764
Q8ZKN4
Q8ZLJ1
Q8ZLT4
Q8ZMM7
Q8ZPS3
Q8ZQ40
Q8ZR37
Q8ZRT0
Q8ZS19
Q93DX1
P0A1V6
P0A2F6
Q7CPL4
Q7CPL6
Q7CQ11
Q7CQY7
Q8ZLT0
Q8ZRB4
Q93GL9

30S ribosomal protein S4
3-oxoacyl-[acyl-carrier-protein] reductase
RNA polymerase sigma factor rpoD
6-phosphofructokinase
Trigger factor
Phosphoenolpyruvate carboxylase
30S ribosomal protein S13
Cysteine desulfurase
Outer membrane protein assembly factor yaeT
Chromosome partition protein mukB
Putative LysR family transcriptional regulator
NADH-quinone oxidoreductase subunit C/D
Enoyl-[acyl-carrier-protein] reductase [NADH]
Phosphopentomutase
ATP synthase subunit alpha
Thioredoxin reductase
Outer membrane protease, receptor for phage OX
Tol protein required for outer membrane integr
Membrane protein
D-3-phosphoglycerate dehydrogenase
Putative hydrolase
DNA polymerase I
Fur regulated Salmonella iron transporter
Secretion system effector
Serine hydroxymethyltransferase
Transcriptional regulatory protein ompR
2-dehydro-3-deoxyphosphooctonate aldolase
S-adenosylmethionine synthetase
Aspartokinase II
Putative RNase R
Cysteine sulfinate desulfinase
VirK-like protein
Phosphoenolpyruvate synthase
Flavoprotein wrbA
Enterobactin synthetase, component F
Dihydrolipoyl dehydrogenase
Aspartokinase I
Putative acetyl-CoA hydrolase
Ribose-phosphate pyrophosphokinase
Single-stranded DNA-binding protein
50S ribosomal protein L16
50S ribosomal protein L18
NifU homolog
Putative phosphate starvation-inducible protei
Argininosuccinate synthase
Putative ABC superfamily
Conjugative transfer: surface exclusion
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5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
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Chemical characterization data

9.3.1 Diethyl 2-acetamido-2-(hex-5-yn-1-yl)malonate

9.3

188

189

9.3.2 2-acetamidooct-7-ynoic acid

190

9.3.3 2-amino-7-octynoic acid (AOA)

191

192

9.3.4 (S)-2-((tert-butoxycarbonyl)amino)-4-(prop-2-yn-1-yloxy)butanoic acid

193

9.3.5 (S)-2-amino-4-(prop-2-yn-1-yloxy)butanoic acid (PHS)

194

195

9.3.6 (S)-methyl 2-((tert-butoxycarbonyl)amino)-4-(prop-2-yn-1-ylthio)butanoate

196

197

9.3.7 (S)-2-((tert-butoxycarbonyl)amino)-4-(prop-2-yn-1-ylthio)butanoic acid

198

199

9.3.8 (S)-2-amino-4-(prop-2-yn-1-ylthio)butanoic acid (EME)

200

201

9.3.9 (R)-2-acetamido-3-(but-3-yn-1-ylthio)propanoic acid

202

203

9.3.10 (R)-2-amino-3-(but-3-yn-1-ylthio)propanoic acid (BCY)

204

205

9.3.11 (R)-2-acetamido-3-(prop-2-yn-1-ylthio)propanoic acid

206

207

9.3.12 (R)-2-amino-3-(prop-2-yn-1-ylthio)propanoic acid (PCY)

208

209

9.3.13 N6-propargyl-adenosine-5’-triphosphate

210

211

at 260 nm.

triethylammonium bicarbonate (pH 7.4, acetic acid, 2% acetonitrile) and 100% acetonitrile and the absorbance was measured

Analytical HPLC trace for N6-propargyl-adenosine-5’-triphosphate. Product was eluted with a linear gradient, using 20 mM
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